{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "code",
      "source": [
        "!pip install pdf2image"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "FYQ0ghIJ_l3o",
        "outputId": "484e6fb2-0a84-41bb-86b8-9a31bb0a2ea7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: pdf2image in /usr/local/lib/python3.10/dist-packages (1.17.0)\n",
            "Requirement already satisfied: pillow in /usr/local/lib/python3.10/dist-packages (from pdf2image) (9.4.0)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install pytesseract"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "zxEoYnyi__KV",
        "outputId": "9588923a-74e4-4a37-a6a4-2bfc05d4bbd0"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: pytesseract in /usr/local/lib/python3.10/dist-packages (0.3.10)\n",
            "Requirement already satisfied: packaging>=21.3 in /usr/local/lib/python3.10/dist-packages (from pytesseract) (23.2)\n",
            "Requirement already satisfied: Pillow>=8.0.0 in /usr/local/lib/python3.10/dist-packages (from pytesseract) (9.4.0)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Install Tesseract OCR\n",
        "!sudo apt install tesseract-ocr\n",
        "# Install pytesseract\n",
        "!sudo apt-get install poppler-utils\n",
        "!pip install pytesseract pdf2image neo4j"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "zC-SfG6Ixh-t",
        "outputId": "4d837541-3d30-486d-eccf-e3a385e0e665"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Reading package lists... Done\n",
            "Building dependency tree... Done\n",
            "Reading state information... Done\n",
            "tesseract-ocr is already the newest version (4.1.1-2.1build1).\n",
            "0 upgraded, 0 newly installed, 0 to remove and 33 not upgraded.\n",
            "Reading package lists... Done\n",
            "Building dependency tree... Done\n",
            "Reading state information... Done\n",
            "poppler-utils is already the newest version (22.02.0-2ubuntu0.3).\n",
            "0 upgraded, 0 newly installed, 0 to remove and 33 not upgraded.\n",
            "Requirement already satisfied: pytesseract in /usr/local/lib/python3.10/dist-packages (0.3.10)\n",
            "Requirement already satisfied: pdf2image in /usr/local/lib/python3.10/dist-packages (1.17.0)\n",
            "Requirement already satisfied: neo4j in /usr/local/lib/python3.10/dist-packages (5.17.0)\n",
            "Requirement already satisfied: packaging>=21.3 in /usr/local/lib/python3.10/dist-packages (from pytesseract) (23.2)\n",
            "Requirement already satisfied: Pillow>=8.0.0 in /usr/local/lib/python3.10/dist-packages (from pytesseract) (9.4.0)\n",
            "Requirement already satisfied: pytz in /usr/local/lib/python3.10/dist-packages (from neo4j) (2023.4)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pdf2image\n",
        "import pytesseract\n",
        "\n",
        "# pdf_path is the path to your locally imported PDF file in Google Colab\n",
        "pdf_path = \"Maternal_Immune_Dysregulation_and_Autism-Understan.pdf\"\n",
        "\n",
        "# Convert the PDF file into a list of PIL Image objects\n",
        "doc = pdf2image.convert_from_path(pdf_path)\n",
        "\n",
        "# Get the article text\n",
        "article = []\n",
        "for page_number, page_image in enumerate(doc):\n",
        "    # Convert the image to RGB mode\n",
        "    page_image = page_image.convert(\"RGB\")\n",
        "\n",
        "    # Perform OCR on the page image and extract text\n",
        "    page_text = pytesseract.image_to_string(page_image).encode(\"utf-8\")\n",
        "\n",
        "    # Append the extracted text to the article list\n",
        "    if page_number < 6:  # Only append text from the first 6 pages\n",
        "        article.append(page_text.decode(\"utf-8\"))\n",
        "\n",
        "# Join the texts of the first 6 pages into a single string\n",
        "article_txt = \" \".join(article)\n"
      ],
      "metadata": {
        "id": "bLyzzyjTq3Rl"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "article_txt"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 122
        },
        "id": "cAzbDBwuuL6b",
        "outputId": "f17c4525-0b28-4db1-835f-5b9f433eea9a"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "\"e frontiers | Frontiers in Psychiatry\\n\\nMINI REVIEW\\npublished: 02 June 2022\\ndoi: 10.3389/fpsyt.2022.834910\\n\\n \\n\\nOPEN ACCESS\\n\\nEdited by:\\nDavid Quentin Beversdorf,\\nUniversity of Missouri, United States\\n\\nReviewed by:\\n\\nStefano Sotgiu,\\n\\nUniversity of Sassari, Italy\\nAntonio M. Persico,\\n\\nUniversity of Modena and Reggio\\nEmilia, Italy\\n\\n*Correspondence:\\nJudy Van de Water\\nJjavandewater@ucdavis.edu\\n\\nSpecialty section:\\n\\nThis article was submitted to\\nAutism,\\n\\na section of the journal\\nFrontiers in Psychiatry\\n\\nReceived: 14 December 2021\\nAccepted: 20 April 2022\\nPublished: 02 June 2022\\n\\nCitation:\\n\\nMcLellan J, Kim DHJ, Bruce M,\\nRamirez-Celis A and Van de Water J\\n(2022) Maternal Immune\\nDysregulation and\\nAutism—Understanding the Role of\\nCytokines, Chemokines and\\nAutoantibodies.\\n\\nFront. Psychiatry 13:834910.\\n\\ndoi: 10.3389/fpsyt.2022.834910\\n\\nCheck for\\nupdates\\n\\nMaternal Immune Dysregulation and\\nAutism-Understanding the Role of\\nCytokines, Chemokines and\\nAutoantibodies\\n\\nJanna McLellan', Danielle H. J. Kim', Matthew Bruce’, Alexandra Ramirez-Celis' and\\nJudy Van de Water ':?*\\n\\n' Division of Rheumatology, Department of Internal Medicine, Allergy, and Clinical Immunology, University of California, Davis,\\nDavis, CA, United States, ? MIND Institute, University of California, Davis, Davis, CA, United States\\n\\nAutism spectrum disorder (ASD) is acknowledged as a highly heterogeneous,\\nbehaviorally defined neurodevelopmental disorder with multiple etiologies. In addition\\nto its high heritability, we have come to recognize a role for maternal immune system\\ndysregulation as a prominent risk factor for the development of ASD in the child.\\nExamples of these risk factors include altered cytokine/chemokine activity and the\\npresence of autoantibodies in mothers that are reactive to proteins in the developing\\nbrain. In addition to large clinical studies, the development of pre-clinical models enables\\nthe ability to evaluate the cellular and molecular underpinnings of immune-related\\npathology. For example, the novel animal models of maternal autoantibody-related (MAR)\\nASD described herein will serve as a preclinical platform for the future testing of targeted\\ntherapeutics for one ‘type’ of ASD. Identification of the cellular targets will advance\\nprecision medicine efforts toward tailored therapeutics and prevention. This minireview\\nhighlights emerging evidence for the role of maternal immune dysregulation as a potential\\nbiomarker, as well as a pathologically relevant mechanism for the development of ASD\\nin offspring. Further, we will discuss the current limitations of these models as well as\\npotential avenues for future research.\\n\\nKeywords: autoantibodies - blood, cytokines, chemokines, neurodevelopment, inflammation, gestational\\ninflammation\\n\\nINTRODUCTION\\n\\nAutism spectrum disorder (ASD) is acknowledged as a highly heterogeneous, behaviorally defined\\nneurodevelopmental disorder with multiple etiologies. In addition to its high heritability, we\\nhave come to recognize a role for maternal immune system dysregulation as a prominent risk\\nfactor for the development of ASD in the child. Examples of these risk factors include altered\\ncytokine/chemokine activity and the presence of autoantibodies in mothers that are reactive\\nto proteins in the developing brain. In addition to large clinical studies, the development of\\npre-clinical models enables the ability to evaluate the cellular and molecular underpinnings of\\nimmune-related pathology. For example, the novel animal models of maternal autoantibody-\\nrelated (MAR) ASD described herein will serve as a preclinical platform for the future testing\\nof targeted therapeutics for one ‘type’ of ASD. Identification of the cellular targets will advance\\n\\n \\n\\nFrontiers in Psychiatry | www.frontiersin.org\\n\\n1 June 2022 | Volume 13 | Article 834910\\n\\x0c McLellan et al.\\n\\nMaternal Risk Factors in ASD\\n\\n \\n\\nprecision medicine efforts toward tailored therapeutics and\\nprevention. This minireview highlights emerging evidence for\\nthe role of maternal immune dysregulation as a potential\\nbiomarker, as well as a pathologically relevant mechanism for the\\ndevelopment of ASD in offspring. Further, we will discuss the\\ncurrent limitations of these models as well as potential avenues\\nfor future research.\\n\\nTHE ROLE OF THE MATERNAL IMMUNE\\nSYSTEM IN THE DEVELOPMENT OF ASD\\n\\nIn the past two decades, an increasingly large number of studies\\nhave provided evidence that maternal immune dysregulation\\ncan impact offspring neurodevelopment (1-11). For example,\\nit is now well-understood that the maternal immune system\\nplays a critical role in the healthy development of the fetus. In\\nfact, maternal immunoglobulin G (IgG) can cross the placenta\\nand enter the fetal compartment, thereby providing early\\nimmunological protection to the infant during the perinatal stage\\n(12, 13). However, this protective mechanism is not selective and\\nharmful antibodies reactive to “self” proteins can also cross the\\nplacenta (14). Once within the fetal compartment, these maternal\\nautoantibodies may bind to their protein targets, potentially\\nimpacting protein function. This is especially dangerous during\\nthe perinatal period given the permissiveness of the blood-\\nbrain barrier (BBB) and vulnerability of the developing central\\nnervous system (CNS) (15). In addition to the production of\\nautoantibodies, other perturbations of the maternal immune\\nsystem can result in harmful effects on the developing fetus. It has\\nbeen shown that alterations in the maternal cytokine/chemokine\\nprofile can result in changes in the inflammatory state, skewed\\ncellular signaling, and altered neurodevelopment (16, 17).\\n\\nCYTOKINES AND CHEMOKINES AS\\nPOTENTIAL BIOMARKERS\\n\\nIn recent years, several researchers have reported on specific\\ncytokines and/or chemokines that are associated with ASD\\nrisk both in children with ASD and mothers that have\\nildren diagnosed with ASD. Interestingly, several cytokines\\nnd chemokines are constitutively expressed throughout the\\ndeveloping CNS (18, 19). Cytokines in the brain perform\\nfunctions similar to those seen in the periphery, acting as\\ncues in cell development and differentiation, and regulating\\nthe types and number of neuronal and non-neuronal cells\\n(20, 21). Together, these complex processes contribute to early\\nneurodevelopment and homeostasis. In the context of maternal-\\nfetal interaction, some cytokines, in particular IL-6, can be\\ntransported from the mother to the offspring and access\\ne developing CNS (17). Although the source of abnormal\\ncytokine levels in mothers during gestation may differ, this could\\nalter placental production and overall levels of cytokines and\\nchemokines in the fetal compartment, impacting the cascade\\nof neurodevelopment.\\n\\nTo date, a variety of clinical studies have demonstrated\\ntered cytokine levels in mothers and neonatal blood samples\\n\\nCc\\nal\\n\\nc\\n\\n \\n\\n2\\n\\nthat are strongly associated with ASD (Table 1), increasing\\nthe potential for cytokines/chemokines to serve as biomarkers\\nfor risk of abnormal neurodevelopment. Most of the reported\\ncytokines associated with ASD induce the BBB to become\\nmore permissive (22) increasing the vulnerability and altering\\nthe homeostatic levels of cytokines in the developing CNS.\\nNumerous researchers have corroborated the concept that\\nsignificant changes in maternal cytokine/chemokine homeostasis\\nare correlated with ASD development even in the absence of\\nmaternal/fetal infection. Such changes in maternal cytokines\\nand chemokines can not only directly impact the fetus but\\ncan also stimulate placental production of pro-inflammatory\\ncytokines within the fetal compartment (17, 23, 24). For example,\\ndysregulation of serum and/or amniotic fluid IL-4, IL-6, and IL-\\n8 have been described in mothers of children with ASD and\\nwere associated with altered behavioral outcomes including non-\\nverbal cognitive ability and stereotypical behaviors in children\\n(25-28). The cytokine IL-17, which has been implicated in\\nseveral neurodevelopmental disorders, including ASD, has been\\nshown to promote inflammation and disrupt the BBB postnatally\\n(29, 30). In addition, IFN-y, which is involved in neuronal\\ndifferentiation and synaptic formation, was shown to be higher\\nin mothers of children with ASD during the second trimester\\n(25, 28), potentially suggesting disrupted synaptic connectivity.\\n\\nStudies have also observed altered cytokine and chemokine\\nlevels in neonates who are later diagnosed with autism. For\\nexample, researchers found that newborns later diagnosed\\nwith ASD have higher peripheral levels of IL-16, which is\\nexpressed throughout the CNS particularly during the early\\nneurodevelopmental period (16, 21). In our recent findings,\\nCCL27, also known as CTACK, was significantly lower in\\nnewborns later diagnosed with ASD. This decrease was\\nassociated with an increase in the risk of both ASD with and\\nwithout intellectual disability when compared to newborns with\\ndevelopmental delay or those with typical development (31).\\nElevated levels of monocyte chemoattractant protein-1 (MCP-\\n1) and macrophage-derived chemokine (MDC) were found in\\nthe amniotic fluid, plasma, cerebellum, and cerebrospinal fluid\\nof children with ASD (10, 32, 33), implying involvement of\\nthese chemokines in neurodevelopment. Increased levels of the\\nchemokines macrophage inflammatory protein-1 (MIP-1) and\\neotaxin are also often noted in children with ASD, and have been\\nassociated with behavioral deficits (10, 34-36).\\n\\nIt is unlikely that one specific cytokine or chemokine plays\\na role in the development of ASD, but rather a combination\\nof cytokines/chemokines are more likely to contribute to the\\nneuropathology associated with autism. The exact consequences\\nof altered cytokine/chemokine levels during pregnancy that\\nlead to the ASD phenotype is an important area of research.\\nFurthermore, the trigger(s) for changes in maternal cytokine\\nand chemokine levels, and how other aspects of the maternal\\nimmune system may also be affected are essential questions to\\naddress. Although the number of research studies that include\\ntime-specific/longitudinal examination as well as mother-infant\\npair-matched studies are lacking, it is promising that similar\\ngroups of cytokines and chemokines are frequently shown to be\\naltered in both children with ASD and their mothers, increasing\\n\\n \\n\\nFrontiers in Psychiatry | www.frontiersin.org\\n\\nJune 2022 | Volume 13 | Article 834910\\n\\x0c McLellan et al.\\n\\nMaternal Risk Factors in ASD\\n\\n \\n\\nTABLE 1 | Maternal cytokines/chemokines and maternal autoantibody targets implicated in ASD.\\n\\n \\n\\n \\n\\nCytokines/chemokines Sample source Reference\\nIL-1, IL-4, IL-5, IL-8, IL-7A, IFN-y Maternal serum collected mid-gestation (25, 26, 28)\\nIL-4, IL-10MCP-1TNF-a, TNF-B Amniotic fluid (27, 32)\\nTarget antigen Protein function\\n\\nCRMP1, CRMP2, STIP1, YBOX Microtubule dynamics, protein chaperone, transcription factor (12-14, 42-44)\\nLDH-A, LDH-B, GDA, NSE Metabolic enzymes (14-16, 37-41)\\nCASPR2 Cell adhesion (45, 52)\\n\\n \\n\\nthe promise of cytokines and chemokines as biomarkers for risk\\nof altered neurodevelopment.\\n\\nMATERNAL AUTOANTIBODY TARGETS IN\\nFETAL BRAIN\\n\\nSeveral groups have now identified multiple brain antigens\\nthat cross-react with maternal IgG and are related to\\nneurodevelopmental impairments in the child, including\\nASD (37-45). Early studies used fetal brain extracts to probe\\nmaternal plasma by western blot (WB) and reported reactivity to\\nbands at ~36 kDa that were present in 10% of the ASD samples\\nvs. only 2% of controls. In addition, they observed increased\\nmaternal IgG cross-reactivity to multiple bands at 27, 36, at\\n73 kD in the ASD-positive mothers (46). Concurrent studies\\nreported similar band patterns of reactivity at 37/73 kDa and\\n39/73 kDa which were ASD specific and not present in controls\\n(47-50). Several groups, including our own, conducted a series\\nof experiments that lead to the identification of eight maternal\\nautoantibody-related (MAR) ASD antigens and their pathogenic\\nepitopes (51-54). The proteins were identified as collapsin\\nresponse mediator proteins 1 and 2 (CRMP1, CRMP2), guanine\\ndeaminase or cypin (GDA), lactate dehydrogenase A and B\\n(LDHA, LDHB), neuron-specific enolase (NSE), stress-induced\\nphosphoprotein-1 (STIP1), and Y-box binding protein 1 (YBX1)\\n(functions are summarized in Table 1). In this early study,\\ninstances of maternal seroreactivity to at least one of the proteins\\nin both the case and control groups was observed, indicating\\nthat reactivity to any single antigen is not enough to predict\\nASD risk. Instead, reactivity to a combination of two or more\\nspecific antigens (MAR ASD patterns) increased the risk of a\\nchild developing ASD with high accuracy: up to 20% of ASD\\ncases and <1% of the controls; the most relevant MAR ASD\\npattern found was LDHA+LDHB+CRMP1+STIP1 (23% ASD\\nvs. 1% TD) (51). In a more recent study using machine learning\\ntechniques, Ramiz-Celis et al. demonstrated that autoantibody\\ncombinations composed of CRMP1+CRMP2, CRMP1+GDA,\\nand NSE+STIP1 predicted up to 20% of ASD cases with 100%\\naccuracy, suggesting a significant potential for these patterns as\\nbiomarkers for ASD risk (52).\\n\\nOther groups have also looked at maternal IgG reactivity\\nto individual brain antigens as potential ASD predictors. Due\\nto their pivotal roles in neurodevelopment, the two most\\nwell-studied candidates are contactin associated protein 2\\n(CASPR2) (43, 44, 55) and N- methyl-D-aspartate receptor\\n\\n(NMDA receptor) (56). Further, several groups have reported\\nthat maternal seroreactivity to these proteins is associated with\\nneurological alterations in the offspring, including ASD (37, 38,\\n40, 57, 58). For example, Brimberg et al. reported that anti-\\nCASPR2 antibodies were elevated in mothers of a child with\\nautism when compared to the controls (37% ASD vs. 8% TD)\\n(44, 59). However, results from a recent Danish study that\\nexamined maternal IgG cross-reactivity against several brain\\nproteins (including CASPR2 and NMDA) and child outcomes\\nconcluded that seroreactivity to both proteins was associated\\nwith intellectual disability but not with ASD specifically (43,\\n60). However, experiments using animal models suggests that\\nmaternal autoantibodies against CASPR2 and NMDA can disrupt\\nproper neuronal function/development and result in ASD-like\\nmanifestations in the offspring (43-45, 56). Given data from\\nthe various studies, the pathologic significance of gestational\\nexposure to maternal autoantibodies is clearly complex and\\nfuture analyses will be needed to determine how their presence\\nleads to specific changes in neurodevelopment.\\n\\nMATERNAL AUTOANTIBODIES AS\\nPOTENTIAL ASD-RISK BIOMARKERS\\n\\nIn one study of 450 mothers of children with ASD and 342\\nmothers of TD children, the presence of select autoantibodies\\nin maternal blood was associated with ~20% of ASD cases\\ncompared to <1% of the typically developing (TD) controls,\\nsuggesting that these autoantibodies appear to be highly specific\\nin their ability to detect risk of a child getting an ASD diagnosis\\n(51, 52). Therefore, at this point in time, the association of autism\\nwith maternal autoantibodies to proteins in developing brain is\\nhigher than any single gene mutation described thus far (61, 62).\\nThis MAR subtype of ASD is now a focus of intense clinical\\nand pre-clinical research. It is believed that the ASD phenotype\\nobserved in children of mothers with these autoantibodies is the\\nresult of gestational exposure to these pathologically significant\\nautoantibodies (47, 63-68). While rigorous clinical validation\\nis still necessary, maternal autoantibodies have the potential to\\nbe used as a precision medicine tool to evaluate the risk of\\na child being diagnosed with autism. The etiological relevance\\nof MAR ASD was supported by multiple clinical studies in\\ndiverse populations and by experimental rodent and non-human\\nprimate animal models [reviewed in (37, 40, 58)], that in the\\nfuture could lead to the development of MAR ASD prophylactic\\ntreatments for women at risk.\\n\\n \\n\\nFrontiers in Psychiatry | www.frontiersin.org\\n\\nJune 2022 | Volume 13 | Article 834910\\n\\x0c McLellan et al. Maternal Risk Factors in ASD\\n\\n \\n\\n \\n\\nMaternal\\nautoantibodies\\n\\nMaternal antibodies\\ntargeting proteins\\nof the fetal brain\\n\\nMaternal\\ncytokines\\n\\n  \\n\\nOffspring with altered\\nneurodevelopment\\n\\n  \\n\\nCytokines and chemokines\\naltering neurodevelopment\\nand neuroimmunity\\n\\nFIGURE 1 | Schematic of maternal cytokines and autoantibodies affecting fetal brain development as studied using animal models. Dysregulation of maternal immune\\nsystem is a strong risk factor for the development of ASD. Alterations in the production of maternal cytokines and chemokines can impact the neurodevelopmental\\nprocess, and the presence of maternal autoantibodies reactive to critical proteins can alter how the developmental trajectory of the brain. Pre-clinical models are used\\n\\n \\n\\nto better understand the underlying mechanisms for both proposed pathways to altered neurodevelopment. The figure was generated by Biorender.\\n\\n \\n\\n \\n\\nAlthough MAR ASD profiles are promising ASD-risk\\nbiomarkers for a subtype of autism, substantial analytical and\\nclinical validation is still needed before they can be introduced\\ninto clinical practice. Meanwhile, the use of in vitro and in vivo\\nanimal models will allow us to better understand the pathogenic\\nmechanisms of maternal autoantibodies in neurodevelopment.\\nIn addition, they will have the potential to facilitate development\\nof prophylactic treatments to mitigate the neurodevelopmental\\nchanges associated with MAR ASD.\\n\\nANIMAL MODELS OF MAR ASD\\n\\nWhile strong correlations between the presence of maternal\\nautoantibodies and ASD diagnosis have been observed, the\\npathological role of maternal autoantibodies in the development\\nof ASD is the focus of ongoing research. Multiple preclinical\\nmodels, including mice, rats, and non-human primates have\\nbeen utilized to understand the underlying pathology associated\\nwith the presence of these maternal autoantibodies (Figure 1).\\nEarly animal models of MAR ASD relied on a passive transfer\\nmethod, utilizing purified antibodies isolated from mothers of\\nchildren with autism or from mothers of typically developing\\nchildren that were transferred to an otherwise healthy animal\\nduring gestation. First conducted in mice, and subsequently in\\nnon-human primates, the passive transfer models yielded two\\nmain findings: (1) They confirmed that maternal antibodies do\\n\\ncross the placenta and can be detected in fetal tissues, including\\nthe brain, and (2) they confirmed that exposure to maternal\\nautoantibodies results in changes in offspring behavior and\\nbrain development. More specifically, the offspring from mouse\\ndams that received IgG from mothers of children with ASD\\nspent more time in self-grooming and marble-burying behavior,\\nreflective of the stereotypic behaviors observed in ASD. They also\\nshowed increased levels of anxiety, a comorbidity many children\\nwith ASD experience (69, 70). Furthermore, IgG deposition was\\nobserved in the brains of offspring from dams treated with\\nIgG from mothers of children with ASD, but not in controls\\n(69, 70). Similar passive transfer models studying antibodies to\\nCASPR2 and NMDA have also yielded important findings. In one\\nstudy, mouse offspring exposed to anti-CASPR2 antibodies at\\ngestational day 13.5 had differences in sociability, as determined\\nby the amount of time spent with an unfamiliar object vs.\\nan unfamiliar stimulus mouse. In addition, fetuses examined 2\\ndays after exposure to anti-CASPR2 antibodies showed reduced\\ncortical thickness and changes in cell proliferation (44). Exposure\\nto the NR1 subunit of NMDA receptor at gestational days 13 and\\n17 resulted in offspring who displayed impaired early postnatal\\nreflexes and decreased prepulse inhibition (56).\\n\\nIn non-human primate passive transfer studies, the results\\nwere similar, with offspring from treated dams displaying\\nincreased stereotypic behaviors with both novel and familiar\\nsocial partners (47). When examining the brains of offspring\\n\\n \\n\\nFrontiers in Psychiatry | www.frontiersin.org\\n\\n4 June 2022 | Volume 13 | Article 834910\\n\\x0c McLellan et al.\\n\\nMaternal Risk Factors in ASD\\n\\n \\n\\nfrom treated dams, investigators noted that male offspring\\nhad a higher rate of brain growth between 3 and 6 months\\nof age, a finding that has been observed in some clinical\\nASD cases and may be correlated with atypical connectivity\\nand altered brain maturation (71, 72). Together, these studies\\nwere essential in validating the hypothesis that maternal\\nautoantibodies have pathologic significance and the potential to\\nalter neurodevelopment (47, 69-71, 73).\\n\\nThe passive transfer model was an essential first step\\nin advancing the understanding of maternal autoantibody\\npathogenesis. However, this route of administration does\\nnot reflect the true exposure a fetus would experience\\nduring pregnancy. Thus, to create a more appropriate mimic\\nof the gestational environment where a fetus would be\\nexposed to maternal autoantibodies throughout pregnancy, we\\ngenerated an antigen-driven model of endogenous exposure.\\nIn contrast to the passive transfer model, the antigen-driven\\nmodel involves immunizing experimental dams with specific\\nprotein combinations prior to pregnancy, to induce selective,\\nendogenous autoantibody production (64). Clinical studies had\\npreviously identified specific patterns of antigen reactivity as\\nwell as the epitopes recognized by the maternal autoantibodies\\nin human samples (51, 53). This knowledge was then used\\nto generate a mouse model with reliable construct validity to\\nclinical MAR ASD. Described briefly, mouse dams were injected\\nwith synthetic peptide epitopes for lactate dehydrogenase A\\nand B (LDH-A and B), collapsin response mediator protein\\n1 (CRMP1), and stress induced phosphoprotein 1 (STIP1), a\\nprotein reactivity pattern identified in clinical samples specific\\nto mothers of children with ASD (53). Once immune tolerance\\nto the self-proteins was bypassed, these dams continuously\\nproduced autoantibodies to the protein epitopes of interest in the\\nabsence of inflammation and other immune perturbations that\\nare also thought to impact offspring development. This approach\\nresulted in offspring that were exposed to the autoantibodies\\nthroughout the gestational period, more closely resembling the\\nexposure noted in clinical MAR ASD (64). Using the antigen-\\ndriven mouse model, researchers were able to test the behavioral\\nand neurological impacts of constant gestational exposure to\\nmaternal autoantibodies. Offspring from treated dams had\\nreduced social behaviors, including fewer bouts of nose-to-nose\\nsniffing and front approaches. In addition, researchers observed\\nelevated repetitive behaviors, decreased ultrasonic vocalizations,\\nand differences in neuroanatomical development; specifically\\nincreased brain volume in the offspring from treated dams (64,\\n74).\\n\\nOur current studies seek to build upon this foundation\\nthrough use of an antigen-driven rat model with an expanded\\nrepertoire of maternal antibody combinations recently identified\\nin a large clinical study (52). Recent work identifying the\\nconsequences of acute peripheral immune activation of offspring\\nneurodevelopment (75), suggests that the rat model is a\\npromising next step in understanding the pathology of maternal\\nautoantibodies. The antigen-driven rat model will allow for\\na more thorough identification of the behavioral and social\\nimpacts of maternal autoantibody exposure, thanks to their more\\ncomplex neuroanatomy and social interactions. Additionally,\\n\\nutilizing the specific autoantibody combinations identified in\\nclinical research will allow us to identify the consequences of\\nexposure to select autoantibodies, providing researchers with\\na better understanding of which autoantibody combinations\\nresult in more severe pathology, and which can be used as risk-\\nbiomarkers. Since the development of this model yields dams that\\nproduce autoantibodies in the absence of inflammation, we can\\ndirectly test how skewing of one arm of the maternal immune\\nsystem impacts offspring behavior and neuroanatomy. The rat\\nmodel will not only be more translationally specific, but it will\\nalso provide researchers with a pre-clinical model in which to\\ntest future therapeutic interventions. In the future, we hope to\\nbe able to generate an antigen-driven non-human primate model\\nto further advance our preclinical model.\\n\\nFUTURE DIRECTIONS\\n\\nClinical studies of MAR ASD have revealed the critical\\nprotein targets for maternal autoantibodies and drawn\\nlinks between the specific autoantibody combinations and\\nASD severity. In addition, they have begun to elucidate\\nother immunological factors, such as variances in maternal\\ncytokine/chemokine profile, that can also be used as predictive\\nmeasures for ASD risk. The use of animal models has\\nhelped to confirm the pathologic significance of at least\\nsome of the maternal autoantibodies, as well as provided\\nresearchers with a means to better understand the downstream\\nmolecular consequences and mechanisms involved in these\\neffects. Despite the advances made thus far, many questions\\nremain which, once answered, will aid in the creation of\\nmore precise diagnostic tools, preventative treatments,\\nand therapeutics.\\n\\nThere are several questions we are unable to answer using\\nthe animal model, such as: What is the triggering event for\\nmaternal autoantibody production in humans? What are the\\nlongstanding immunological impacts on exposed children? How\\ndoes previous history of autoimmune disease influence ASD\\nrisk through the MAR mechanism? How do autoantibody\\nand cytokine/chemokine levels prior to pregnancy compare\\nto those present during and after pregnancy? To develop\\ntargeted therapeutics, it will also be important to further\\nidentify when offspring are most vulnerable to autoantibody\\nand/or cytokine/chemokine exposure. To answer these questions,\\ncontinued clinical studies and use of our pre-clinical models will\\nbe necessary. The development of a more sophisticated model\\nusing non-human primates would increase the translational\\nability to the more complex behaviors seen in autism. Although\\nsome non-human primate studies have been completed, an\\nantigen-driven model is currently under development, and\\nwe remain hopeful that this will soon be another model for\\nresearchers to utilize. Future research will continue to elucidate\\nthe mechanisms by which maternal autoantibodies impact\\ntheir target proteins, and the optimal intervention strategies\\nto mitigate damage. In addition, we will aim to identify\\nconnections between maternal cytokine/chemokine changes and\\nautoantibody production.\\n\\n \\n\\nFrontiers in Psychiatry | www.frontiersin.org\\n\\nJune 2022 | Volume 13 | Article 834910\\n\\x0c McLellan et al.\\n\\nMaternal Risk Factors in ASD\\n\\n \\n\\nCONCLUSIONS\\n\\nAutism is an incredibly complex disorder with a wide range of\\nbehavioral and cognitive phenotypes. Despite multiple known\\netiologies, a preventative strategy for the disorder remains\\nto be discovered. Furthermore, testing for specific phenotypic\\nsubsets of ASD are also lacking. MAR ASD is one subtype\\nof autism in which the maternal immune system plays a\\ncritical role. We now know that specific risk factors exist\\nfor immune mediated ASD, including maternal autoantibody\\nproduction, and skewed maternal and fetal chemokine/cytokine\\nprofile. While much is left to be discovered, we continue\\nto use clinical studies and refined animal models to tease\\napart the mechanisms by which MAR ASD develops. Further,\\nstudies are underway to understand how neonatal cytokines\\nand chemokines influence symptom severity as well as the\\nrelationship between maternal immune dysregulation during\\ngestation and changes in the brain of affected offspring.\\n\\nREFERENCES\\n\\n1. Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke $, Abdallah\\nM, et al. Maternal infection requiring hospitalization during pregnancy\\nand autism spectrum disorders. J Autism Dev Disord. (2010) 40:1423.\\ndoi: 10.1007/s10803-010-1006-y\\n\\n2. Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection\\ncauses marked behavioral and pharmacological changes in the offspring[[/i]].\\nJ Neurosci. (2003) 23:297. doi: 10.1523/JNEUROSCI.23-01-00297.2003\\n\\n3. Stubbs EG, Crawford ML. Depressed lymphocyte responsiveness in autistic\\nchildren. J Autism Child Schizophr. (1977) 7:49. doi: 10.1007/BF01531114\\n\\n4. Plioplys AV, Greaves A, Kazemi K, Silverman E. Lymphocyte\\nfunction in autism and Rett syndrome. Neuropsychobiology. (1994)\\n29:12. doi: 10.1159/000119056\\n\\n5. Warren RP, Foster A, Margaretten NC. [[i]]Reduced natural killer cell activity\\nin autism[[/i]]. Journal for the American Academy of Child e& Adolescent\\nPsychiatry. (1987) 26:333. doi: 10.1097/00004583-198705000-00008\\n\\n6. Sweeten TL, Posey DJ, McDougle CJ. High blood monocyte counts and\\nneopterin levels in children with autistic disorder. Am J Psychiatry. (2003)\\n160:1691. doi: 10.1176/appi.ajp.160.9.1691\\n\\n7. MeadJ, Ashwood P. Evidence supporting an altered immune response in ASD.\\nImmunol Lett. (2015) 163:49. doi: 10.1016/j.imlet.2014.11.006\\n\\n8. Abdallah MW, Larsen N, Grove J, Bonefeld-Jorgensen EC, Norgaard-\\nPedersen B, Hougaard DM, et al. Neonatal chemokine levels and risk of autism\\nspectrum disorders: findings from a Danish historic birth cohort follow-up\\nstudy. Cytokine. (2013) 61:370. doi: 10.1016/j.cyto.2012.11.015\\n\\n9. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water\\nJ. Elevated plasma cytokines in autism spectrum disorders provide evidence\\nof immune dysfunction and are associated with impaired behavioral outcome.\\nBrain Behav Immun. (2011) 25:40. doi: 10.1016/j.bbi.2010.08.003\\n\\n10. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van\\nde Water J. Associations of impaired behaviors with elevated plasma\\nchemokines in autism spectrum disorders. J Neuroimmunol. (2011)\\n232:196. doi: 10.1016/j.jneuroim.2010.10.025\\n\\n11. Zerbo O, Yoshida C, Grether JK, Van de Water J, Ashwood P, Delorenze\\nGN, et al. Neonatal cytokines and chemokines and risk of Autism Spectrum\\nDisorder: the Early Markers for Autism (EMA) study: a case-control study. J\\nNeuroinflammation. (2014) 11:113. doi: 10.1186/1742-2094-11-113\\n\\n12. Garty BZ, Ludomirsky A, Danon YL, Peter JB, Douglas SD. Placental\\ntransfer of immunoglobulin G subclasses. Clin Diagn Lab Immunol. (1994)\\n1:667. doi: 10.1128/cdli.1.6.667-669.1994\\n\\n13. Roopenian DC, Akilesh $. FcRn: the neonatal Fc receptor comes of age. Nat\\nRev Immunol. (2007) 7:715. doi: 10.1038/nri2155\\n\\nWe hope this knowledge will yield future preventatives\\nand treatments.\\n\\nAUTHOR CONTRIBUTIONS\\n\\nThis mini-review contains review of research performed by\\neach of the authors. JV is the senior author and oversaw\\nall aspects of this mini-review. JM is the first author and\\ncompiled all of the information from the other authors as\\nwell as wrote the animal model section. DK wrote the section\\non maternal immune activation. MB developed the animal\\nmodels and edited the entire review. AR-C wrote the section on\\nmaternal autoantibodies. All authors contributed to the article\\nand approved the submitted version.\\n\\nFUNDING\\n\\nNICHD funded IDDRC P50 (P50HD103526).\\n\\n14. Pakhathirathien P, Janjindamai W, Dissaneevate $, Thatrimontrichai A,\\nManeenil G. Neonatal outcomes in pregnant women with systemic lupus\\nerythematosus: a 13-year experience in Southern Thailand. J Trop Pediatr.\\n(2021) 67:58. doi: 10.1093/tropej/fmab058\\n\\n15. Saunders NR,  Liddelow $A, —Dziegielewska KM.\\nmechanisms in the developing brain. Front\\n3:46. doi: 10.3389/fphar.2012.00046\\n\\n16. Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL, Hertz-Picciotto\\nI, et al. Neonatal cytokine profiles associated with autism spectrum disorder.\\nBiol Psychiatry. (2017) 81:442. doi: 10.1016/j.biopsych.2015.08.007\\n\\n17. Dammann O, Leviton A. Maternal intrauterine infection, cytokines,\\nand brain damage in the preterm newborn. Pediatr Res. (1997)\\n42:1. doi: 10.1203/00006450-199707000-00001\\n\\n18. Deverman BE, Patterson PH. Cytokines and CNS development. Neuron.\\n(2009) 64:61. doi: 10.1016/j.neuron.2009.09.002\\n\\n19. Mousa A, Bakhiet M. Role of cytokine signaling during nervous system\\ndevelopment. Int J Mol Sci. (2013) 14:13931. doi: 10.3390/ijms140713931\\n\\n20. Ramesh G, MacLean AG, Philipp MT. Cytokines and chemokines at the\\ncrossroads of neuro-inflammation, neurodegeneration, and neuropathic pain.\\nMediators Inflamm. (2013) 2013:480739. doi: 10.1155/2013/480739\\n\\n21. Goines PE, Ashwood P. Cytokine dysregulation in autism spectrum disorders\\n(ASD): possible role of the environment. Neurotoxicol Teratol. (2013)\\n36:67. doi: 10.1016/j.ntt.2012.07.006\\n\\n22. Yang C, Hawkins KE, Dore $, Candelario-Jalil E. Neuroinflammatory\\nmechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol\\nCell Physiol. (2019) 316:C135. doi: 10.1152/ajpcell.00136.2018\\n\\n23. Hauguel-de Mouzon $, Guerre-Millo M. The placenta\\nnetwork and inflammatory signals. Placenta. (2006)\\n8. doi: 10.1016/j.placenta.2005.08.009\\n\\n24. Siwetz M, Blaschitz A, El-Heliebi A, Hiden U, Desoye G, Huppertz B, et al.\\n‘TNF-alpha alters the inflammatory secretion profile of human first trimester\\nplacenta. Lab Invest. (2016) 96:428. doi: 10.1038/labinvest.2015.159\\n\\n25. Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen\\nR, et al. Increased midgestational IFN-gamma, IL-4 and IL-5 in women\\nbearing a child with autism: a case-control study. Mol Autism. (2011)\\n2:13. doi: 10.1186/2040-2392-2-13\\n\\n26. Carter M, Casey $, O'Keeffe GW, Gibson L, Murray DM. Mid-\\ngestation cytokine profiles in of children affected by\\nautism spectrum disorder: a case-control study. Sci Rep. (2021)\\n11:22315. doi: 10.1038/s41598-021-01662-z\\n\\n27. Ghassabian A, Albert PS, Hornig M, Yeung E, Cherkerzian $, Goldstein RB, et\\nal. Gestational cytokine concentrations and neurocognitive development at 7\\nyears. Transl Psychiatry. (2018) 8:64. doi: 10.1038/s41398-018-0112-z\\n\\nBarrier\\n\\nPharmacol. (2012)\\n\\n \\n\\ncytokine\\n27:794-\\n\\nmothers\\n\\n \\n\\nFrontiers in Psychiatry | www.frontiersin.org\\n\\nJune 2022 | Volume 13 | Article 834910\\n\\x0c\""
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 30
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import nltk\n",
        "nltk.download('punkt')\n",
        "\n",
        "#text preprocessing\n",
        "def clean_text(text):\n",
        "  \"\"\"Remove section titles and figure descriptions from text\"\"\"\n",
        "  clean = \"\\n\".join([row for row in text.split(\"\\n\") if (len(row.split(\" \"))) > 3 and not (row.startswith(\"(a)\"))\n",
        "                    and not row.startswith(\"Figure\")])\n",
        "  return clean\n",
        "\n",
        "text = article_txt.split(\"INTRODUCTION\")[1]\n",
        "ctext = clean_text(text)\n",
        "sentences = nltk.tokenize.sent_tokenize(ctext)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "VAZZrkoFlyM7",
        "outputId": "b9e6c52b-59aa-495c-edd4-ef39a6026882"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "[nltk_data] Downloading package punkt to /root/nltk_data...\n",
            "[nltk_data]   Package punkt is already up-to-date!\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#Retreive the article sentences in a list\n",
        "sentences"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "0qKpdRpB4pX7",
        "outputId": "62a5074a-cf78-40d1-f58d-080bf6470e24"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['Autism spectrum disorder (ASD) is acknowledged as a highly heterogeneous, behaviorally defined\\nneurodevelopmental disorder with multiple etiologies.',\n",
              " 'In addition to its high heritability, we\\nhave come to recognize a role for maternal immune system dysregulation as a prominent risk\\nfactor for the development of ASD in the child.',\n",
              " 'Examples of these risk factors include altered\\ncytokine/chemokine activity and the presence of autoantibodies in mothers that are reactive\\nto proteins in the developing brain.',\n",
              " 'In addition to large clinical studies, the development of\\npre-clinical models enables the ability to evaluate the cellular and molecular underpinnings of\\nimmune-related pathology.',\n",
              " 'For example, the novel animal models of maternal autoantibody-\\nrelated (MAR) ASD described herein will serve as a preclinical platform for the future testing\\nof targeted therapeutics for one ‘type’ of ASD.',\n",
              " 'Identification of the cellular targets will advance\\nFrontiers in Psychiatry | www.frontiersin.org\\n1 June 2022 | Volume 13 | Article 834910\\n\\x0c McLellan et al.',\n",
              " 'Maternal Risk Factors in ASD\\nprecision medicine efforts toward tailored therapeutics and\\nprevention.',\n",
              " 'This minireview highlights emerging evidence for\\nthe role of maternal immune dysregulation as a potential\\nbiomarker, as well as a pathologically relevant mechanism for the\\ndevelopment of ASD in offspring.',\n",
              " 'Further, we will discuss the\\ncurrent limitations of these models as well as potential avenues\\nTHE ROLE OF THE MATERNAL IMMUNE\\nSYSTEM IN THE DEVELOPMENT OF ASD\\nIn the past two decades, an increasingly large number of studies\\nhave provided evidence that maternal immune dysregulation\\ncan impact offspring neurodevelopment (1-11).',\n",
              " 'For example,\\nit is now well-understood that the maternal immune system\\nplays a critical role in the healthy development of the fetus.',\n",
              " 'In\\nfact, maternal immunoglobulin G (IgG) can cross the placenta\\nand enter the fetal compartment, thereby providing early\\nimmunological protection to the infant during the perinatal stage\\n(12, 13).',\n",
              " 'However, this protective mechanism is not selective and\\nharmful antibodies reactive to “self” proteins can also cross the\\nplacenta (14).',\n",
              " 'Once within the fetal compartment, these maternal\\nautoantibodies may bind to their protein targets, potentially\\nimpacting protein function.',\n",
              " 'This is especially dangerous during\\nthe perinatal period given the permissiveness of the blood-\\nbrain barrier (BBB) and vulnerability of the developing central\\nnervous system (CNS) (15).',\n",
              " 'In addition to the production of\\nautoantibodies, other perturbations of the maternal immune\\nsystem can result in harmful effects on the developing fetus.',\n",
              " 'It has\\nbeen shown that alterations in the maternal cytokine/chemokine\\nprofile can result in changes in the inflammatory state, skewed\\ncellular signaling, and altered neurodevelopment (16, 17).',\n",
              " 'CYTOKINES AND CHEMOKINES AS\\nIn recent years, several researchers have reported on specific\\ncytokines and/or chemokines that are associated with ASD\\nrisk both in children with ASD and mothers that have\\nildren diagnosed with ASD.',\n",
              " 'Interestingly, several cytokines\\nnd chemokines are constitutively expressed throughout the\\ndeveloping CNS (18, 19).',\n",
              " 'Cytokines in the brain perform\\nfunctions similar to those seen in the periphery, acting as\\ncues in cell development and differentiation, and regulating\\nthe types and number of neuronal and non-neuronal cells\\n(20, 21).',\n",
              " 'Together, these complex processes contribute to early\\nneurodevelopment and homeostasis.',\n",
              " 'In the context of maternal-\\nfetal interaction, some cytokines, in particular IL-6, can be\\ntransported from the mother to the offspring and access\\ne developing CNS (17).',\n",
              " 'Although the source of abnormal\\ncytokine levels in mothers during gestation may differ, this could\\nalter placental production and overall levels of cytokines and\\nchemokines in the fetal compartment, impacting the cascade\\nTo date, a variety of clinical studies have demonstrated\\ntered cytokine levels in mothers and neonatal blood samples\\nthat are strongly associated with ASD (Table 1), increasing\\nthe potential for cytokines/chemokines to serve as biomarkers\\nfor risk of abnormal neurodevelopment.',\n",
              " 'Most of the reported\\ncytokines associated with ASD induce the BBB to become\\nmore permissive (22) increasing the vulnerability and altering\\nthe homeostatic levels of cytokines in the developing CNS.',\n",
              " 'Numerous researchers have corroborated the concept that\\nsignificant changes in maternal cytokine/chemokine homeostasis\\nare correlated with ASD development even in the absence of\\nmaternal/fetal infection.',\n",
              " 'Such changes in maternal cytokines\\nand chemokines can not only directly impact the fetus but\\ncan also stimulate placental production of pro-inflammatory\\ncytokines within the fetal compartment (17, 23, 24).',\n",
              " 'For example,\\ndysregulation of serum and/or amniotic fluid IL-4, IL-6, and IL-\\n8 have been described in mothers of children with ASD and\\nwere associated with altered behavioral outcomes including non-\\nverbal cognitive ability and stereotypical behaviors in children\\n(25-28).',\n",
              " 'The cytokine IL-17, which has been implicated in\\nseveral neurodevelopmental disorders, including ASD, has been\\nshown to promote inflammation and disrupt the BBB postnatally\\n(29, 30).',\n",
              " 'In addition, IFN-y, which is involved in neuronal\\ndifferentiation and synaptic formation, was shown to be higher\\nin mothers of children with ASD during the second trimester\\n(25, 28), potentially suggesting disrupted synaptic connectivity.',\n",
              " 'Studies have also observed altered cytokine and chemokine\\nlevels in neonates who are later diagnosed with autism.',\n",
              " 'For\\nexample, researchers found that newborns later diagnosed\\nwith ASD have higher peripheral levels of IL-16, which is\\nexpressed throughout the CNS particularly during the early\\nneurodevelopmental period (16, 21).',\n",
              " 'In our recent findings,\\nCCL27, also known as CTACK, was significantly lower in\\nnewborns later diagnosed with ASD.',\n",
              " 'This decrease was\\nassociated with an increase in the risk of both ASD with and\\nwithout intellectual disability when compared to newborns with\\ndevelopmental delay or those with typical development (31).',\n",
              " 'Elevated levels of monocyte chemoattractant protein-1 (MCP-\\n1) and macrophage-derived chemokine (MDC) were found in\\nthe amniotic fluid, plasma, cerebellum, and cerebrospinal fluid\\nof children with ASD (10, 32, 33), implying involvement of\\nthese chemokines in neurodevelopment.',\n",
              " 'Increased levels of the\\nchemokines macrophage inflammatory protein-1 (MIP-1) and\\neotaxin are also often noted in children with ASD, and have been\\nassociated with behavioral deficits (10, 34-36).',\n",
              " 'It is unlikely that one specific cytokine or chemokine plays\\na role in the development of ASD, but rather a combination\\nof cytokines/chemokines are more likely to contribute to the\\nneuropathology associated with autism.',\n",
              " 'The exact consequences\\nof altered cytokine/chemokine levels during pregnancy that\\nlead to the ASD phenotype is an important area of research.',\n",
              " 'Furthermore, the trigger(s) for changes in maternal cytokine\\nand chemokine levels, and how other aspects of the maternal\\nimmune system may also be affected are essential questions to\\naddress.',\n",
              " 'Although the number of research studies that include\\ntime-specific/longitudinal examination as well as mother-infant\\npair-matched studies are lacking, it is promising that similar\\ngroups of cytokines and chemokines are frequently shown to be\\naltered in both children with ASD and their mothers, increasing\\nFrontiers in Psychiatry | www.frontiersin.org\\nJune 2022 | Volume 13 | Article 834910\\n\\x0c McLellan et al.',\n",
              " 'Maternal Risk Factors in ASD\\nTABLE 1 | Maternal cytokines/chemokines and maternal autoantibody targets implicated in ASD.',\n",
              " 'Cytokines/chemokines Sample source Reference\\nIL-1, IL-4, IL-5, IL-8, IL-7A, IFN-y Maternal serum collected mid-gestation (25, 26, 28)\\nIL-4, IL-10MCP-1TNF-a, TNF-B Amniotic fluid (27, 32)\\nTarget antigen Protein function\\nCRMP1, CRMP2, STIP1, YBOX Microtubule dynamics, protein chaperone, transcription factor (12-14, 42-44)\\nLDH-A, LDH-B, GDA, NSE Metabolic enzymes (14-16, 37-41)\\nCASPR2 Cell adhesion (45, 52)\\nthe promise of cytokines and chemokines as biomarkers for risk\\nMATERNAL AUTOANTIBODY TARGETS IN\\nSeveral groups have now identified multiple brain antigens\\nthat cross-react with maternal IgG and are related to\\nneurodevelopmental impairments in the child, including\\nASD (37-45).',\n",
              " 'Early studies used fetal brain extracts to probe\\nmaternal plasma by western blot (WB) and reported reactivity to\\nbands at ~36 kDa that were present in 10% of the ASD samples\\nvs. only 2% of controls.',\n",
              " 'In addition, they observed increased\\nmaternal IgG cross-reactivity to multiple bands at 27, 36, at\\n73 kD in the ASD-positive mothers (46).',\n",
              " 'Concurrent studies\\nreported similar band patterns of reactivity at 37/73 kDa and\\n39/73 kDa which were ASD specific and not present in controls\\n(47-50).',\n",
              " 'Several groups, including our own, conducted a series\\nof experiments that lead to the identification of eight maternal\\nautoantibody-related (MAR) ASD antigens and their pathogenic\\nepitopes (51-54).',\n",
              " 'The proteins were identified as collapsin\\nresponse mediator proteins 1 and 2 (CRMP1, CRMP2), guanine\\ndeaminase or cypin (GDA), lactate dehydrogenase A and B\\n(LDHA, LDHB), neuron-specific enolase (NSE), stress-induced\\nphosphoprotein-1 (STIP1), and Y-box binding protein 1 (YBX1)\\n(functions are summarized in Table 1).',\n",
              " 'In this early study,\\ninstances of maternal seroreactivity to at least one of the proteins\\nin both the case and control groups was observed, indicating\\nthat reactivity to any single antigen is not enough to predict\\nASD risk.',\n",
              " 'Instead, reactivity to a combination of two or more\\nspecific antigens (MAR ASD patterns) increased the risk of a\\nchild developing ASD with high accuracy: up to 20% of ASD\\ncases and <1% of the controls; the most relevant MAR ASD\\npattern found was LDHA+LDHB+CRMP1+STIP1 (23% ASD\\nvs. 1% TD) (51).',\n",
              " 'In a more recent study using machine learning\\ntechniques, Ramiz-Celis et al.',\n",
              " 'demonstrated that autoantibody\\ncombinations composed of CRMP1+CRMP2, CRMP1+GDA,\\nand NSE+STIP1 predicted up to 20% of ASD cases with 100%\\naccuracy, suggesting a significant potential for these patterns as\\nbiomarkers for ASD risk (52).',\n",
              " 'Other groups have also looked at maternal IgG reactivity\\nto individual brain antigens as potential ASD predictors.',\n",
              " 'Due\\nto their pivotal roles in neurodevelopment, the two most\\nwell-studied candidates are contactin associated protein 2\\n(CASPR2) (43, 44, 55) and N- methyl-D-aspartate receptor\\n(NMDA receptor) (56).',\n",
              " 'Further, several groups have reported\\nthat maternal seroreactivity to these proteins is associated with\\nneurological alterations in the offspring, including ASD (37, 38,\\n40, 57, 58).',\n",
              " 'For example, Brimberg et al.',\n",
              " 'reported that anti-\\nCASPR2 antibodies were elevated in mothers of a child with\\nautism when compared to the controls (37% ASD vs. 8% TD)\\n(44, 59).',\n",
              " 'However, results from a recent Danish study that\\nexamined maternal IgG cross-reactivity against several brain\\nproteins (including CASPR2 and NMDA) and child outcomes\\nconcluded that seroreactivity to both proteins was associated\\nwith intellectual disability but not with ASD specifically (43,\\n60).',\n",
              " 'However, experiments using animal models suggests that\\nmaternal autoantibodies against CASPR2 and NMDA can disrupt\\nproper neuronal function/development and result in ASD-like\\nmanifestations in the offspring (43-45, 56).',\n",
              " 'Given data from\\nthe various studies, the pathologic significance of gestational\\nexposure to maternal autoantibodies is clearly complex and\\nfuture analyses will be needed to determine how their presence\\nleads to specific changes in neurodevelopment.',\n",
              " 'In one study of 450 mothers of children with ASD and 342\\nmothers of TD children, the presence of select autoantibodies\\nin maternal blood was associated with ~20% of ASD cases\\ncompared to <1% of the typically developing (TD) controls,\\nsuggesting that these autoantibodies appear to be highly specific\\nin their ability to detect risk of a child getting an ASD diagnosis\\n(51, 52).',\n",
              " 'Therefore, at this point in time, the association of autism\\nwith maternal autoantibodies to proteins in developing brain is\\nhigher than any single gene mutation described thus far (61, 62).',\n",
              " 'This MAR subtype of ASD is now a focus of intense clinical\\nand pre-clinical research.',\n",
              " 'It is believed that the ASD phenotype\\nobserved in children of mothers with these autoantibodies is the\\nresult of gestational exposure to these pathologically significant\\nautoantibodies (47, 63-68).',\n",
              " 'While rigorous clinical validation\\nis still necessary, maternal autoantibodies have the potential to\\nbe used as a precision medicine tool to evaluate the risk of\\na child being diagnosed with autism.',\n",
              " 'The etiological relevance\\nof MAR ASD was supported by multiple clinical studies in\\ndiverse populations and by experimental rodent and non-human\\nprimate animal models [reviewed in (37, 40, 58)], that in the\\nfuture could lead to the development of MAR ASD prophylactic\\ntreatments for women at risk.',\n",
              " 'Frontiers in Psychiatry | www.frontiersin.org\\nJune 2022 | Volume 13 | Article 834910\\n\\x0c McLellan et al.',\n",
              " 'Maternal Risk Factors in ASD\\nof the fetal brain\\nFIGURE 1 | Schematic of maternal cytokines and autoantibodies affecting fetal brain development as studied using animal models.',\n",
              " 'Dysregulation of maternal immune\\nsystem is a strong risk factor for the development of ASD.',\n",
              " 'Alterations in the production of maternal cytokines and chemokines can impact the neurodevelopmental\\nprocess, and the presence of maternal autoantibodies reactive to critical proteins can alter how the developmental trajectory of the brain.',\n",
              " 'Pre-clinical models are used\\nto better understand the underlying mechanisms for both proposed pathways to altered neurodevelopment.',\n",
              " 'The figure was generated by Biorender.',\n",
              " 'Although MAR ASD profiles are promising ASD-risk\\nbiomarkers for a subtype of autism, substantial analytical and\\nclinical validation is still needed before they can be introduced\\ninto clinical practice.',\n",
              " 'Meanwhile, the use of in vitro and in vivo\\nanimal models will allow us to better understand the pathogenic\\nmechanisms of maternal autoantibodies in neurodevelopment.',\n",
              " 'In addition, they will have the potential to facilitate development\\nof prophylactic treatments to mitigate the neurodevelopmental\\nchanges associated with MAR ASD.',\n",
              " 'ANIMAL MODELS OF MAR ASD\\nWhile strong correlations between the presence of maternal\\nautoantibodies and ASD diagnosis have been observed, the\\npathological role of maternal autoantibodies in the development\\nof ASD is the focus of ongoing research.',\n",
              " 'Multiple preclinical\\nmodels, including mice, rats, and non-human primates have\\nbeen utilized to understand the underlying pathology associated\\nwith the presence of these maternal autoantibodies (Figure 1).',\n",
              " 'Early animal models of MAR ASD relied on a passive transfer\\nmethod, utilizing purified antibodies isolated from mothers of\\nchildren with autism or from mothers of typically developing\\nchildren that were transferred to an otherwise healthy animal\\nduring gestation.',\n",
              " 'First conducted in mice, and subsequently in\\nnon-human primates, the passive transfer models yielded two\\nmain findings: (1) They confirmed that maternal antibodies do\\ncross the placenta and can be detected in fetal tissues, including\\nthe brain, and (2) they confirmed that exposure to maternal\\nautoantibodies results in changes in offspring behavior and\\nbrain development.',\n",
              " 'More specifically, the offspring from mouse\\ndams that received IgG from mothers of children with ASD\\nspent more time in self-grooming and marble-burying behavior,\\nreflective of the stereotypic behaviors observed in ASD.',\n",
              " 'They also\\nshowed increased levels of anxiety, a comorbidity many children\\nwith ASD experience (69, 70).',\n",
              " 'Furthermore, IgG deposition was\\nobserved in the brains of offspring from dams treated with\\nIgG from mothers of children with ASD, but not in controls\\n(69, 70).',\n",
              " 'Similar passive transfer models studying antibodies to\\nCASPR2 and NMDA have also yielded important findings.',\n",
              " 'In one\\nstudy, mouse offspring exposed to anti-CASPR2 antibodies at\\ngestational day 13.5 had differences in sociability, as determined\\nby the amount of time spent with an unfamiliar object vs.\\nan unfamiliar stimulus mouse.',\n",
              " 'In addition, fetuses examined 2\\ndays after exposure to anti-CASPR2 antibodies showed reduced\\ncortical thickness and changes in cell proliferation (44).',\n",
              " 'Exposure\\nto the NR1 subunit of NMDA receptor at gestational days 13 and\\n17 resulted in offspring who displayed impaired early postnatal\\nreflexes and decreased prepulse inhibition (56).',\n",
              " 'In non-human primate passive transfer studies, the results\\nwere similar, with offspring from treated dams displaying\\nincreased stereotypic behaviors with both novel and familiar\\nsocial partners (47).',\n",
              " 'When examining the brains of offspring\\nFrontiers in Psychiatry | www.frontiersin.org\\n4 June 2022 | Volume 13 | Article 834910\\n\\x0c McLellan et al.',\n",
              " 'Maternal Risk Factors in ASD\\nfrom treated dams, investigators noted that male offspring\\nhad a higher rate of brain growth between 3 and 6 months\\nof age, a finding that has been observed in some clinical\\nASD cases and may be correlated with atypical connectivity\\nand altered brain maturation (71, 72).',\n",
              " 'Together, these studies\\nwere essential in validating the hypothesis that maternal\\nautoantibodies have pathologic significance and the potential to\\nalter neurodevelopment (47, 69-71, 73).',\n",
              " 'The passive transfer model was an essential first step\\nin advancing the understanding of maternal autoantibody\\npathogenesis.',\n",
              " 'However, this route of administration does\\nnot reflect the true exposure a fetus would experience\\nduring pregnancy.',\n",
              " 'Thus, to create a more appropriate mimic\\nof the gestational environment where a fetus would be\\nexposed to maternal autoantibodies throughout pregnancy, we\\ngenerated an antigen-driven model of endogenous exposure.',\n",
              " 'In contrast to the passive transfer model, the antigen-driven\\nmodel involves immunizing experimental dams with specific\\nprotein combinations prior to pregnancy, to induce selective,\\nendogenous autoantibody production (64).',\n",
              " 'Clinical studies had\\npreviously identified specific patterns of antigen reactivity as\\nwell as the epitopes recognized by the maternal autoantibodies\\nin human samples (51, 53).',\n",
              " 'This knowledge was then used\\nto generate a mouse model with reliable construct validity to\\nclinical MAR ASD.',\n",
              " 'Described briefly, mouse dams were injected\\nwith synthetic peptide epitopes for lactate dehydrogenase A\\nand B (LDH-A and B), collapsin response mediator protein\\n1 (CRMP1), and stress induced phosphoprotein 1 (STIP1), a\\nprotein reactivity pattern identified in clinical samples specific\\nto mothers of children with ASD (53).',\n",
              " 'Once immune tolerance\\nto the self-proteins was bypassed, these dams continuously\\nproduced autoantibodies to the protein epitopes of interest in the\\nabsence of inflammation and other immune perturbations that\\nare also thought to impact offspring development.',\n",
              " 'This approach\\nresulted in offspring that were exposed to the autoantibodies\\nthroughout the gestational period, more closely resembling the\\nexposure noted in clinical MAR ASD (64).',\n",
              " 'Using the antigen-\\ndriven mouse model, researchers were able to test the behavioral\\nand neurological impacts of constant gestational exposure to\\nmaternal autoantibodies.',\n",
              " 'Offspring from treated dams had\\nreduced social behaviors, including fewer bouts of nose-to-nose\\nsniffing and front approaches.',\n",
              " 'In addition, researchers observed\\nelevated repetitive behaviors, decreased ultrasonic vocalizations,\\nand differences in neuroanatomical development; specifically\\nincreased brain volume in the offspring from treated dams (64,\\nOur current studies seek to build upon this foundation\\nthrough use of an antigen-driven rat model with an expanded\\nrepertoire of maternal antibody combinations recently identified\\nin a large clinical study (52).',\n",
              " 'Recent work identifying the\\nconsequences of acute peripheral immune activation of offspring\\nneurodevelopment (75), suggests that the rat model is a\\npromising next step in understanding the pathology of maternal\\nautoantibodies.',\n",
              " 'The antigen-driven rat model will allow for\\na more thorough identification of the behavioral and social\\nimpacts of maternal autoantibody exposure, thanks to their more\\ncomplex neuroanatomy and social interactions.',\n",
              " 'Additionally,\\nutilizing the specific autoantibody combinations identified in\\nclinical research will allow us to identify the consequences of\\nexposure to select autoantibodies, providing researchers with\\na better understanding of which autoantibody combinations\\nresult in more severe pathology, and which can be used as risk-\\nbiomarkers.',\n",
              " 'Since the development of this model yields dams that\\nproduce autoantibodies in the absence of inflammation, we can\\ndirectly test how skewing of one arm of the maternal immune\\nsystem impacts offspring behavior and neuroanatomy.',\n",
              " 'The rat\\nmodel will not only be more translationally specific, but it will\\nalso provide researchers with a pre-clinical model in which to\\ntest future therapeutic interventions.',\n",
              " 'In the future, we hope to\\nbe able to generate an antigen-driven non-human primate model\\nto further advance our preclinical model.',\n",
              " 'Clinical studies of MAR ASD have revealed the critical\\nprotein targets for maternal autoantibodies and drawn\\nlinks between the specific autoantibody combinations and\\nASD severity.',\n",
              " 'In addition, they have begun to elucidate\\nother immunological factors, such as variances in maternal\\ncytokine/chemokine profile, that can also be used as predictive\\nmeasures for ASD risk.',\n",
              " 'The use of animal models has\\nhelped to confirm the pathologic significance of at least\\nsome of the maternal autoantibodies, as well as provided\\nresearchers with a means to better understand the downstream\\nmolecular consequences and mechanisms involved in these\\neffects.',\n",
              " 'Despite the advances made thus far, many questions\\nremain which, once answered, will aid in the creation of\\nmore precise diagnostic tools, preventative treatments,\\nThere are several questions we are unable to answer using\\nthe animal model, such as: What is the triggering event for\\nmaternal autoantibody production in humans?',\n",
              " 'What are the\\nlongstanding immunological impacts on exposed children?',\n",
              " 'How\\ndoes previous history of autoimmune disease influence ASD\\nrisk through the MAR mechanism?',\n",
              " 'How do autoantibody\\nand cytokine/chemokine levels prior to pregnancy compare\\nto those present during and after pregnancy?',\n",
              " 'To develop\\ntargeted therapeutics, it will also be important to further\\nidentify when offspring are most vulnerable to autoantibody\\nand/or cytokine/chemokine exposure.',\n",
              " 'To answer these questions,\\ncontinued clinical studies and use of our pre-clinical models will\\nbe necessary.',\n",
              " 'The development of a more sophisticated model\\nusing non-human primates would increase the translational\\nability to the more complex behaviors seen in autism.',\n",
              " 'Although\\nsome non-human primate studies have been completed, an\\nantigen-driven model is currently under development, and\\nwe remain hopeful that this will soon be another model for\\nresearchers to utilize.',\n",
              " 'Future research will continue to elucidate\\nthe mechanisms by which maternal autoantibodies impact\\ntheir target proteins, and the optimal intervention strategies\\nto mitigate damage.',\n",
              " 'In addition, we will aim to identify\\nconnections between maternal cytokine/chemokine changes and\\nFrontiers in Psychiatry | www.frontiersin.org\\nJune 2022 | Volume 13 | Article 834910\\n\\x0c McLellan et al.',\n",
              " 'Maternal Risk Factors in ASD\\nAutism is an incredibly complex disorder with a wide range of\\nbehavioral and cognitive phenotypes.',\n",
              " 'Despite multiple known\\netiologies, a preventative strategy for the disorder remains\\nto be discovered.',\n",
              " 'Furthermore, testing for specific phenotypic\\nsubsets of ASD are also lacking.',\n",
              " 'MAR ASD is one subtype\\nof autism in which the maternal immune system plays a\\ncritical role.',\n",
              " 'We now know that specific risk factors exist\\nfor immune mediated ASD, including maternal autoantibody\\nproduction, and skewed maternal and fetal chemokine/cytokine\\nprofile.',\n",
              " 'While much is left to be discovered, we continue\\nto use clinical studies and refined animal models to tease\\napart the mechanisms by which MAR ASD develops.',\n",
              " 'Further,\\nstudies are underway to understand how neonatal cytokines\\nand chemokines influence symptom severity as well as the\\nrelationship between maternal immune dysregulation during\\ngestation and changes in the brain of affected offspring.',\n",
              " '1.',\n",
              " 'Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke $, Abdallah\\nM, et al.',\n",
              " 'Maternal infection requiring hospitalization during pregnancy\\nand autism spectrum disorders.',\n",
              " 'J Autism Dev Disord.',\n",
              " '(2010) 40:1423.',\n",
              " '2.',\n",
              " 'Shi L, Fatemi SH, Sidwell RW, Patterson PH.',\n",
              " 'Maternal influenza infection\\ncauses marked behavioral and pharmacological changes in the offspring[[/i]].',\n",
              " 'J Neurosci.',\n",
              " '(2003) 23:297. doi: 10.1523/JNEUROSCI.23-01-00297.2003\\n3.',\n",
              " 'Stubbs EG, Crawford ML.',\n",
              " 'Depressed lymphocyte responsiveness in autistic\\nchildren.',\n",
              " 'J Autism Child Schizophr.',\n",
              " '(1977) 7:49. doi: 10.1007/BF01531114\\n4.',\n",
              " 'Plioplys AV, Greaves A, Kazemi K, Silverman E. Lymphocyte\\nfunction in autism and Rett syndrome.',\n",
              " 'Neuropsychobiology.',\n",
              " '(1994)\\n5.',\n",
              " 'Warren RP, Foster A, Margaretten NC.',\n",
              " '[[i]]Reduced natural killer cell activity\\nin autism[[/i]].',\n",
              " 'Journal for the American Academy of Child e& Adolescent\\nPsychiatry.',\n",
              " '(1987) 26:333. doi: 10.1097/00004583-198705000-00008\\n6.',\n",
              " 'Sweeten TL, Posey DJ, McDougle CJ.',\n",
              " 'High blood monocyte counts and\\nneopterin levels in children with autistic disorder.',\n",
              " 'Am J Psychiatry.',\n",
              " '(2003)\\n7.',\n",
              " 'MeadJ, Ashwood P. Evidence supporting an altered immune response in ASD.',\n",
              " 'Immunol Lett.',\n",
              " '(2015) 163:49. doi: 10.1016/j.imlet.2014.11.006\\n8.',\n",
              " 'Abdallah MW, Larsen N, Grove J, Bonefeld-Jorgensen EC, Norgaard-\\nPedersen B, Hougaard DM, et al.',\n",
              " 'Neonatal chemokine levels and risk of autism\\nspectrum disorders: findings from a Danish historic birth cohort follow-up\\nstudy.',\n",
              " 'Cytokine.',\n",
              " '(2013) 61:370. doi: 10.1016/j.cyto.2012.11.015\\n9.',\n",
              " 'Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water\\nJ. Elevated plasma cytokines in autism spectrum disorders provide evidence\\nof immune dysfunction and are associated with impaired behavioral outcome.',\n",
              " 'Brain Behav Immun.',\n",
              " '(2011) 25:40. doi: 10.1016/j.bbi.2010.08.003\\n10.',\n",
              " 'Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van\\nde Water J.',\n",
              " 'Associations of impaired behaviors with elevated plasma\\nchemokines in autism spectrum disorders.',\n",
              " 'J Neuroimmunol.',\n",
              " '(2011)\\n11.',\n",
              " 'Zerbo O, Yoshida C, Grether JK, Van de Water J, Ashwood P, Delorenze\\nGN, et al.',\n",
              " 'Neonatal cytokines and chemokines and risk of Autism Spectrum\\nDisorder: the Early Markers for Autism (EMA) study: a case-control study.',\n",
              " 'J\\nNeuroinflammation.',\n",
              " '(2014) 11:113. doi: 10.1186/1742-2094-11-113\\n12.',\n",
              " 'Garty BZ, Ludomirsky A, Danon YL, Peter JB, Douglas SD.',\n",
              " 'Placental\\ntransfer of immunoglobulin G subclasses.',\n",
              " 'Clin Diagn Lab Immunol.',\n",
              " '(1994)\\n13.',\n",
              " 'Roopenian DC, Akilesh $.',\n",
              " 'FcRn: the neonatal Fc receptor comes of age.',\n",
              " 'Nat\\nRev Immunol.',\n",
              " '(2007) 7:715. doi: 10.1038/nri2155\\nWe hope this knowledge will yield future preventatives\\nThis mini-review contains review of research performed by\\neach of the authors.',\n",
              " 'JV is the senior author and oversaw\\nall aspects of this mini-review.',\n",
              " 'JM is the first author and\\ncompiled all of the information from the other authors as\\nwell as wrote the animal model section.',\n",
              " 'DK wrote the section\\non maternal immune activation.',\n",
              " 'MB developed the animal\\nmodels and edited the entire review.',\n",
              " 'AR-C wrote the section on\\nmaternal autoantibodies.',\n",
              " 'All authors contributed to the article\\nand approved the submitted version.',\n",
              " 'NICHD funded IDDRC P50 (P50HD103526).',\n",
              " '14.',\n",
              " 'Pakhathirathien P, Janjindamai W, Dissaneevate $, Thatrimontrichai A,\\nManeenil G. Neonatal outcomes in pregnant women with systemic lupus\\nerythematosus: a 13-year experience in Southern Thailand.',\n",
              " 'J Trop Pediatr.',\n",
              " '(2021) 67:58. doi: 10.1093/tropej/fmab058\\n15.',\n",
              " 'Saunders NR,  Liddelow $A, —Dziegielewska KM.',\n",
              " 'mechanisms in the developing brain.',\n",
              " 'Front\\n16.',\n",
              " 'Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL, Hertz-Picciotto\\nI, et al.',\n",
              " 'Neonatal cytokine profiles associated with autism spectrum disorder.',\n",
              " 'Biol Psychiatry.',\n",
              " '(2017) 81:442. doi: 10.1016/j.biopsych.2015.08.007\\n17.',\n",
              " 'Dammann O, Leviton A. Maternal intrauterine infection, cytokines,\\nand brain damage in the preterm newborn.',\n",
              " 'Pediatr Res.',\n",
              " '(1997)\\n18.',\n",
              " 'Deverman BE, Patterson PH.',\n",
              " 'Cytokines and CNS development.',\n",
              " 'Neuron.',\n",
              " '(2009) 64:61. doi: 10.1016/j.neuron.2009.09.002\\n19.',\n",
              " 'Mousa A, Bakhiet M. Role of cytokine signaling during nervous system\\ndevelopment.',\n",
              " 'Int J Mol Sci.',\n",
              " '(2013) 14:13931. doi: 10.3390/ijms140713931\\n20.',\n",
              " 'Ramesh G, MacLean AG, Philipp MT.',\n",
              " 'Cytokines and chemokines at the\\ncrossroads of neuro-inflammation, neurodegeneration, and neuropathic pain.',\n",
              " 'Mediators Inflamm.',\n",
              " '(2013) 2013:480739. doi: 10.1155/2013/480739\\n21.',\n",
              " 'Goines PE, Ashwood P. Cytokine dysregulation in autism spectrum disorders\\n(ASD): possible role of the environment.',\n",
              " 'Neurotoxicol Teratol.',\n",
              " '(2013)\\n22.',\n",
              " 'Yang C, Hawkins KE, Dore $, Candelario-Jalil E. Neuroinflammatory\\nmechanisms of blood-brain barrier damage in ischemic stroke.',\n",
              " 'Am J Physiol\\nCell Physiol.',\n",
              " '(2019) 316:C135.',\n",
              " 'doi: 10.1152/ajpcell.00136.2018\\n23.',\n",
              " 'Hauguel-de Mouzon $, Guerre-Millo M. The placenta\\nnetwork and inflammatory signals.',\n",
              " 'Placenta.',\n",
              " '(2006)\\n24.',\n",
              " 'Siwetz M, Blaschitz A, El-Heliebi A, Hiden U, Desoye G, Huppertz B, et al.',\n",
              " '‘TNF-alpha alters the inflammatory secretion profile of human first trimester\\nplacenta.',\n",
              " 'Lab Invest.',\n",
              " '(2016) 96:428. doi: 10.1038/labinvest.2015.159\\n25.',\n",
              " 'Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen\\nR, et al.',\n",
              " 'Increased midgestational IFN-gamma, IL-4 and IL-5 in women\\nbearing a child with autism: a case-control study.',\n",
              " 'Mol Autism.',\n",
              " '(2011)\\n26.',\n",
              " \"Carter M, Casey $, O'Keeffe GW, Gibson L, Murray DM.\",\n",
              " 'Mid-\\ngestation cytokine profiles in of children affected by\\nautism spectrum disorder: a case-control study.',\n",
              " 'Sci Rep. (2021)\\n27.',\n",
              " 'Ghassabian A, Albert PS, Hornig M, Yeung E, Cherkerzian $, Goldstein RB, et\\nal.',\n",
              " 'Gestational cytokine concentrations and neurocognitive development at 7\\nyears.',\n",
              " 'Transl Psychiatry.',\n",
              " '(2018) 8:64. doi: 10.1038/s41398-018-0112-z\\nFrontiers in Psychiatry | www.frontiersin.org\\nJune 2022 | Volume 13 | Article 834910']"
            ]
          },
          "metadata": {},
          "execution_count": 80
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "http://bern2.korea.ac.kr/documentation   BERN2 (Advanced Biomedical Entity Recognition and Normalization), a tool that improves the previous neural network-based NER tool (Kim et al., 2019) by employing a multi-task NER model and neural network-based NEN models to achieve much faster and more accurate inference"
      ],
      "metadata": {
        "id": "eoGZrCg730BP"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import hashlib\n",
        "import requests\n",
        "\n",
        "def query_plain(text, url=\"http://bern2.korea.ac.kr/plain\"):\n",
        "    try:\n",
        "        response = requests.post(url, json={'text': text})\n",
        "        response.raise_for_status()  # Raise an exception for non-200 status codes\n",
        "        return response.json()\n",
        "    except requests.exceptions.HTTPError as http_err:\n",
        "        print(f\"HTTP error occurred: {http_err}\")\n",
        "    except requests.exceptions.RequestException as req_err:\n",
        "        print(f\"Request exception occurred: {req_err}\")\n",
        "    except json.JSONDecodeError:\n",
        "        pass  # Ignore JSON decoding errors and move on to the next sentence\n",
        "\n",
        "\n",
        "if __name__ == '__main__':\n",
        "\n",
        "    # Initialize an empty list to store annotations for each sentence\n",
        "    annotations = []\n",
        "\n",
        "    # Iterate over each sentence and retrieve annotations\n",
        "    for sentence in sentences:\n",
        "        annotations.append(query_plain(sentence))\n",
        "\n",
        "    # Print annotations for each sentence\n",
        "    for idx, annotation in enumerate(annotations):\n",
        "        print(f\"Annotations for Sentence {idx + 1}: {annotation}\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "P2M5_uys4jTr",
        "outputId": "380ac400-a746-467c-997d-0847ca9fccdb"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Annotations for Sentence 1: {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'Autism spectrum disorder', 'obj': 'disease', 'prob': 0.9999997019767761, 'span': {'begin': 0, 'end': 24}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999947547912598, 'span': {'begin': 26, 'end': 29}}, {'id': ['mesh:D065886'], 'is_neural_normalized': False, 'mention': 'neurodevelopmental disorder', 'obj': 'disease', 'prob': 0.9999985098838806, 'span': {'begin': 95, 'end': 122}}], 'text': 'Autism spectrum disorder (ASD) is acknowledged as a highly heterogeneous, behaviorally defined neurodevelopmental disorder with multiple etiologies.', 'timestamp': 'Thu Feb 15 20:40:11 +0000 2024'}\n",
            "Annotations for Sentence 2: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998526573181152, 'span': {'begin': 162, 'end': 165}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.9401512742042542, 'span': {'begin': 173, 'end': 178}}], 'text': 'In addition to its high heritability, we have come to recognize a role for maternal immune system dysregulation as a prominent risk factor for the development of ASD in the child.', 'timestamp': 'Thu Feb 15 20:40:12 +0000 2024'}\n",
            "Annotations for Sentence 3: {'annotations': [], 'text': 'Examples of these risk factors include altered cytokine/chemokine activity and the presence of autoantibodies in mothers that are reactive to proteins in the developing brain.', 'timestamp': 'Thu Feb 15 20:40:13 +0000 2024'}\n",
            "Annotations for Sentence 4: {'annotations': [], 'text': 'In addition to large clinical studies, the development of pre-clinical models enables the ability to evaluate the cellular and molecular underpinnings of immune-related pathology.', 'timestamp': 'Thu Feb 15 20:40:14 +0000 2024'}\n",
            "Annotations for Sentence 5: {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'maternal autoantibody- related (MAR) ASD', 'obj': 'disease', 'prob': 0.9991886615753174, 'span': {'begin': 40, 'end': 80}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998546838760376, 'span': {'begin': 199, 'end': 202}}], 'text': 'For example, the novel animal models of maternal autoantibody- related (MAR) ASD described herein will serve as a preclinical platform for the future testing of targeted therapeutics for one type of ASD.', 'timestamp': 'Thu Feb 15 20:40:15 +0000 2024'}\n",
            "Annotations for Sentence 6: {'annotations': [], 'text': 'Identification of the cellular targets will advance Frontiers in Psychiatry | www.frontiersin.org 1 June 2022 | Volume 13 | Article 834910   McLellan et al.', 'timestamp': 'Thu Feb 15 20:40:16 +0000 2024'}\n",
            "Annotations for Sentence 7: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9997811913490295, 'span': {'begin': 25, 'end': 28}}], 'text': 'Maternal Risk Factors in ASD precision medicine efforts toward tailored therapeutics and prevention.', 'timestamp': 'Thu Feb 15 20:40:17 +0000 2024'}\n",
            "Annotations for Sentence 8: {'annotations': [{'id': ['mesh:D007154'], 'is_neural_normalized': True, 'mention': 'maternal immune dysregulation', 'obj': 'disease', 'prob': 0.9331035017967224, 'span': {'begin': 61, 'end': 90}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998258948326111, 'span': {'begin': 187, 'end': 190}}], 'text': 'This minireview highlights emerging evidence for the role of maternal immune dysregulation as a potential biomarker, as well as a pathologically relevant mechanism for the development of ASD in offspring.', 'timestamp': 'Thu Feb 15 20:40:17 +0000 2024'}\n",
            "Annotations for Sentence 9: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999520778656006, 'span': {'begin': 155, 'end': 158}}, {'id': ['mesh:D007154'], 'is_neural_normalized': True, 'mention': 'maternal immune dysregulation', 'obj': 'disease', 'prob': 0.9525726437568665, 'span': {'begin': 252, 'end': 281}}], 'text': 'Further, we will discuss the current limitations of these models as well as potential avenues THE ROLE OF THE MATERNAL IMMUNE SYSTEM IN THE DEVELOPMENT OF ASD In the past two decades, an increasingly large number of studies have provided evidence that maternal immune dysregulation can impact offspring neurodevelopment (1-11).', 'timestamp': 'Thu Feb 15 20:40:18 +0000 2024'}\n",
            "Annotations for Sentence 10: {'annotations': [], 'text': 'For example, it is now well-understood that the maternal immune system plays a critical role in the healthy development of the fetus.', 'timestamp': 'Thu Feb 15 20:40:19 +0000 2024'}\n",
            "Annotations for Sentence 11: {'annotations': [{'id': ['NCBIGene:3500'], 'is_neural_normalized': True, 'mention': 'maternal immunoglobulin G', 'obj': 'gene', 'prob': 0.9953225255012512, 'span': {'begin': 9, 'end': 34}}, {'id': ['NCBIGene:8857'], 'is_neural_normalized': True, 'mention': 'IgG', 'obj': 'gene', 'prob': 0.9908105134963989, 'span': {'begin': 36, 'end': 39}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'infant', 'obj': 'species', 'prob': 0.5590081810951233, 'span': {'begin': 153, 'end': 159}}], 'text': 'In fact, maternal immunoglobulin G (IgG) can cross the placenta and enter the fetal compartment, thereby providing early immunological protection to the infant during the perinatal stage (12, 13).', 'timestamp': 'Thu Feb 15 20:40:21 +0000 2024'}\n",
            "Annotations for Sentence 12: {'annotations': [], 'text': 'However, this protective mechanism is not selective and harmful antibodies reactive to self proteins can also cross the placenta (14).', 'timestamp': 'Thu Feb 15 20:40:21 +0000 2024'}\n",
            "Annotations for Sentence 13: {'annotations': [], 'text': 'Once within the fetal compartment, these maternal autoantibodies may bind to their protein targets, potentially impacting protein function.', 'timestamp': 'Thu Feb 15 20:40:22 +0000 2024'}\n",
            "Annotations for Sentence 14: {'annotations': [], 'text': 'This is especially dangerous during the perinatal period given the permissiveness of the blood- brain barrier (BBB) and vulnerability of the developing central nervous system (CNS) (15).', 'timestamp': 'Thu Feb 15 20:40:23 +0000 2024'}\n",
            "Annotations for Sentence 15: {'annotations': [], 'text': 'In addition to the production of autoantibodies, other perturbations of the maternal immune system can result in harmful effects on the developing fetus.', 'timestamp': 'Thu Feb 15 20:40:24 +0000 2024'}\n",
            "Annotations for Sentence 16: {'annotations': [], 'text': 'It has been shown that alterations in the maternal cytokine/chemokine profile can result in changes in the inflammatory state, skewed cellular signaling, and altered neurodevelopment (16, 17).', 'timestamp': 'Thu Feb 15 20:40:25 +0000 2024'}\n",
            "Annotations for Sentence 17: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9994564652442932, 'span': {'begin': 144, 'end': 147}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9628236889839172, 'span': {'begin': 161, 'end': 169}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999626874923706, 'span': {'begin': 175, 'end': 178}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999051094055176, 'span': {'begin': 223, 'end': 226}}], 'text': 'CYTOKINES AND CHEMOKINES AS In recent years, several researchers have reported on specific cytokines and/or chemokines that are associated with ASD risk both in children with ASD and mothers that have ildren diagnosed with ASD.', 'timestamp': 'Thu Feb 15 20:40:26 +0000 2024'}\n",
            "Annotations for Sentence 18: {'annotations': [], 'text': 'Interestingly, several cytokines nd chemokines are constitutively expressed throughout the developing CNS (18, 19).', 'timestamp': 'Thu Feb 15 20:40:27 +0000 2024'}\n",
            "Annotations for Sentence 19: {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'neuronal and non-neuronal cells', 'obj': 'cell_type', 'prob': 0.8246024250984192, 'span': {'begin': 176, 'end': 207}}], 'text': 'Cytokines in the brain perform functions similar to those seen in the periphery, acting as cues in cell development and differentiation, and regulating the types and number of neuronal and non-neuronal cells (20, 21).', 'timestamp': 'Thu Feb 15 20:40:28 +0000 2024'}\n",
            "Annotations for Sentence 20: {'annotations': [], 'text': 'Together, these complex processes contribute to early neurodevelopment and homeostasis.', 'timestamp': 'Thu Feb 15 20:40:29 +0000 2024'}\n",
            "Annotations for Sentence 21: {'annotations': [{'id': ['NCBIGene:3569'], 'is_neural_normalized': False, 'mention': 'IL-6', 'obj': 'gene', 'prob': 0.9753560423851013, 'span': {'begin': 77, 'end': 81}}], 'text': 'In the context of maternal- fetal interaction, some cytokines, in particular IL-6, can be transported from the mother to the offspring and access e developing CNS (17).', 'timestamp': 'Thu Feb 15 20:40:30 +0000 2024'}\n",
            "Annotations for Sentence 22: {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'neonatal blood samples', 'obj': 'cell_type', 'prob': 0.7486866116523743, 'span': {'begin': 315, 'end': 337}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9997453093528748, 'span': {'begin': 372, 'end': 375}}], 'text': 'Although the source of abnormal cytokine levels in mothers during gestation may differ, this could alter placental production and overall levels of cytokines and chemokines in the fetal compartment, impacting the cascade To date, a variety of clinical studies have demonstrated tered cytokine levels in mothers and neonatal blood samples that are strongly associated with ASD (Table 1), increasing the potential for cytokines/chemokines to serve as biomarkers for risk of abnormal neurodevelopment.', 'timestamp': 'Thu Feb 15 20:40:31 +0000 2024'}\n",
            "Annotations for Sentence 23: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.999893069267273, 'span': {'begin': 47, 'end': 50}}], 'text': 'Most of the reported cytokines associated with ASD induce the BBB to become more permissive (22) increasing the vulnerability and altering the homeostatic levels of cytokines in the developing CNS.', 'timestamp': 'Thu Feb 15 20:40:32 +0000 2024'}\n",
            "Annotations for Sentence 24: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998290538787842, 'span': {'begin': 139, 'end': 142}}, {'id': ['mesh:D011225', 'mim:189800'], 'is_neural_normalized': True, 'mention': 'maternal/fetal infection', 'obj': 'disease', 'prob': 0.999851405620575, 'span': {'begin': 178, 'end': 202}}], 'text': 'Numerous researchers have corroborated the concept that significant changes in maternal cytokine/chemokine homeostasis are correlated with ASD development even in the absence of maternal/fetal infection.', 'timestamp': 'Thu Feb 15 20:40:33 +0000 2024'}\n",
            "Annotations for Sentence 25: {'annotations': [], 'text': 'Such changes in maternal cytokines and chemokines can not only directly impact the fetus but can also stimulate placental production of pro-inflammatory cytokines within the fetal compartment (17, 23, 24).', 'timestamp': 'Thu Feb 15 20:40:34 +0000 2024'}\n",
            "Annotations for Sentence 26: {'annotations': [{'id': ['NCBIGene:215', '81693'], 'is_neural_normalized': True, 'mention': 'amniotic', 'obj': 'gene', 'prob': 0.6666468977928162, 'span': {'begin': 43, 'end': 51}}, {'id': ['NCBIGene:3565'], 'is_neural_normalized': False, 'mention': 'IL-4', 'obj': 'gene', 'prob': 0.7701614499092102, 'span': {'begin': 58, 'end': 62}}, {'id': ['NCBIGene:3569'], 'is_neural_normalized': False, 'mention': 'IL-6', 'obj': 'gene', 'prob': 0.9902611374855042, 'span': {'begin': 64, 'end': 68}}, {'id': ['NCBIGene:3576'], 'is_neural_normalized': False, 'mention': 'IL- 8', 'obj': 'gene', 'prob': 0.9871503114700317, 'span': {'begin': 74, 'end': 79}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.8173210620880127, 'span': {'begin': 114, 'end': 122}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.999924898147583, 'span': {'begin': 128, 'end': 131}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9794467687606812, 'span': {'begin': 256, 'end': 264}}], 'text': 'For example, dysregulation of serum and/or amniotic fluid IL-4, IL-6, and IL- 8 have been described in mothers of children with ASD and were associated with altered behavioral outcomes including non- verbal cognitive ability and stereotypical behaviors in children (25-28).', 'timestamp': 'Thu Feb 15 20:40:36 +0000 2024'}\n",
            "Annotations for Sentence 27: {'annotations': [{'id': ['NCBIGene:3605'], 'is_neural_normalized': True, 'mention': 'cytokine IL-17', 'obj': 'gene', 'prob': 0.6681621670722961, 'span': {'begin': 4, 'end': 18}}, {'id': ['mesh:D065886'], 'is_neural_normalized': False, 'mention': 'neurodevelopmental disorders', 'obj': 'disease', 'prob': 0.9995962381362915, 'span': {'begin': 57, 'end': 85}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999783039093018, 'span': {'begin': 97, 'end': 100}}], 'text': 'The cytokine IL-17, which has been implicated in several neurodevelopmental disorders, including ASD, has been shown to promote inflammation and disrupt the BBB postnatally (29, 30).', 'timestamp': 'Thu Feb 15 20:40:37 +0000 2024'}\n",
            "Annotations for Sentence 28: {'annotations': [{'id': ['NCBIGene:3458'], 'is_neural_normalized': False, 'mention': 'IFN-y', 'obj': 'gene', 'prob': 0.9915488958358765, 'span': {'begin': 13, 'end': 18}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9744454026222229, 'span': {'begin': 127, 'end': 135}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999674558639526, 'span': {'begin': 141, 'end': 144}}], 'text': 'In addition, IFN-y, which is involved in neuronal differentiation and synaptic formation, was shown to be higher in mothers of children with ASD during the second trimester (25, 28), potentially suggesting disrupted synaptic connectivity.', 'timestamp': 'Thu Feb 15 20:40:38 +0000 2024'}\n",
            "Annotations for Sentence 29: {'annotations': [{'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999977350234985, 'span': {'begin': 106, 'end': 112}}], 'text': 'Studies have also observed altered cytokine and chemokine levels in neonates who are later diagnosed with autism.', 'timestamp': 'Thu Feb 15 20:40:39 +0000 2024'}\n",
            "Annotations for Sentence 30: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999656677246094, 'span': {'begin': 66, 'end': 69}}, {'id': ['NCBIGene:3603'], 'is_neural_normalized': False, 'mention': 'IL-16', 'obj': 'gene', 'prob': 0.994965672492981, 'span': {'begin': 103, 'end': 108}}], 'text': 'For example, researchers found that newborns later diagnosed with ASD have higher peripheral levels of IL-16, which is expressed throughout the CNS particularly during the early neurodevelopmental period (16, 21).', 'timestamp': 'Thu Feb 15 20:40:40 +0000 2024'}\n",
            "Annotations for Sentence 31: {'annotations': [{'id': ['NCBIGene:10850'], 'is_neural_normalized': False, 'mention': 'CCL27', 'obj': 'gene', 'prob': 0.9837304353713989, 'span': {'begin': 24, 'end': 29}}, {'id': ['NCBIGene:10850'], 'is_neural_normalized': False, 'mention': 'CTACK', 'obj': 'gene', 'prob': 0.9465448260307312, 'span': {'begin': 45, 'end': 50}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999552965164185, 'span': {'begin': 109, 'end': 112}}], 'text': 'In our recent findings, CCL27, also known as CTACK, was significantly lower in newborns later diagnosed with ASD.', 'timestamp': 'Thu Feb 15 20:40:43 +0000 2024'}\n",
            "Annotations for Sentence 32: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999957084655762, 'span': {'begin': 66, 'end': 69}}, {'id': ['mesh:D008607'], 'is_neural_normalized': False, 'mention': 'intellectual disability', 'obj': 'disease', 'prob': 0.9999973177909851, 'span': {'begin': 87, 'end': 110}}, {'id': ['mesh:D002658'], 'is_neural_normalized': False, 'mention': 'developmental delay', 'obj': 'disease', 'prob': 0.9999982118606567, 'span': {'begin': 142, 'end': 161}}], 'text': 'This decrease was associated with an increase in the risk of both ASD with and without intellectual disability when compared to newborns with developmental delay or those with typical development (31).', 'timestamp': 'Thu Feb 15 20:40:44 +0000 2024'}\n",
            "Annotations for Sentence 33: {'annotations': [{'id': ['NCBIGene:6347'], 'is_neural_normalized': False, 'mention': 'monocyte chemoattractant protein-1', 'obj': 'gene', 'prob': 0.9976604580879211, 'span': {'begin': 19, 'end': 53}}, {'id': ['NCBIGene:6347'], 'is_neural_normalized': False, 'mention': 'MCP- 1', 'obj': 'gene', 'prob': 0.996988832950592, 'span': {'begin': 55, 'end': 61}}, {'id': ['NCBIGene:6367'], 'is_neural_normalized': False, 'mention': 'macrophage-derived chemokine', 'obj': 'gene', 'prob': 0.9942678809165955, 'span': {'begin': 67, 'end': 95}}, {'id': ['NCBIGene:6367'], 'is_neural_normalized': False, 'mention': 'MDC', 'obj': 'gene', 'prob': 0.9877848029136658, 'span': {'begin': 97, 'end': 100}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9334511160850525, 'span': {'begin': 183, 'end': 191}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999099969863892, 'span': {'begin': 197, 'end': 200}}], 'text': 'Elevated levels of monocyte chemoattractant protein-1 (MCP- 1) and macrophage-derived chemokine (MDC) were found in the amniotic fluid, plasma, cerebellum, and cerebrospinal fluid of children with ASD (10, 32, 33), implying involvement of these chemokines in neurodevelopment.', 'timestamp': 'Thu Feb 15 20:40:46 +0000 2024'}\n",
            "Annotations for Sentence 34: {'annotations': [{'id': ['NCBIGene:6348'], 'is_neural_normalized': True, 'mention': 'macrophage inflammatory protein-1', 'obj': 'gene', 'prob': 0.9729967713356018, 'span': {'begin': 35, 'end': 68}}, {'id': ['NCBIGene:3842'], 'is_neural_normalized': False, 'mention': 'MIP-1', 'obj': 'gene', 'prob': 0.995566725730896, 'span': {'begin': 70, 'end': 75}}, {'id': ['NCBIGene:6356'], 'is_neural_normalized': True, 'mention': 'eotaxin', 'obj': 'gene', 'prob': 0.728026270866394, 'span': {'begin': 81, 'end': 88}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9049980640411377, 'span': {'begin': 113, 'end': 121}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999443292617798, 'span': {'begin': 127, 'end': 130}}], 'text': 'Increased levels of the chemokines macrophage inflammatory protein-1 (MIP-1) and eotaxin are also often noted in children with ASD, and have been associated with behavioral deficits (10, 34-36).', 'timestamp': 'Thu Feb 15 20:40:48 +0000 2024'}\n",
            "Annotations for Sentence 35: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999014139175415, 'span': {'begin': 90, 'end': 93}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999974966049194, 'span': {'begin': 212, 'end': 218}}], 'text': 'It is unlikely that one specific cytokine or chemokine plays a role in the development of ASD, but rather a combination of cytokines/chemokines are more likely to contribute to the neuropathology associated with autism.', 'timestamp': 'Thu Feb 15 20:40:49 +0000 2024'}\n",
            "Annotations for Sentence 36: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9997778534889221, 'span': {'begin': 94, 'end': 97}}], 'text': 'The exact consequences of altered cytokine/chemokine levels during pregnancy that lead to the ASD phenotype is an important area of research.', 'timestamp': 'Thu Feb 15 20:40:50 +0000 2024'}\n",
            "Annotations for Sentence 37: {'annotations': [], 'text': 'Furthermore, the trigger(s) for changes in maternal cytokine and chemokine levels, and how other aspects of the maternal immune system may also be affected are essential questions to address.', 'timestamp': 'Thu Feb 15 20:40:51 +0000 2024'}\n",
            "Annotations for Sentence 38: {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'infant', 'obj': 'species', 'prob': 0.845718264579773, 'span': {'begin': 110, 'end': 116}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9482090473175049, 'span': {'begin': 258, 'end': 266}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999017715454102, 'span': {'begin': 272, 'end': 275}}], 'text': 'Although the number of research studies that include time-specific/longitudinal examination as well as mother-infant pair-matched studies are lacking, it is promising that similar groups of cytokines and chemokines are frequently shown to be altered in both children with ASD and their mothers, increasing Frontiers in Psychiatry | www.frontiersin.org June 2022 | Volume 13 | Article 834910   McLellan et al.', 'timestamp': 'Thu Feb 15 20:40:52 +0000 2024'}\n",
            "Annotations for Sentence 39: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999369382858276, 'span': {'begin': 25, 'end': 28}}, {'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'maternal autoantibody targets', 'obj': 'DNA', 'prob': 0.5790223479270935, 'span': {'begin': 73, 'end': 102}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999796152114868, 'span': {'begin': 117, 'end': 120}}], 'text': 'Maternal Risk Factors in ASD TABLE 1 | Maternal cytokines/chemokines and maternal autoantibody targets implicated in ASD.', 'timestamp': 'Thu Feb 15 20:40:52 +0000 2024'}\n",
            "Annotations for Sentence 40: {'annotations': [{'id': ['NCBIGene:3552'], 'is_neural_normalized': False, 'mention': 'IL-1', 'obj': 'gene', 'prob': 0.99137282371521, 'span': {'begin': 45, 'end': 49}}, {'id': ['NCBIGene:3565'], 'is_neural_normalized': False, 'mention': 'IL-4', 'obj': 'gene', 'prob': 0.9811803102493286, 'span': {'begin': 51, 'end': 55}}, {'id': ['NCBIGene:3567'], 'is_neural_normalized': False, 'mention': 'IL-5', 'obj': 'gene', 'prob': 0.9802108407020569, 'span': {'begin': 57, 'end': 61}}, {'id': ['NCBIGene:3576'], 'is_neural_normalized': False, 'mention': 'IL-8', 'obj': 'gene', 'prob': 0.9743618965148926, 'span': {'begin': 63, 'end': 67}}, {'id': ['NCBIGene:3574'], 'is_neural_normalized': True, 'mention': 'IL-7A', 'obj': 'gene', 'prob': 0.9953019618988037, 'span': {'begin': 69, 'end': 74}}, {'id': ['NCBIGene:3458'], 'is_neural_normalized': False, 'mention': 'IFN-y', 'obj': 'gene', 'prob': 0.9906409382820129, 'span': {'begin': 76, 'end': 81}}, {'id': ['NCBIGene:3565'], 'is_neural_normalized': False, 'mention': 'IL-4', 'obj': 'gene', 'prob': 0.9942848086357117, 'span': {'begin': 134, 'end': 138}}, {'id': ['NCBIGene:3587'], 'is_neural_normalized': True, 'mention': 'IL-10MCP-1TNF-a', 'obj': 'gene', 'prob': 0.9929863810539246, 'span': {'begin': 140, 'end': 155}}, {'id': ['NCBIGene:4049'], 'is_neural_normalized': False, 'mention': 'TNF-B', 'obj': 'gene', 'prob': 0.99400395154953, 'span': {'begin': 157, 'end': 162}}, {'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'CRMP1', 'obj': 'gene', 'prob': 0.9900533556938171, 'span': {'begin': 219, 'end': 224}}, {'id': ['NCBIGene:1808'], 'is_neural_normalized': False, 'mention': 'CRMP2', 'obj': 'gene', 'prob': 0.9846120476722717, 'span': {'begin': 226, 'end': 231}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'STIP1', 'obj': 'gene', 'prob': 0.9933784604072571, 'span': {'begin': 233, 'end': 238}}, {'id': ['NCBIGene:4904'], 'is_neural_normalized': True, 'mention': 'YBOX', 'obj': 'gene', 'prob': 0.9891681671142578, 'span': {'begin': 240, 'end': 244}}, {'id': ['NCBIGene:3939'], 'is_neural_normalized': False, 'mention': 'LDH-A', 'obj': 'gene', 'prob': 0.9970669150352478, 'span': {'begin': 322, 'end': 327}}, {'id': ['NCBIGene:3945'], 'is_neural_normalized': False, 'mention': 'LDH-B', 'obj': 'gene', 'prob': 0.996402382850647, 'span': {'begin': 329, 'end': 334}}, {'id': ['NCBIGene:9615'], 'is_neural_normalized': False, 'mention': 'GDA', 'obj': 'gene', 'prob': 0.9944157600402832, 'span': {'begin': 336, 'end': 339}}, {'id': ['NCBIGene:2026'], 'is_neural_normalized': False, 'mention': 'NSE', 'obj': 'gene', 'prob': 0.9953380823135376, 'span': {'begin': 341, 'end': 344}}, {'id': ['NCBIGene:26047'], 'is_neural_normalized': False, 'mention': 'CASPR2', 'obj': 'gene', 'prob': 0.9425560832023621, 'span': {'begin': 378, 'end': 384}}, {'id': ['NCBIGene:9247'], 'is_neural_normalized': True, 'mention': 'maternal IgG', 'obj': 'gene', 'prob': 0.9910596609115601, 'span': {'begin': 585, 'end': 597}}, {'id': ['mesh:D065886'], 'is_neural_normalized': False, 'mention': 'neurodevelopmental impairments', 'obj': 'disease', 'prob': 0.9999959468841553, 'span': {'begin': 617, 'end': 647}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.716987669467926, 'span': {'begin': 655, 'end': 660}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.999992847442627, 'span': {'begin': 672, 'end': 675}}], 'text': 'Cytokines/chemokines Sample source Reference IL-1, IL-4, IL-5, IL-8, IL-7A, IFN-y Maternal serum collected mid-gestation (25, 26, 28) IL-4, IL-10MCP-1TNF-a, TNF-B Amniotic fluid (27, 32) Target antigen Protein function CRMP1, CRMP2, STIP1, YBOX Microtubule dynamics, protein chaperone, transcription factor (12-14, 42-44) LDH-A, LDH-B, GDA, NSE Metabolic enzymes (14-16, 37-41) CASPR2 Cell adhesion (45, 52) the promise of cytokines and chemokines as biomarkers for risk MATERNAL AUTOANTIBODY TARGETS IN Several groups have now identified multiple brain antigens that cross-react with maternal IgG and are related to neurodevelopmental impairments in the child, including ASD (37-45).', 'timestamp': 'Thu Feb 15 20:40:57 +0000 2024'}\n",
            "Annotations for Sentence 41: {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'maternal plasma', 'obj': 'cell_type', 'prob': 0.573803186416626, 'span': {'begin': 49, 'end': 64}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999656677246094, 'span': {'begin': 162, 'end': 165}}], 'text': 'Early studies used fetal brain extracts to probe maternal plasma by western blot (WB) and reported reactivity to bands at ~36 kDa that were present in 10% of the ASD samples vs. only 2% of controls.', 'timestamp': 'Thu Feb 15 20:40:58 +0000 2024'}\n",
            "Annotations for Sentence 42: {'annotations': [{'id': ['NCBIGene:9247'], 'is_neural_normalized': True, 'mention': 'maternal IgG', 'obj': 'gene', 'prob': 0.9775835275650024, 'span': {'begin': 37, 'end': 49}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998959302902222, 'span': {'begin': 112, 'end': 115}}], 'text': 'In addition, they observed increased maternal IgG cross-reactivity to multiple bands at 27, 36, at 73 kD in the ASD-positive mothers (46).', 'timestamp': 'Thu Feb 15 20:40:59 +0000 2024'}\n",
            "Annotations for Sentence 43: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999517202377319, 'span': {'begin': 102, 'end': 105}}], 'text': 'Concurrent studies reported similar band patterns of reactivity at 37/73 kDa and 39/73 kDa which were ASD specific and not present in controls (47-50).', 'timestamp': 'Thu Feb 15 20:41:00 +0000 2024'}\n",
            "Annotations for Sentence 44: {'annotations': [{'id': ['NCBIGene:54828'], 'is_neural_normalized': True, 'mention': 'maternal autoantibody', 'obj': 'gene', 'prob': 0.7877233624458313, 'span': {'begin': 110, 'end': 131}}, {'id': ['NCBIGene:3659'], 'is_neural_normalized': False, 'mention': 'MAR', 'obj': 'gene', 'prob': 0.710262656211853, 'span': {'begin': 141, 'end': 144}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999457597732544, 'span': {'begin': 146, 'end': 149}}, {'id': ['NCBIGene:414'], 'is_neural_normalized': True, 'mention': 'ASD antigens', 'obj': 'gene', 'prob': 0.5137134194374084, 'span': {'begin': 146, 'end': 158}}], 'text': 'Several groups, including our own, conducted a series of experiments that lead to the identification of eight maternal autoantibody-related (MAR) ASD antigens and their pathogenic epitopes (51-54).', 'timestamp': 'Thu Feb 15 20:41:01 +0000 2024'}\n",
            "Annotations for Sentence 45: {'annotations': [{'id': ['NCBIGene:1400'], 'is_neural_normalized': True, 'mention': 'collapsin response mediator proteins 1 and 2', 'obj': 'gene', 'prob': 0.9983932375907898, 'span': {'begin': 32, 'end': 76}}, {'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'CRMP1', 'obj': 'gene', 'prob': 0.9858659505844116, 'span': {'begin': 78, 'end': 83}}, {'id': ['NCBIGene:1808'], 'is_neural_normalized': False, 'mention': 'CRMP2', 'obj': 'gene', 'prob': 0.9871776103973389, 'span': {'begin': 85, 'end': 90}}, {'id': ['mesh:D006147'], 'is_neural_normalized': False, 'mention': 'guanine', 'obj': 'drug', 'prob': 0.9984839558601379, 'span': {'begin': 93, 'end': 100}}, {'id': ['NCBIGene:9615'], 'is_neural_normalized': False, 'mention': 'guanine deaminase', 'obj': 'gene', 'prob': 0.9783497452735901, 'span': {'begin': 93, 'end': 110}}, {'id': ['NCBIGene:9615'], 'is_neural_normalized': False, 'mention': 'cypin', 'obj': 'gene', 'prob': 0.9633235335350037, 'span': {'begin': 114, 'end': 119}}, {'id': ['NCBIGene:9615'], 'is_neural_normalized': False, 'mention': 'GDA', 'obj': 'gene', 'prob': 0.9967974424362183, 'span': {'begin': 121, 'end': 124}}, {'id': ['mesh:D019344'], 'is_neural_normalized': False, 'mention': 'lactate', 'obj': 'drug', 'prob': 0.9954426288604736, 'span': {'begin': 127, 'end': 134}}, {'id': ['NCBIGene:3939'], 'is_neural_normalized': False, 'mention': 'lactate dehydrogenase A', 'obj': 'gene', 'prob': 0.981489896774292, 'span': {'begin': 127, 'end': 150}}, {'id': ['NCBIGene:3939'], 'is_neural_normalized': False, 'mention': 'LDHA', 'obj': 'gene', 'prob': 0.9975763559341431, 'span': {'begin': 158, 'end': 162}}, {'id': ['NCBIGene:3945'], 'is_neural_normalized': False, 'mention': 'LDHB', 'obj': 'gene', 'prob': 0.9959751963615417, 'span': {'begin': 164, 'end': 168}}, {'id': ['NCBIGene:2026'], 'is_neural_normalized': False, 'mention': 'neuron-specific enolase', 'obj': 'gene', 'prob': 0.9964224696159363, 'span': {'begin': 171, 'end': 194}}, {'id': ['NCBIGene:2026'], 'is_neural_normalized': False, 'mention': 'NSE', 'obj': 'gene', 'prob': 0.9927749037742615, 'span': {'begin': 196, 'end': 199}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'stress-induced phosphoprotein-1', 'obj': 'gene', 'prob': 0.9960516691207886, 'span': {'begin': 202, 'end': 233}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'STIP1', 'obj': 'gene', 'prob': 0.9951144456863403, 'span': {'begin': 235, 'end': 240}}, {'id': ['NCBIGene:4904'], 'is_neural_normalized': False, 'mention': 'YBX1', 'obj': 'gene', 'prob': 0.9972219467163086, 'span': {'begin': 272, 'end': 276}}], 'text': 'The proteins were identified as collapsin response mediator proteins 1 and 2 (CRMP1, CRMP2), guanine deaminase or cypin (GDA), lactate dehydrogenase A and B (LDHA, LDHB), neuron-specific enolase (NSE), stress-induced phosphoprotein-1 (STIP1), and Y-box binding protein 1 (YBX1) (functions are summarized in Table 1).', 'timestamp': 'Thu Feb 15 20:41:09 +0000 2024'}\n",
            "Annotations for Sentence 46: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999120235443115, 'span': {'begin': 214, 'end': 217}}], 'text': 'In this early study, instances of maternal seroreactivity to at least one of the proteins in both the case and control groups was observed, indicating that reactivity to any single antigen is not enough to predict ASD risk.', 'timestamp': 'Thu Feb 15 20:41:10 +0000 2024'}\n",
            "Annotations for Sentence 47: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9322324395179749, 'span': {'begin': 75, 'end': 78}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.9590169787406921, 'span': {'begin': 113, 'end': 118}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999744892120361, 'span': {'begin': 130, 'end': 133}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998156428337097, 'span': {'begin': 167, 'end': 170}}, {'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9258397817611694, 'span': {'begin': 220, 'end': 227}}, {'id': ['NCBIGene:3939'], 'is_neural_normalized': False, 'mention': 'LDHA', 'obj': 'gene', 'prob': 0.9976282715797424, 'span': {'begin': 246, 'end': 250}}, {'id': ['NCBIGene:3945'], 'is_neural_normalized': False, 'mention': 'LDHB', 'obj': 'gene', 'prob': 0.9982452392578125, 'span': {'begin': 251, 'end': 255}}, {'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'CRMP1', 'obj': 'gene', 'prob': 0.9974269866943359, 'span': {'begin': 256, 'end': 261}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'STIP1', 'obj': 'gene', 'prob': 0.9981192350387573, 'span': {'begin': 262, 'end': 267}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999300241470337, 'span': {'begin': 273, 'end': 276}}, {'id': ['mesh:D010900'], 'is_neural_normalized': True, 'mention': 'TD', 'obj': 'disease', 'prob': nan, 'span': {'begin': 284, 'end': 286}}], 'text': 'Instead, reactivity to a combination of two or more specific antigens (MAR ASD patterns) increased the risk of a child developing ASD with high accuracy: up to 20% of ASD cases and <1% of the controls; the most relevant MAR ASD pattern found was LDHA+LDHB+CRMP1+STIP1 (23% ASD vs. 1% TD) (51).', 'timestamp': 'Thu Feb 15 20:41:12 +0000 2024'}\n",
            "Annotations for Sentence 48: {'annotations': [], 'text': 'In a more recent study using machine learning techniques, Ramiz-Celis et al.', 'timestamp': 'Thu Feb 15 20:41:13 +0000 2024'}\n",
            "Annotations for Sentence 49: {'annotations': [{'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'CRMP1', 'obj': 'gene', 'prob': 0.9960671067237854, 'span': {'begin': 56, 'end': 61}}, {'id': ['NCBIGene:1808'], 'is_neural_normalized': False, 'mention': 'CRMP2', 'obj': 'gene', 'prob': 0.9976612329483032, 'span': {'begin': 62, 'end': 67}}, {'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'CRMP1', 'obj': 'gene', 'prob': 0.9948980212211609, 'span': {'begin': 69, 'end': 74}}, {'id': ['NCBIGene:9615'], 'is_neural_normalized': False, 'mention': 'GDA', 'obj': 'gene', 'prob': 0.998193085193634, 'span': {'begin': 75, 'end': 78}}, {'id': ['NCBIGene:2026'], 'is_neural_normalized': False, 'mention': 'NSE', 'obj': 'gene', 'prob': 0.997380793094635, 'span': {'begin': 84, 'end': 87}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'STIP1', 'obj': 'gene', 'prob': 0.9986073970794678, 'span': {'begin': 88, 'end': 93}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9997978806495667, 'span': {'begin': 117, 'end': 120}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999234676361084, 'span': {'begin': 219, 'end': 222}}], 'text': 'demonstrated that autoantibody combinations composed of CRMP1+CRMP2, CRMP1+GDA, and NSE+STIP1 predicted up to 20% of ASD cases with 100% accuracy, suggesting a significant potential for these patterns as biomarkers for ASD risk (52).', 'timestamp': 'Thu Feb 15 20:41:16 +0000 2024'}\n",
            "Annotations for Sentence 50: {'annotations': [{'id': ['NCBIGene:9247'], 'is_neural_normalized': True, 'mention': 'maternal IgG', 'obj': 'gene', 'prob': 0.9053129553794861, 'span': {'begin': 33, 'end': 45}}, {'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'brain', 'obj': 'DNA', 'prob': 0.46132969856262207, 'span': {'begin': 71, 'end': 76}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999372959136963, 'span': {'begin': 99, 'end': 102}}], 'text': 'Other groups have also looked at maternal IgG reactivity to individual brain antigens as potential ASD predictors.', 'timestamp': 'Thu Feb 15 20:41:17 +0000 2024'}\n",
            "Annotations for Sentence 51: {'annotations': [{'id': ['NCBIGene:26047'], 'is_neural_normalized': True, 'mention': 'contactin associated protein 2', 'obj': 'gene', 'prob': 0.9972642064094543, 'span': {'begin': 89, 'end': 119}}, {'id': ['NCBIGene:26047'], 'is_neural_normalized': False, 'mention': 'CASPR2', 'obj': 'gene', 'prob': 0.9953427910804749, 'span': {'begin': 121, 'end': 127}}, {'id': ['mesh:D016202'], 'is_neural_normalized': False, 'mention': 'N- methyl-D-aspartate', 'obj': 'drug', 'prob': 0.9991720914840698, 'span': {'begin': 146, 'end': 167}}, {'id': ['NCBIGene:2902'], 'is_neural_normalized': True, 'mention': 'N- methyl-D-aspartate receptor', 'obj': 'gene', 'prob': 0.9530954360961914, 'span': {'begin': 146, 'end': 176}}, {'id': ['mesh:D016202'], 'is_neural_normalized': False, 'mention': 'NMDA', 'obj': 'drug', 'prob': 0.9997475147247314, 'span': {'begin': 178, 'end': 182}}, {'id': ['NCBIGene:2902'], 'is_neural_normalized': True, 'mention': 'NMDA receptor', 'obj': 'gene', 'prob': 0.9870545268058777, 'span': {'begin': 178, 'end': 191}}], 'text': 'Due to their pivotal roles in neurodevelopment, the two most well-studied candidates are contactin associated protein 2 (CASPR2) (43, 44, 55) and N- methyl-D-aspartate receptor (NMDA receptor) (56).', 'timestamp': 'Thu Feb 15 20:41:19 +0000 2024'}\n",
            "Annotations for Sentence 52: {'annotations': [{'id': ['mesh:D009422'], 'is_neural_normalized': True, 'mention': 'neurological alterations', 'obj': 'disease', 'prob': 0.999948263168335, 'span': {'begin': 104, 'end': 128}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.999984622001648, 'span': {'begin': 157, 'end': 160}}], 'text': 'Further, several groups have reported that maternal seroreactivity to these proteins is associated with neurological alterations in the offspring, including ASD (37, 38, 40, 57, 58).', 'timestamp': 'Thu Feb 15 20:41:20 +0000 2024'}\n",
            "Annotations for Sentence 53: {'annotations': [], 'text': 'For example, Brimberg et al.', 'timestamp': 'Thu Feb 15 20:41:21 +0000 2024'}\n",
            "Annotations for Sentence 54: {'annotations': [{'id': ['NCBIGene:26047'], 'is_neural_normalized': True, 'mention': 'anti- CASPR2 antibodies', 'obj': 'gene', 'prob': 0.9898569583892822, 'span': {'begin': 14, 'end': 37}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.8592066168785095, 'span': {'begin': 68, 'end': 73}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999979734420776, 'span': {'begin': 79, 'end': 85}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9996733665466309, 'span': {'begin': 121, 'end': 124}}], 'text': 'reported that anti- CASPR2 antibodies were elevated in mothers of a child with autism when compared to the controls (37% ASD vs. 8% TD) (44, 59).', 'timestamp': 'Thu Feb 15 20:41:22 +0000 2024'}\n",
            "Annotations for Sentence 55: {'annotations': [{'id': ['NCBIGene:9247'], 'is_neural_normalized': True, 'mention': 'maternal IgG', 'obj': 'gene', 'prob': 0.9856336116790771, 'span': {'begin': 58, 'end': 70}}, {'id': ['NCBIGene:26047'], 'is_neural_normalized': False, 'mention': 'CASPR2', 'obj': 'gene', 'prob': 0.9740037322044373, 'span': {'begin': 130, 'end': 136}}, {'id': ['mesh:D016202'], 'is_neural_normalized': False, 'mention': 'NMDA', 'obj': 'drug', 'prob': 0.9994372725486755, 'span': {'begin': 141, 'end': 145}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.901480495929718, 'span': {'begin': 151, 'end': 156}}, {'id': ['mesh:D008607'], 'is_neural_normalized': False, 'mention': 'intellectual disability', 'obj': 'disease', 'prob': 0.9999987483024597, 'span': {'begin': 233, 'end': 256}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999923706054688, 'span': {'begin': 270, 'end': 273}}], 'text': 'However, results from a recent Danish study that examined maternal IgG cross-reactivity against several brain proteins (including CASPR2 and NMDA) and child outcomes concluded that seroreactivity to both proteins was associated with intellectual disability but not with ASD specifically (43, 60).', 'timestamp': 'Thu Feb 15 20:41:23 +0000 2024'}\n",
            "Annotations for Sentence 56: {'annotations': [{'id': ['NCBIGene:26047'], 'is_neural_normalized': False, 'mention': 'CASPR2', 'obj': 'gene', 'prob': 0.9802144765853882, 'span': {'begin': 87, 'end': 93}}, {'id': ['mesh:D016202'], 'is_neural_normalized': False, 'mention': 'NMDA', 'obj': 'drug', 'prob': 0.9988634586334229, 'span': {'begin': 98, 'end': 102}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999508857727051, 'span': {'begin': 166, 'end': 169}}], 'text': 'However, experiments using animal models suggests that maternal autoantibodies against CASPR2 and NMDA can disrupt proper neuronal function/development and result in ASD-like manifestations in the offspring (43-45, 56).', 'timestamp': 'Thu Feb 15 20:41:25 +0000 2024'}\n",
            "Annotations for Sentence 57: {'annotations': [], 'text': 'Given data from the various studies, the pathologic significance of gestational exposure to maternal autoantibodies is clearly complex and future analyses will be needed to determine how their presence leads to specific changes in neurodevelopment.', 'timestamp': 'Thu Feb 15 20:41:26 +0000 2024'}\n",
            "Annotations for Sentence 58: {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9813899397850037, 'span': {'begin': 31, 'end': 39}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999244213104248, 'span': {'begin': 45, 'end': 48}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.957843005657196, 'span': {'begin': 71, 'end': 79}}, {'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'maternal blood', 'obj': 'cell_type', 'prob': 0.5321471691131592, 'span': {'begin': 122, 'end': 136}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.999728262424469, 'span': {'begin': 165, 'end': 168}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.9294071793556213, 'span': {'begin': 337, 'end': 342}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999080896377563, 'span': {'begin': 354, 'end': 357}}], 'text': 'In one study of 450 mothers of children with ASD and 342 mothers of TD children, the presence of select autoantibodies in maternal blood was associated with ~20% of ASD cases compared to <1% of the typically developing (TD) controls, suggesting that these autoantibodies appear to be highly specific in their ability to detect risk of a child getting an ASD diagnosis (51, 52).', 'timestamp': 'Thu Feb 15 20:41:27 +0000 2024'}\n",
            "Annotations for Sentence 59: {'annotations': [{'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999973773956299, 'span': {'begin': 53, 'end': 59}}, {'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'single gene mutation', 'obj': 'DNA', 'prob': 0.721057116985321, 'span': {'begin': 140, 'end': 160}}], 'text': 'Therefore, at this point in time, the association of autism with maternal autoantibodies to proteins in developing brain is higher than any single gene mutation described thus far (61, 62).', 'timestamp': 'Thu Feb 15 20:41:27 +0000 2024'}\n",
            "Annotations for Sentence 60: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9997871518135071, 'span': {'begin': 20, 'end': 23}}], 'text': 'This MAR subtype of ASD is now a focus of intense clinical and pre-clinical research.', 'timestamp': 'Thu Feb 15 20:41:28 +0000 2024'}\n",
            "Annotations for Sentence 61: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999113082885742, 'span': {'begin': 24, 'end': 27}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.8521215915679932, 'span': {'begin': 50, 'end': 58}}], 'text': 'It is believed that the ASD phenotype observed in children of mothers with these autoantibodies is the result of gestational exposure to these pathologically significant autoantibodies (47, 63-68).', 'timestamp': 'Thu Feb 15 20:41:29 +0000 2024'}\n",
            "Annotations for Sentence 62: {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.8464388251304626, 'span': {'begin': 164, 'end': 169}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999940395355225, 'span': {'begin': 191, 'end': 197}}], 'text': 'While rigorous clinical validation is still necessary, maternal autoantibodies have the potential to be used as a precision medicine tool to evaluate the risk of a child being diagnosed with autism.', 'timestamp': 'Thu Feb 15 20:41:30 +0000 2024'}\n",
            "Annotations for Sentence 63: {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9988762140274048, 'span': {'begin': 29, 'end': 36}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.8766207695007324, 'span': {'begin': 138, 'end': 143}}, {'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9999220967292786, 'span': {'begin': 246, 'end': 253}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'women', 'obj': 'species', 'prob': 0.8597068786621094, 'span': {'begin': 282, 'end': 287}}], 'text': 'The etiological relevance of MAR ASD was supported by multiple clinical studies in diverse populations and by experimental rodent and non-human primate animal models [reviewed in (37, 40, 58)], that in the future could lead to the development of MAR ASD prophylactic treatments for women at risk.', 'timestamp': 'Thu Feb 15 20:41:31 +0000 2024'}\n",
            "Annotations for Sentence 64: {'annotations': [], 'text': 'Frontiers in Psychiatry | www.frontiersin.org June 2022 | Volume 13 | Article 834910   McLellan et al.', 'timestamp': 'Thu Feb 15 20:41:32 +0000 2024'}\n",
            "Annotations for Sentence 65: {'annotations': [{'id': ['mesh:D000757', 'mim:206500'], 'is_neural_normalized': True, 'mention': 'ASD of the fetal brain', 'obj': 'disease', 'prob': 0.9774920344352722, 'span': {'begin': 25, 'end': 47}}], 'text': 'Maternal Risk Factors in ASD of the fetal brain FIGURE 1 | Schematic of maternal cytokines and autoantibodies affecting fetal brain development as studied using animal models.', 'timestamp': 'Thu Feb 15 20:41:33 +0000 2024'}\n",
            "Annotations for Sentence 66: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999264478683472, 'span': {'begin': 87, 'end': 90}}], 'text': 'Dysregulation of maternal immune system is a strong risk factor for the development of ASD.', 'timestamp': 'Thu Feb 15 20:41:34 +0000 2024'}\n",
            "Annotations for Sentence 67: {'annotations': [], 'text': 'Alterations in the production of maternal cytokines and chemokines can impact the neurodevelopmental process, and the presence of maternal autoantibodies reactive to critical proteins can alter how the developmental trajectory of the brain.', 'timestamp': 'Thu Feb 15 20:41:35 +0000 2024'}\n",
            "Annotations for Sentence 68: {'annotations': [], 'text': 'Pre-clinical models are used to better understand the underlying mechanisms for both proposed pathways to altered neurodevelopment.', 'timestamp': 'Thu Feb 15 20:41:36 +0000 2024'}\n",
            "Annotations for Sentence 69: {'annotations': [], 'text': 'The figure was generated by Biorender.', 'timestamp': 'Thu Feb 15 20:41:36 +0000 2024'}\n",
            "Annotations for Sentence 70: {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'MAR ASD profiles', 'obj': 'DNA', 'prob': 0.5918079018592834, 'span': {'begin': 9, 'end': 25}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9716665148735046, 'span': {'begin': 13, 'end': 16}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999064207077026, 'span': {'begin': 40, 'end': 43}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999983310699463, 'span': {'begin': 77, 'end': 83}}], 'text': 'Although MAR ASD profiles are promising ASD-risk biomarkers for a subtype of autism, substantial analytical and clinical validation is still needed before they can be introduced into clinical practice.', 'timestamp': 'Thu Feb 15 20:41:37 +0000 2024'}\n",
            "Annotations for Sentence 71: {'annotations': [], 'text': 'Meanwhile, the use of in vitro and in vivo animal models will allow us to better understand the pathogenic mechanisms of maternal autoantibodies in neurodevelopment.', 'timestamp': 'Thu Feb 15 20:41:38 +0000 2024'}\n",
            "Annotations for Sentence 72: {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9999203085899353, 'span': {'begin': 154, 'end': 161}}], 'text': 'In addition, they will have the potential to facilitate development of prophylactic treatments to mitigate the neurodevelopmental changes associated with MAR ASD.', 'timestamp': 'Thu Feb 15 20:41:39 +0000 2024'}\n",
            "Annotations for Sentence 73: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9307954907417297, 'span': {'begin': 21, 'end': 24}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998507499694824, 'span': {'begin': 103, 'end': 106}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999523162841797, 'span': {'begin': 208, 'end': 211}}], 'text': 'ANIMAL MODELS OF MAR ASD While strong correlations between the presence of maternal autoantibodies and ASD diagnosis have been observed, the pathological role of maternal autoantibodies in the development of ASD is the focus of ongoing research.', 'timestamp': 'Thu Feb 15 20:41:40 +0000 2024'}\n",
            "Annotations for Sentence 74: {'annotations': [{'id': ['NCBITaxon:10095'], 'is_neural_normalized': False, 'mention': 'mice', 'obj': 'species', 'prob': 0.9878788590431213, 'span': {'begin': 39, 'end': 43}}, {'id': ['NCBITaxon:10116'], 'is_neural_normalized': False, 'mention': 'rats', 'obj': 'species', 'prob': 0.9822346568107605, 'span': {'begin': 45, 'end': 49}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.6242618560791016, 'span': {'begin': 59, 'end': 64}}], 'text': 'Multiple preclinical models, including mice, rats, and non-human primates have been utilized to understand the underlying pathology associated with the presence of these maternal autoantibodies (Figure 1).', 'timestamp': 'Thu Feb 15 20:41:41 +0000 2024'}\n",
            "Annotations for Sentence 75: {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.999980628490448, 'span': {'begin': 23, 'end': 30}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9740291833877563, 'span': {'begin': 123, 'end': 131}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999924898147583, 'span': {'begin': 137, 'end': 143}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.948393702507019, 'span': {'begin': 184, 'end': 192}}], 'text': 'Early animal models of MAR ASD relied on a passive transfer method, utilizing purified antibodies isolated from mothers of children with autism or from mothers of typically developing children that were transferred to an otherwise healthy animal during gestation.', 'timestamp': 'Thu Feb 15 20:41:42 +0000 2024'}\n",
            "Annotations for Sentence 76: {'annotations': [{'id': ['NCBITaxon:10095'], 'is_neural_normalized': False, 'mention': 'mice', 'obj': 'species', 'prob': 0.9801454544067383, 'span': {'begin': 19, 'end': 23}}], 'text': 'First conducted in mice, and subsequently in non-human primates, the passive transfer models yielded two main findings: (1) They confirmed that maternal antibodies do cross the placenta and can be detected in fetal tissues, including the brain, and (2) they confirmed that exposure to maternal autoantibodies results in changes in offspring behavior and brain development.', 'timestamp': 'Thu Feb 15 20:41:43 +0000 2024'}\n",
            "Annotations for Sentence 77: {'annotations': [{'id': ['NCBITaxon:10090'], 'is_neural_normalized': False, 'mention': 'mouse', 'obj': 'species', 'prob': 0.9445799589157104, 'span': {'begin': 38, 'end': 43}}, {'id': ['NCBIGene:8857'], 'is_neural_normalized': True, 'mention': 'IgG', 'obj': 'gene', 'prob': 0.9953233599662781, 'span': {'begin': 63, 'end': 66}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9677581787109375, 'span': {'begin': 83, 'end': 91}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999326467514038, 'span': {'begin': 97, 'end': 100}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999603033065796, 'span': {'begin': 215, 'end': 218}}], 'text': 'More specifically, the offspring from mouse dams that received IgG from mothers of children with ASD spent more time in self-grooming and marble-burying behavior, reflective of the stereotypic behaviors observed in ASD.', 'timestamp': 'Thu Feb 15 20:41:44 +0000 2024'}\n",
            "Annotations for Sentence 78: {'annotations': [{'id': ['mesh:D001008', 'mim:607834'], 'is_neural_normalized': False, 'mention': 'anxiety', 'obj': 'disease', 'prob': 0.9460899829864502, 'span': {'begin': 37, 'end': 44}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9344565272331238, 'span': {'begin': 65, 'end': 73}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999786615371704, 'span': {'begin': 79, 'end': 82}}], 'text': 'They also showed increased levels of anxiety, a comorbidity many children with ASD experience (69, 70).', 'timestamp': 'Thu Feb 15 20:41:45 +0000 2024'}\n",
            "Annotations for Sentence 79: {'annotations': [{'id': ['NCBIGene:8857'], 'is_neural_normalized': True, 'mention': 'IgG', 'obj': 'gene', 'prob': 0.9935850501060486, 'span': {'begin': 13, 'end': 16}}, {'id': ['NCBIGene:8857'], 'is_neural_normalized': True, 'mention': 'IgG', 'obj': 'gene', 'prob': 0.9950403571128845, 'span': {'begin': 91, 'end': 94}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9565671682357788, 'span': {'begin': 111, 'end': 119}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999264478683472, 'span': {'begin': 125, 'end': 128}}], 'text': 'Furthermore, IgG deposition was observed in the brains of offspring from dams treated with IgG from mothers of children with ASD, but not in controls (69, 70).', 'timestamp': 'Thu Feb 15 20:41:46 +0000 2024'}\n",
            "Annotations for Sentence 80: {'annotations': [{'id': ['NCBIGene:26047'], 'is_neural_normalized': False, 'mention': 'CASPR2', 'obj': 'gene', 'prob': 0.9702601432800293, 'span': {'begin': 55, 'end': 61}}, {'id': ['mesh:D016202'], 'is_neural_normalized': False, 'mention': 'NMDA', 'obj': 'drug', 'prob': 0.9982113838195801, 'span': {'begin': 66, 'end': 70}}], 'text': 'Similar passive transfer models studying antibodies to CASPR2 and NMDA have also yielded important findings.', 'timestamp': 'Thu Feb 15 20:41:48 +0000 2024'}\n",
            "Annotations for Sentence 81: {'annotations': [{'id': ['NCBITaxon:10090'], 'is_neural_normalized': False, 'mention': 'mouse', 'obj': 'species', 'prob': 0.9756489396095276, 'span': {'begin': 14, 'end': 19}}, {'id': ['NCBIGene:26047'], 'is_neural_normalized': True, 'mention': 'anti-CASPR2 antibodies', 'obj': 'gene', 'prob': 0.9893642663955688, 'span': {'begin': 41, 'end': 63}}, {'id': ['NCBITaxon:10090'], 'is_neural_normalized': False, 'mention': 'mouse', 'obj': 'species', 'prob': 0.9755010008811951, 'span': {'begin': 215, 'end': 220}}], 'text': 'In one study, mouse offspring exposed to anti-CASPR2 antibodies at gestational day 13.5 had differences in sociability, as determined by the amount of time spent with an unfamiliar object vs. an unfamiliar stimulus mouse.', 'timestamp': 'Thu Feb 15 20:41:49 +0000 2024'}\n",
            "Annotations for Sentence 82: {'annotations': [{'id': ['NCBIGene:26047'], 'is_neural_normalized': True, 'mention': 'anti-CASPR2 antibodies', 'obj': 'gene', 'prob': 0.9924180507659912, 'span': {'begin': 55, 'end': 77}}], 'text': 'In addition, fetuses examined 2 days after exposure to anti-CASPR2 antibodies showed reduced cortical thickness and changes in cell proliferation (44).', 'timestamp': 'Thu Feb 15 20:41:50 +0000 2024'}\n",
            "Annotations for Sentence 83: {'annotations': [{'id': ['NCBIGene:2902', '27158'], 'is_neural_normalized': True, 'mention': 'NR1 subunit', 'obj': 'gene', 'prob': 0.9828261137008667, 'span': {'begin': 16, 'end': 27}}, {'id': ['mesh:D016202'], 'is_neural_normalized': False, 'mention': 'NMDA', 'obj': 'drug', 'prob': 0.9993700385093689, 'span': {'begin': 31, 'end': 35}}, {'id': ['NCBIGene:2902'], 'is_neural_normalized': True, 'mention': 'NMDA receptor', 'obj': 'gene', 'prob': 0.964963972568512, 'span': {'begin': 31, 'end': 44}}], 'text': 'Exposure to the NR1 subunit of NMDA receptor at gestational days 13 and 17 resulted in offspring who displayed impaired early postnatal reflexes and decreased prepulse inhibition (56).', 'timestamp': 'Thu Feb 15 20:41:51 +0000 2024'}\n",
            "Annotations for Sentence 84: {'annotations': [], 'text': 'In non-human primate passive transfer studies, the results were similar, with offspring from treated dams displaying increased stereotypic behaviors with both novel and familiar social partners (47).', 'timestamp': 'Thu Feb 15 20:41:52 +0000 2024'}\n",
            "Annotations for Sentence 85: {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'offspring', 'obj': 'cell_type', 'prob': 0.5227325558662415, 'span': {'begin': 29, 'end': 38}}], 'text': 'When examining the brains of offspring Frontiers in Psychiatry | www.frontiersin.org 4 June 2022 | Volume 13 | Article 834910   McLellan et al.', 'timestamp': 'Thu Feb 15 20:41:53 +0000 2024'}\n",
            "Annotations for Sentence 86: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999769926071167, 'span': {'begin': 25, 'end': 28}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9995729327201843, 'span': {'begin': 203, 'end': 206}}], 'text': 'Maternal Risk Factors in ASD from treated dams, investigators noted that male offspring had a higher rate of brain growth between 3 and 6 months of age, a finding that has been observed in some clinical ASD cases and may be correlated with atypical connectivity and altered brain maturation (71, 72).', 'timestamp': 'Thu Feb 15 20:41:54 +0000 2024'}\n",
            "Annotations for Sentence 87: {'annotations': [], 'text': 'Together, these studies were essential in validating the hypothesis that maternal autoantibodies have pathologic significance and the potential to alter neurodevelopment (47, 69-71, 73).', 'timestamp': 'Thu Feb 15 20:41:55 +0000 2024'}\n",
            "Annotations for Sentence 88: {'annotations': [], 'text': 'The passive transfer model was an essential first step in advancing the understanding of maternal autoantibody pathogenesis.', 'timestamp': 'Thu Feb 15 20:41:56 +0000 2024'}\n",
            "Annotations for Sentence 89: {'annotations': [], 'text': 'However, this route of administration does not reflect the true exposure a fetus would experience during pregnancy.', 'timestamp': 'Thu Feb 15 20:41:57 +0000 2024'}\n",
            "Annotations for Sentence 90: {'annotations': [], 'text': 'Thus, to create a more appropriate mimic of the gestational environment where a fetus would be exposed to maternal autoantibodies throughout pregnancy, we generated an antigen-driven model of endogenous exposure.', 'timestamp': 'Thu Feb 15 20:41:57 +0000 2024'}\n",
            "Annotations for Sentence 91: {'annotations': [], 'text': 'In contrast to the passive transfer model, the antigen-driven model involves immunizing experimental dams with specific protein combinations prior to pregnancy, to induce selective, endogenous autoantibody production (64).', 'timestamp': 'Thu Feb 15 20:41:58 +0000 2024'}\n",
            "Annotations for Sentence 92: {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'epitopes', 'obj': 'DNA', 'prob': 0.49439477920532227, 'span': {'begin': 98, 'end': 106}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.9834879040718079, 'span': {'begin': 152, 'end': 157}}], 'text': 'Clinical studies had previously identified specific patterns of antigen reactivity as well as the epitopes recognized by the maternal autoantibodies in human samples (51, 53).', 'timestamp': 'Thu Feb 15 20:41:59 +0000 2024'}\n",
            "Annotations for Sentence 93: {'annotations': [{'id': ['NCBITaxon:10090'], 'is_neural_normalized': False, 'mention': 'mouse', 'obj': 'species', 'prob': 0.9757382273674011, 'span': {'begin': 43, 'end': 48}}, {'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9999598860740662, 'span': {'begin': 100, 'end': 107}}], 'text': 'This knowledge was then used to generate a mouse model with reliable construct validity to clinical MAR ASD.', 'timestamp': 'Thu Feb 15 20:42:00 +0000 2024'}\n",
            "Annotations for Sentence 94: {'annotations': [{'id': ['NCBITaxon:10090'], 'is_neural_normalized': False, 'mention': 'mouse', 'obj': 'species', 'prob': 0.9806675910949707, 'span': {'begin': 19, 'end': 24}}, {'id': ['mesh:D019344'], 'is_neural_normalized': False, 'mention': 'lactate', 'obj': 'drug', 'prob': 0.9905713796615601, 'span': {'begin': 80, 'end': 87}}, {'id': ['NCBIGene:3945'], 'is_neural_normalized': True, 'mention': 'lactate dehydrogenase A and B', 'obj': 'gene', 'prob': 0.9942095279693604, 'span': {'begin': 80, 'end': 109}}, {'id': ['NCBIGene:3945'], 'is_neural_normalized': True, 'mention': 'LDH-A and B', 'obj': 'gene', 'prob': 0.994158923625946, 'span': {'begin': 111, 'end': 122}}, {'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'collapsin response mediator protein 1', 'obj': 'gene', 'prob': 0.9981132745742798, 'span': {'begin': 125, 'end': 162}}, {'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'CRMP1', 'obj': 'gene', 'prob': 0.994620680809021, 'span': {'begin': 164, 'end': 169}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'stress induced phosphoprotein 1', 'obj': 'gene', 'prob': 0.9963170886039734, 'span': {'begin': 176, 'end': 207}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'STIP1', 'obj': 'gene', 'prob': 0.9952114224433899, 'span': {'begin': 209, 'end': 214}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.923226535320282, 'span': {'begin': 300, 'end': 308}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999514818191528, 'span': {'begin': 314, 'end': 317}}], 'text': 'Described briefly, mouse dams were injected with synthetic peptide epitopes for lactate dehydrogenase A and B (LDH-A and B), collapsin response mediator protein 1 (CRMP1), and stress induced phosphoprotein 1 (STIP1), a protein reactivity pattern identified in clinical samples specific to mothers of children with ASD (53).', 'timestamp': 'Thu Feb 15 20:42:07 +0000 2024'}\n",
            "Annotations for Sentence 95: {'annotations': [{'id': ['mesh:D007249'], 'is_neural_normalized': False, 'mention': 'inflammation', 'obj': 'disease', 'prob': 0.9850060343742371, 'span': {'begin': 159, 'end': 171}}], 'text': 'Once immune tolerance to the self-proteins was bypassed, these dams continuously produced autoantibodies to the protein epitopes of interest in the absence of inflammation and other immune perturbations that are also thought to impact offspring development.', 'timestamp': 'Thu Feb 15 20:42:08 +0000 2024'}\n",
            "Annotations for Sentence 96: {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9999671578407288, 'span': {'begin': 166, 'end': 173}}], 'text': 'This approach resulted in offspring that were exposed to the autoantibodies throughout the gestational period, more closely resembling the exposure noted in clinical MAR ASD (64).', 'timestamp': 'Thu Feb 15 20:42:09 +0000 2024'}\n",
            "Annotations for Sentence 97: {'annotations': [{'id': ['NCBITaxon:10090'], 'is_neural_normalized': False, 'mention': 'mouse', 'obj': 'species', 'prob': 0.9768286943435669, 'span': {'begin': 26, 'end': 31}}], 'text': 'Using the antigen- driven mouse model, researchers were able to test the behavioral and neurological impacts of constant gestational exposure to maternal autoantibodies.', 'timestamp': 'Thu Feb 15 20:42:10 +0000 2024'}\n",
            "Annotations for Sentence 98: {'annotations': [], 'text': 'Offspring from treated dams had reduced social behaviors, including fewer bouts of nose-to-nose sniffing and front approaches.', 'timestamp': 'Thu Feb 15 20:42:10 +0000 2024'}\n",
            "Annotations for Sentence 99: {'annotations': [{'id': ['NCBITaxon:10116'], 'is_neural_normalized': False, 'mention': 'rat', 'obj': 'species', 'prob': 0.9778521060943604, 'span': {'begin': 313, 'end': 316}}], 'text': 'In addition, researchers observed elevated repetitive behaviors, decreased ultrasonic vocalizations, and differences in neuroanatomical development; specifically increased brain volume in the offspring from treated dams (64, Our current studies seek to build upon this foundation through use of an antigen-driven rat model with an expanded repertoire of maternal antibody combinations recently identified in a large clinical study (52).', 'timestamp': 'Thu Feb 15 20:42:11 +0000 2024'}\n",
            "Annotations for Sentence 100: {'annotations': [{'id': ['NCBITaxon:10116'], 'is_neural_normalized': False, 'mention': 'rat', 'obj': 'species', 'prob': 0.9581597447395325, 'span': {'begin': 133, 'end': 136}}], 'text': 'Recent work identifying the consequences of acute peripheral immune activation of offspring neurodevelopment (75), suggests that the rat model is a promising next step in understanding the pathology of maternal autoantibodies.', 'timestamp': 'Thu Feb 15 20:42:12 +0000 2024'}\n",
            "Annotations for Sentence 101: {'annotations': [{'id': ['NCBITaxon:10116'], 'is_neural_normalized': False, 'mention': 'rat', 'obj': 'species', 'prob': 0.9754912257194519, 'span': {'begin': 19, 'end': 22}}], 'text': 'The antigen-driven rat model will allow for a more thorough identification of the behavioral and social impacts of maternal autoantibody exposure, thanks to their more complex neuroanatomy and social interactions.', 'timestamp': 'Thu Feb 15 20:42:13 +0000 2024'}\n",
            "Annotations for Sentence 102: {'annotations': [], 'text': 'Additionally, utilizing the specific autoantibody combinations identified in clinical research will allow us to identify the consequences of exposure to select autoantibodies, providing researchers with a better understanding of which autoantibody combinations result in more severe pathology, and which can be used as risk- biomarkers.', 'timestamp': 'Thu Feb 15 20:42:14 +0000 2024'}\n",
            "Annotations for Sentence 103: {'annotations': [], 'text': 'Since the development of this model yields dams that produce autoantibodies in the absence of inflammation, we can directly test how skewing of one arm of the maternal immune system impacts offspring behavior and neuroanatomy.', 'timestamp': 'Thu Feb 15 20:42:15 +0000 2024'}\n",
            "Annotations for Sentence 104: {'annotations': [{'id': ['NCBITaxon:10116'], 'is_neural_normalized': False, 'mention': 'rat', 'obj': 'species', 'prob': 0.9773371815681458, 'span': {'begin': 4, 'end': 7}}], 'text': 'The rat model will not only be more translationally specific, but it will also provide researchers with a pre-clinical model in which to test future therapeutic interventions.', 'timestamp': 'Thu Feb 15 20:42:16 +0000 2024'}\n",
            "Annotations for Sentence 105: {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.8369669914245605, 'span': {'begin': 68, 'end': 73}}], 'text': 'In the future, we hope to be able to generate an antigen-driven non-human primate model to further advance our preclinical model.', 'timestamp': 'Thu Feb 15 20:42:17 +0000 2024'}\n",
            "Annotations for Sentence 106: {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9902240037918091, 'span': {'begin': 20, 'end': 27}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998918771743774, 'span': {'begin': 166, 'end': 169}}], 'text': 'Clinical studies of MAR ASD have revealed the critical protein targets for maternal autoantibodies and drawn links between the specific autoantibody combinations and ASD severity.', 'timestamp': 'Thu Feb 15 20:42:18 +0000 2024'}\n",
            "Annotations for Sentence 107: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998979568481445, 'span': {'begin': 178, 'end': 181}}], 'text': 'In addition, they have begun to elucidate other immunological factors, such as variances in maternal cytokine/chemokine profile, that can also be used as predictive measures for ASD risk.', 'timestamp': 'Thu Feb 15 20:42:19 +0000 2024'}\n",
            "Annotations for Sentence 108: {'annotations': [], 'text': 'The use of animal models has helped to confirm the pathologic significance of at least some of the maternal autoantibodies, as well as provided researchers with a means to better understand the downstream molecular consequences and mechanisms involved in these effects.', 'timestamp': 'Thu Feb 15 20:42:19 +0000 2024'}\n",
            "Annotations for Sentence 109: {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'humans', 'obj': 'species', 'prob': 0.9901012182235718, 'span': {'begin': 318, 'end': 324}}], 'text': 'Despite the advances made thus far, many questions remain which, once answered, will aid in the creation of more precise diagnostic tools, preventative treatments, There are several questions we are unable to answer using the animal model, such as: What is the triggering event for maternal autoantibody production in humans?', 'timestamp': 'Thu Feb 15 20:42:20 +0000 2024'}\n",
            "Annotations for Sentence 110: {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9892298579216003, 'span': {'begin': 59, 'end': 67}}], 'text': 'What are the longstanding immunological impacts on exposed children?', 'timestamp': 'Thu Feb 15 20:42:21 +0000 2024'}\n",
            "Annotations for Sentence 111: {'annotations': [{'id': ['mesh:D001327', 'mim:109100'], 'is_neural_normalized': False, 'mention': 'autoimmune disease', 'obj': 'disease', 'prob': 0.999987006187439, 'span': {'begin': 29, 'end': 47}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999896287918091, 'span': {'begin': 58, 'end': 61}}, {'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'MAR', 'obj': 'DNA', 'prob': 0.8635894060134888, 'span': {'begin': 79, 'end': 82}}], 'text': 'How does previous history of autoimmune disease influence ASD risk through the MAR mechanism?', 'timestamp': 'Thu Feb 15 20:42:22 +0000 2024'}\n",
            "Annotations for Sentence 112: {'annotations': [], 'text': 'How do autoantibody and cytokine/chemokine levels prior to pregnancy compare to those present during and after pregnancy?', 'timestamp': 'Thu Feb 15 20:42:23 +0000 2024'}\n",
            "Annotations for Sentence 113: {'annotations': [], 'text': 'To develop targeted therapeutics, it will also be important to further identify when offspring are most vulnerable to autoantibody and/or cytokine/chemokine exposure.', 'timestamp': 'Thu Feb 15 20:42:24 +0000 2024'}\n",
            "Annotations for Sentence 114: {'annotations': [], 'text': 'To answer these questions, continued clinical studies and use of our pre-clinical models will be necessary.', 'timestamp': 'Thu Feb 15 20:42:25 +0000 2024'}\n",
            "Annotations for Sentence 115: {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.6483522057533264, 'span': {'begin': 56, 'end': 61}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999978542327881, 'span': {'begin': 150, 'end': 156}}], 'text': 'The development of a more sophisticated model using non-human primates would increase the translational ability to the more complex behaviors seen in autism.', 'timestamp': 'Thu Feb 15 20:42:26 +0000 2024'}\n",
            "Annotations for Sentence 116: {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.908327043056488, 'span': {'begin': 18, 'end': 23}}, {'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'antigen', 'obj': 'cell_line', 'prob': 0.5355033874511719, 'span': {'begin': 64, 'end': 71}}], 'text': 'Although some non-human primate studies have been completed, an antigen-driven model is currently under development, and we remain hopeful that this will soon be another model for researchers to utilize.', 'timestamp': 'Thu Feb 15 20:42:27 +0000 2024'}\n",
            "Annotations for Sentence 117: {'annotations': [], 'text': 'Future research will continue to elucidate the mechanisms by which maternal autoantibodies impact their target proteins, and the optimal intervention strategies to mitigate damage.', 'timestamp': 'Thu Feb 15 20:42:28 +0000 2024'}\n",
            "Annotations for Sentence 118: {'annotations': [], 'text': 'In addition, we will aim to identify connections between maternal cytokine/chemokine changes and Frontiers in Psychiatry | www.frontiersin.org June 2022 | Volume 13 | Article 834910   McLellan et al.', 'timestamp': 'Thu Feb 15 20:42:28 +0000 2024'}\n",
            "Annotations for Sentence 119: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999856948852539, 'span': {'begin': 25, 'end': 28}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'Autism', 'obj': 'disease', 'prob': 0.9999972581863403, 'span': {'begin': 29, 'end': 35}}], 'text': 'Maternal Risk Factors in ASD Autism is an incredibly complex disorder with a wide range of behavioral and cognitive phenotypes.', 'timestamp': 'Thu Feb 15 20:42:29 +0000 2024'}\n",
            "Annotations for Sentence 120: {'annotations': [], 'text': 'Despite multiple known etiologies, a preventative strategy for the disorder remains to be discovered.', 'timestamp': 'Thu Feb 15 20:42:30 +0000 2024'}\n",
            "Annotations for Sentence 121: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999479055404663, 'span': {'begin': 56, 'end': 59}}], 'text': 'Furthermore, testing for specific phenotypic subsets of ASD are also lacking.', 'timestamp': 'Thu Feb 15 20:42:31 +0000 2024'}\n",
            "Annotations for Sentence 122: {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9999834895133972, 'span': {'begin': 0, 'end': 7}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999951124191284, 'span': {'begin': 26, 'end': 32}}], 'text': 'MAR ASD is one subtype of autism in which the maternal immune system plays a critical role.', 'timestamp': 'Thu Feb 15 20:42:32 +0000 2024'}\n",
            "Annotations for Sentence 123: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9943702816963196, 'span': {'begin': 65, 'end': 68}}], 'text': 'We now know that specific risk factors exist for immune mediated ASD, including maternal autoantibody production, and skewed maternal and fetal chemokine/cytokine profile.', 'timestamp': 'Thu Feb 15 20:42:33 +0000 2024'}\n",
            "Annotations for Sentence 124: {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9999322295188904, 'span': {'begin': 138, 'end': 145}}], 'text': 'While much is left to be discovered, we continue to use clinical studies and refined animal models to tease apart the mechanisms by which MAR ASD develops.', 'timestamp': 'Thu Feb 15 20:42:34 +0000 2024'}\n",
            "Annotations for Sentence 125: {'annotations': [{'id': ['mesh:D007154'], 'is_neural_normalized': True, 'mention': 'maternal immune dysregulation', 'obj': 'disease', 'prob': 0.9988955855369568, 'span': {'begin': 145, 'end': 174}}], 'text': 'Further, studies are underway to understand how neonatal cytokines and chemokines influence symptom severity as well as the relationship between maternal immune dysregulation during gestation and changes in the brain of affected offspring.', 'timestamp': 'Thu Feb 15 20:42:35 +0000 2024'}\n",
            "Annotations for Sentence 126: {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:42:35 +0000 2024'}\n",
            "Annotations for Sentence 127: {'annotations': [], 'text': 'Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke $, Abdallah M, et al.', 'timestamp': 'Thu Feb 15 20:42:36 +0000 2024'}\n",
            "Annotations for Sentence 128: {'annotations': [{'id': ['mesh:D011645'], 'is_neural_normalized': True, 'mention': 'Maternal infection', 'obj': 'disease', 'prob': 0.9649432897567749, 'span': {'begin': 0, 'end': 18}}, {'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorders', 'obj': 'disease', 'prob': 0.9999992847442627, 'span': {'begin': 66, 'end': 91}}], 'text': 'Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders.', 'timestamp': 'Thu Feb 15 20:42:37 +0000 2024'}\n",
            "Annotations for Sentence 129: {'annotations': [], 'text': 'J Autism Dev Disord.', 'timestamp': 'Thu Feb 15 20:42:38 +0000 2024'}\n",
            "Annotations for Sentence 130: {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:42:39 +0000 2024'}\n",
            "Annotations for Sentence 131: {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:42:40 +0000 2024'}\n",
            "Annotations for Sentence 132: {'annotations': [], 'text': 'Shi L, Fatemi SH, Sidwell RW, Patterson PH.', 'timestamp': 'Thu Feb 15 20:42:41 +0000 2024'}\n",
            "Annotations for Sentence 133: {'annotations': [{'id': ['mesh:D007251'], 'is_neural_normalized': True, 'mention': 'Maternal influenza infection', 'obj': 'disease', 'prob': 0.9814167022705078, 'span': {'begin': 0, 'end': 28}}], 'text': 'Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring[[/i]].', 'timestamp': 'Thu Feb 15 20:42:42 +0000 2024'}\n",
            "Annotations for Sentence 134: {'annotations': [], 'text': 'J Neurosci.', 'timestamp': 'Thu Feb 15 20:42:42 +0000 2024'}\n",
            "Annotations for Sentence 135: {'annotations': [], 'text': '(2003) 23:297. doi: 10.1523/JNEUROSCI.23-01-00297.2003 3.', 'timestamp': 'Thu Feb 15 20:42:43 +0000 2024'}\n",
            "Annotations for Sentence 136: {'annotations': [], 'text': 'Stubbs EG, Crawford ML.', 'timestamp': 'Thu Feb 15 20:42:44 +0000 2024'}\n",
            "Annotations for Sentence 137: {'annotations': [{'id': ['CL:0000542'], 'is_neural_normalized': False, 'mention': 'lymphocyte', 'obj': 'cell_type', 'prob': 0.8063668012619019, 'span': {'begin': 10, 'end': 20}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autistic', 'obj': 'disease', 'prob': 0.9999948740005493, 'span': {'begin': 39, 'end': 47}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9225614666938782, 'span': {'begin': 48, 'end': 56}}], 'text': 'Depressed lymphocyte responsiveness in autistic children.', 'timestamp': 'Thu Feb 15 20:42:45 +0000 2024'}\n",
            "Annotations for Sentence 138: {'annotations': [], 'text': 'J Autism Child Schizophr.', 'timestamp': 'Thu Feb 15 20:42:46 +0000 2024'}\n",
            "Annotations for Sentence 139: {'annotations': [], 'text': '(1977) 7:49. doi: 10.1007/BF01531114 4.', 'timestamp': 'Thu Feb 15 20:42:47 +0000 2024'}\n",
            "Annotations for Sentence 140: {'annotations': [{'id': ['CL:0000542'], 'is_neural_normalized': False, 'mention': 'Lymphocyte', 'obj': 'cell_type', 'prob': 0.7759126424789429, 'span': {'begin': 47, 'end': 57}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999985694885254, 'span': {'begin': 70, 'end': 76}}, {'id': ['mesh:D015518', 'mim:312750'], 'is_neural_normalized': False, 'mention': 'Rett syndrome', 'obj': 'disease', 'prob': 0.9999986886978149, 'span': {'begin': 81, 'end': 94}}], 'text': 'Plioplys AV, Greaves A, Kazemi K, Silverman E. Lymphocyte function in autism and Rett syndrome.', 'timestamp': 'Thu Feb 15 20:42:48 +0000 2024'}\n",
            "Annotations for Sentence 141: {'annotations': [], 'text': 'Neuropsychobiology.', 'timestamp': 'Thu Feb 15 20:42:49 +0000 2024'}\n",
            "Annotations for Sentence 142: {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:42:50 +0000 2024'}\n",
            "Annotations for Sentence 143: {'annotations': [], 'text': 'Warren RP, Foster A, Margaretten NC.', 'timestamp': 'Thu Feb 15 20:42:51 +0000 2024'}\n",
            "Annotations for Sentence 144: {'annotations': [{'id': ['CL:0000623'], 'is_neural_normalized': False, 'mention': 'natural killer cell', 'obj': 'cell_type', 'prob': 0.9017917513847351, 'span': {'begin': 13, 'end': 32}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.999996542930603, 'span': {'begin': 45, 'end': 51}}], 'text': '[[i]]Reduced natural killer cell activity in autism[[/i]].', 'timestamp': 'Thu Feb 15 20:42:52 +0000 2024'}\n",
            "Annotations for Sentence 145: {'annotations': [], 'text': 'Journal for the American Academy of Child e& Adolescent Psychiatry.', 'timestamp': 'Thu Feb 15 20:42:52 +0000 2024'}\n",
            "Annotations for Sentence 146: {'annotations': [], 'text': '(1987) 26:333. doi: 10.1097/00004583-198705000-00008 6.', 'timestamp': 'Thu Feb 15 20:42:53 +0000 2024'}\n",
            "Annotations for Sentence 147: {'annotations': [], 'text': 'Sweeten TL, Posey DJ, McDougle CJ.', 'timestamp': 'Thu Feb 15 20:42:54 +0000 2024'}\n",
            "Annotations for Sentence 148: {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'blood monocyte', 'obj': 'cell_type', 'prob': 0.8414391279220581, 'span': {'begin': 5, 'end': 19}}, {'id': ['mesh:D019798'], 'is_neural_normalized': False, 'mention': 'neopterin', 'obj': 'drug', 'prob': 0.9659011363983154, 'span': {'begin': 31, 'end': 40}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9142366051673889, 'span': {'begin': 51, 'end': 59}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autistic disorder', 'obj': 'disease', 'prob': 0.9999994039535522, 'span': {'begin': 65, 'end': 82}}], 'text': 'High blood monocyte counts and neopterin levels in children with autistic disorder.', 'timestamp': 'Thu Feb 15 20:42:55 +0000 2024'}\n",
            "Annotations for Sentence 149: {'annotations': [], 'text': 'Am J Psychiatry.', 'timestamp': 'Thu Feb 15 20:42:56 +0000 2024'}\n",
            "Annotations for Sentence 150: {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:42:57 +0000 2024'}\n",
            "Annotations for Sentence 151: {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999289512634277, 'span': {'begin': 68, 'end': 71}}], 'text': 'MeadJ, Ashwood P. Evidence supporting an altered immune response in ASD.', 'timestamp': 'Thu Feb 15 20:42:58 +0000 2024'}\n",
            "Annotations for Sentence 152: {'annotations': [], 'text': 'Immunol Lett.', 'timestamp': 'Thu Feb 15 20:42:59 +0000 2024'}\n",
            "Annotations for Sentence 153: {'annotations': [], 'text': '(2015) 163:49. doi: 10.1016/j.imlet.2014.11.006 8.', 'timestamp': 'Thu Feb 15 20:43:00 +0000 2024'}\n",
            "Annotations for Sentence 154: {'annotations': [], 'text': 'Abdallah MW, Larsen N, Grove J, Bonefeld-Jorgensen EC, Norgaard- Pedersen B, Hougaard DM, et al.', 'timestamp': 'Thu Feb 15 20:43:01 +0000 2024'}\n",
            "Annotations for Sentence 155: {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorders', 'obj': 'disease', 'prob': 0.9999992251396179, 'span': {'begin': 38, 'end': 63}}], 'text': 'Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study.', 'timestamp': 'Thu Feb 15 20:43:02 +0000 2024'}\n",
            "Annotations for Sentence 156: {'annotations': [], 'text': 'Cytokine.', 'timestamp': 'Thu Feb 15 20:43:03 +0000 2024'}\n",
            "Annotations for Sentence 157: {'annotations': [], 'text': '(2013) 61:370. doi: 10.1016/j.cyto.2012.11.015 9.', 'timestamp': 'Thu Feb 15 20:43:04 +0000 2024'}\n",
            "Annotations for Sentence 158: {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorders', 'obj': 'disease', 'prob': 0.9999992251396179, 'span': {'begin': 108, 'end': 133}}, {'id': ['mesh:D007154'], 'is_neural_normalized': False, 'mention': 'immune dysfunction', 'obj': 'disease', 'prob': 0.9997198581695557, 'span': {'begin': 154, 'end': 172}}], 'text': 'Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.', 'timestamp': 'Thu Feb 15 20:43:07 +0000 2024'}\n",
            "Annotations for Sentence 159: {'annotations': [], 'text': 'Brain Behav Immun.', 'timestamp': 'Thu Feb 15 20:43:08 +0000 2024'}\n",
            "Annotations for Sentence 160: {'annotations': [], 'text': '(2011) 25:40. doi: 10.1016/j.bbi.2010.08.003 10.', 'timestamp': 'Thu Feb 15 20:43:09 +0000 2024'}\n",
            "Annotations for Sentence 161: {'annotations': [], 'text': 'Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J.', 'timestamp': 'Thu Feb 15 20:43:10 +0000 2024'}\n",
            "Annotations for Sentence 162: {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorders', 'obj': 'disease', 'prob': 0.9999993443489075, 'span': {'begin': 70, 'end': 95}}], 'text': 'Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.', 'timestamp': 'Thu Feb 15 20:43:10 +0000 2024'}\n",
            "Annotations for Sentence 163: {'annotations': [], 'text': 'J Neuroimmunol.', 'timestamp': 'Thu Feb 15 20:43:11 +0000 2024'}\n",
            "Annotations for Sentence 164: {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:43:12 +0000 2024'}\n",
            "Annotations for Sentence 165: {'annotations': [], 'text': 'Zerbo O, Yoshida C, Grether JK, Van de Water J, Ashwood P, Delorenze GN, et al.', 'timestamp': 'Thu Feb 15 20:43:13 +0000 2024'}\n",
            "Annotations for Sentence 166: {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'Autism Spectrum Disorder', 'obj': 'disease', 'prob': 0.9999990463256836, 'span': {'begin': 46, 'end': 70}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'Autism', 'obj': 'disease', 'prob': 0.9998787641525269, 'span': {'begin': 94, 'end': 100}}], 'text': 'Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study.', 'timestamp': 'Thu Feb 15 20:43:14 +0000 2024'}\n",
            "Annotations for Sentence 167: {'annotations': [], 'text': 'J Neuroinflammation.', 'timestamp': 'Thu Feb 15 20:43:15 +0000 2024'}\n",
            "Annotations for Sentence 168: {'annotations': [], 'text': '(2014) 11:113. doi: 10.1186/1742-2094-11-113 12.', 'timestamp': 'Thu Feb 15 20:43:16 +0000 2024'}\n",
            "Annotations for Sentence 169: {'annotations': [], 'text': 'Garty BZ, Ludomirsky A, Danon YL, Peter JB, Douglas SD.', 'timestamp': 'Thu Feb 15 20:43:17 +0000 2024'}\n",
            "Annotations for Sentence 170: {'annotations': [{'id': ['NCBIGene:7057'], 'is_neural_normalized': True, 'mention': 'immunoglobulin G', 'obj': 'gene', 'prob': 0.9951131939888, 'span': {'begin': 22, 'end': 38}}], 'text': 'Placental transfer of immunoglobulin G subclasses.', 'timestamp': 'Thu Feb 15 20:43:18 +0000 2024'}\n",
            "Annotations for Sentence 171: {'annotations': [], 'text': 'Clin Diagn Lab Immunol.', 'timestamp': 'Thu Feb 15 20:43:20 +0000 2024'}\n",
            "Annotations for Sentence 172: {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:43:20 +0000 2024'}\n",
            "Annotations for Sentence 173: {'annotations': [], 'text': 'Roopenian DC, Akilesh $.', 'timestamp': 'Thu Feb 15 20:43:21 +0000 2024'}\n",
            "Annotations for Sentence 174: {'annotations': [{'id': ['NCBIGene:2217'], 'is_neural_normalized': False, 'mention': 'FcRn', 'obj': 'gene', 'prob': 0.9936323761940002, 'span': {'begin': 0, 'end': 4}}, {'id': ['NCBIGene:2217'], 'is_neural_normalized': False, 'mention': 'neonatal Fc receptor', 'obj': 'gene', 'prob': 0.9971632957458496, 'span': {'begin': 10, 'end': 30}}], 'text': 'FcRn: the neonatal Fc receptor comes of age.', 'timestamp': 'Thu Feb 15 20:43:23 +0000 2024'}\n",
            "Annotations for Sentence 175: {'annotations': [], 'text': 'Nat Rev Immunol.', 'timestamp': 'Thu Feb 15 20:43:23 +0000 2024'}\n",
            "Annotations for Sentence 176: {'annotations': [], 'text': '(2007) 7:715. doi: 10.1038/nri2155 We hope this knowledge will yield future preventatives This mini-review contains review of research performed by each of the authors.', 'timestamp': 'Thu Feb 15 20:43:24 +0000 2024'}\n",
            "Annotations for Sentence 177: {'annotations': [], 'text': 'JV is the senior author and oversaw all aspects of this mini-review.', 'timestamp': 'Thu Feb 15 20:43:25 +0000 2024'}\n",
            "Annotations for Sentence 178: {'annotations': [], 'text': 'JM is the first author and compiled all of the information from the other authors as well as wrote the animal model section.', 'timestamp': 'Thu Feb 15 20:43:26 +0000 2024'}\n",
            "Annotations for Sentence 179: {'annotations': [], 'text': 'DK wrote the section on maternal immune activation.', 'timestamp': 'Thu Feb 15 20:43:27 +0000 2024'}\n",
            "Annotations for Sentence 180: {'annotations': [], 'text': 'MB developed the animal models and edited the entire review.', 'timestamp': 'Thu Feb 15 20:43:28 +0000 2024'}\n",
            "Annotations for Sentence 181: {'annotations': [], 'text': 'AR-C wrote the section on maternal autoantibodies.', 'timestamp': 'Thu Feb 15 20:43:29 +0000 2024'}\n",
            "Annotations for Sentence 182: {'annotations': [], 'text': 'All authors contributed to the article and approved the submitted version.', 'timestamp': 'Thu Feb 15 20:43:30 +0000 2024'}\n",
            "Annotations for Sentence 183: {'annotations': [], 'text': 'NICHD funded IDDRC P50 (P50HD103526).', 'timestamp': 'Thu Feb 15 20:43:31 +0000 2024'}\n",
            "Annotations for Sentence 184: {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:43:31 +0000 2024'}\n",
            "Annotations for Sentence 185: {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'women', 'obj': 'species', 'prob': 0.9427354335784912, 'span': {'begin': 112, 'end': 117}}, {'id': ['mesh:D008180', 'mim:152700'], 'is_neural_normalized': False, 'mention': 'systemic lupus erythematosus', 'obj': 'disease', 'prob': 0.9999992251396179, 'span': {'begin': 123, 'end': 151}}], 'text': 'Pakhathirathien P, Janjindamai W, Dissaneevate $, Thatrimontrichai A, Maneenil G. Neonatal outcomes in pregnant women with systemic lupus erythematosus: a 13-year experience in Southern Thailand.', 'timestamp': 'Thu Feb 15 20:43:33 +0000 2024'}\n",
            "Annotations for Sentence 186: {'annotations': [], 'text': 'J Trop Pediatr.', 'timestamp': 'Thu Feb 15 20:43:34 +0000 2024'}\n",
            "Annotations for Sentence 187: {'annotations': [], 'text': '(2021) 67:58. doi: 10.1093/tropej/fmab058 15.', 'timestamp': 'Thu Feb 15 20:43:34 +0000 2024'}\n",
            "Annotations for Sentence 188: {'annotations': [], 'text': 'Saunders NR,  Liddelow $A, Dziegielewska KM.', 'timestamp': 'Thu Feb 15 20:43:35 +0000 2024'}\n",
            "Annotations for Sentence 189: {'annotations': [], 'text': 'mechanisms in the developing brain.', 'timestamp': 'Thu Feb 15 20:43:36 +0000 2024'}\n",
            "Annotations for Sentence 190: {'annotations': [], 'text': 'Front 16.', 'timestamp': 'Thu Feb 15 20:43:37 +0000 2024'}\n",
            "Annotations for Sentence 191: {'annotations': [], 'text': 'Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL, Hertz-Picciotto I, et al.', 'timestamp': 'Thu Feb 15 20:43:38 +0000 2024'}\n",
            "Annotations for Sentence 192: {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorder', 'obj': 'disease', 'prob': 0.9999993443489075, 'span': {'begin': 43, 'end': 67}}], 'text': 'Neonatal cytokine profiles associated with autism spectrum disorder.', 'timestamp': 'Thu Feb 15 20:43:39 +0000 2024'}\n",
            "Annotations for Sentence 193: {'annotations': [], 'text': 'Biol Psychiatry.', 'timestamp': 'Thu Feb 15 20:43:39 +0000 2024'}\n",
            "Annotations for Sentence 194: {'annotations': [], 'text': '(2017) 81:442. doi: 10.1016/j.biopsych.2015.08.007 17.', 'timestamp': 'Thu Feb 15 20:43:40 +0000 2024'}\n",
            "Annotations for Sentence 195: {'annotations': [{'id': ['mesh:D011251'], 'is_neural_normalized': True, 'mention': 'Maternal intrauterine infection', 'obj': 'disease', 'prob': 0.9912474751472473, 'span': {'begin': 22, 'end': 53}}, {'id': ['mesh:D001930'], 'is_neural_normalized': True, 'mention': 'brain damage', 'obj': 'disease', 'prob': 0.9999803304672241, 'span': {'begin': 70, 'end': 82}}], 'text': 'Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn.', 'timestamp': 'Thu Feb 15 20:43:41 +0000 2024'}\n",
            "Annotations for Sentence 196: {'annotations': [], 'text': 'Pediatr Res.', 'timestamp': 'Thu Feb 15 20:43:42 +0000 2024'}\n",
            "Annotations for Sentence 197: {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:43:43 +0000 2024'}\n",
            "Annotations for Sentence 198: {'annotations': [], 'text': 'Deverman BE, Patterson PH.', 'timestamp': 'Thu Feb 15 20:43:44 +0000 2024'}\n",
            "Annotations for Sentence 199: {'annotations': [], 'text': 'Cytokines and CNS development.', 'timestamp': 'Thu Feb 15 20:43:45 +0000 2024'}\n",
            "Annotations for Sentence 200: {'annotations': [], 'text': 'Neuron.', 'timestamp': 'Thu Feb 15 20:43:46 +0000 2024'}\n",
            "Annotations for Sentence 201: {'annotations': [], 'text': '(2009) 64:61. doi: 10.1016/j.neuron.2009.09.002 19.', 'timestamp': 'Thu Feb 15 20:43:47 +0000 2024'}\n",
            "Annotations for Sentence 202: {'annotations': [], 'text': 'Mousa A, Bakhiet M. Role of cytokine signaling during nervous system development.', 'timestamp': 'Thu Feb 15 20:43:48 +0000 2024'}\n",
            "Annotations for Sentence 203: {'annotations': [], 'text': 'Int J Mol Sci.', 'timestamp': 'Thu Feb 15 20:43:48 +0000 2024'}\n",
            "Annotations for Sentence 204: {'annotations': [], 'text': '(2013) 14:13931. doi: 10.3390/ijms140713931 20.', 'timestamp': 'Thu Feb 15 20:43:49 +0000 2024'}\n",
            "Annotations for Sentence 205: {'annotations': [], 'text': 'Ramesh G, MacLean AG, Philipp MT.', 'timestamp': 'Thu Feb 15 20:43:50 +0000 2024'}\n",
            "Annotations for Sentence 206: {'annotations': [{'id': ['mesh:D020078'], 'is_neural_normalized': True, 'mention': 'neuro-inflammation', 'obj': 'disease', 'prob': 0.999734103679657, 'span': {'begin': 46, 'end': 64}}, {'id': ['mesh:D009410'], 'is_neural_normalized': False, 'mention': 'neurodegeneration', 'obj': 'disease', 'prob': 0.9999966621398926, 'span': {'begin': 66, 'end': 83}}, {'id': ['mesh:D009437'], 'is_neural_normalized': False, 'mention': 'neuropathic pain', 'obj': 'disease', 'prob': 0.9999893307685852, 'span': {'begin': 89, 'end': 105}}], 'text': 'Cytokines and chemokines at the crossroads of neuro-inflammation, neurodegeneration, and neuropathic pain.', 'timestamp': 'Thu Feb 15 20:43:51 +0000 2024'}\n",
            "Annotations for Sentence 207: {'annotations': [], 'text': 'Mediators Inflamm.', 'timestamp': 'Thu Feb 15 20:43:52 +0000 2024'}\n",
            "Annotations for Sentence 208: {'annotations': [], 'text': '(2013) 2013:480739. doi: 10.1155/2013/480739 21.', 'timestamp': 'Thu Feb 15 20:43:53 +0000 2024'}\n",
            "Annotations for Sentence 209: {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorders', 'obj': 'disease', 'prob': 0.9999995231628418, 'span': {'begin': 48, 'end': 73}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.999997615814209, 'span': {'begin': 75, 'end': 78}}], 'text': 'Goines PE, Ashwood P. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.', 'timestamp': 'Thu Feb 15 20:43:54 +0000 2024'}\n",
            "Annotations for Sentence 210: {'annotations': [], 'text': 'Neurotoxicol Teratol.', 'timestamp': 'Thu Feb 15 20:43:54 +0000 2024'}\n",
            "Annotations for Sentence 211: {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:43:55 +0000 2024'}\n",
            "Annotations for Sentence 212: {'annotations': [{'id': ['mesh:D000083242'], 'is_neural_normalized': False, 'mention': 'ischemic stroke', 'obj': 'disease', 'prob': 0.9999961256980896, 'span': {'begin': 110, 'end': 125}}], 'text': 'Yang C, Hawkins KE, Dore $, Candelario-Jalil E. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.', 'timestamp': 'Thu Feb 15 20:43:57 +0000 2024'}\n",
            "Annotations for Sentence 213: {'annotations': [], 'text': 'Am J Physiol Cell Physiol.', 'timestamp': 'Thu Feb 15 20:43:57 +0000 2024'}\n",
            "Annotations for Sentence 214: {'annotations': [], 'text': '(2019) 316:C135.', 'timestamp': 'Thu Feb 15 20:43:58 +0000 2024'}\n",
            "Annotations for Sentence 215: {'annotations': [], 'text': 'doi: 10.1152/ajpcell.00136.2018 23.', 'timestamp': 'Thu Feb 15 20:43:59 +0000 2024'}\n",
            "Annotations for Sentence 216: {'annotations': [], 'text': 'Hauguel-de Mouzon $, Guerre-Millo M. The placenta network and inflammatory signals.', 'timestamp': 'Thu Feb 15 20:44:00 +0000 2024'}\n",
            "Annotations for Sentence 217: {'annotations': [], 'text': 'Placenta.', 'timestamp': 'Thu Feb 15 20:44:01 +0000 2024'}\n",
            "Annotations for Sentence 218: {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:44:02 +0000 2024'}\n",
            "Annotations for Sentence 219: {'annotations': [], 'text': 'Siwetz M, Blaschitz A, El-Heliebi A, Hiden U, Desoye G, Huppertz B, et al.', 'timestamp': 'Thu Feb 15 20:44:05 +0000 2024'}\n",
            "Annotations for Sentence 220: {'annotations': [{'id': ['NCBIGene:7124'], 'is_neural_normalized': False, 'mention': 'TNF-alpha', 'obj': 'gene', 'prob': 0.9898688197135925, 'span': {'begin': 0, 'end': 9}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.9918531775474548, 'span': {'begin': 55, 'end': 60}}], 'text': 'TNF-alpha alters the inflammatory secretion profile of human first trimester placenta.', 'timestamp': 'Thu Feb 15 20:44:06 +0000 2024'}\n",
            "Annotations for Sentence 221: {'annotations': [], 'text': 'Lab Invest.', 'timestamp': 'Thu Feb 15 20:44:07 +0000 2024'}\n",
            "Annotations for Sentence 222: {'annotations': [], 'text': '(2016) 96:428. doi: 10.1038/labinvest.2015.159 25.', 'timestamp': 'Thu Feb 15 20:44:08 +0000 2024'}\n",
            "Annotations for Sentence 223: {'annotations': [], 'text': 'Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen R, et al.', 'timestamp': 'Thu Feb 15 20:44:09 +0000 2024'}\n",
            "Annotations for Sentence 224: {'annotations': [{'id': ['NCBIGene:3458'], 'is_neural_normalized': False, 'mention': 'IFN-gamma', 'obj': 'gene', 'prob': 0.9894703030586243, 'span': {'begin': 25, 'end': 34}}, {'id': ['NCBIGene:3565'], 'is_neural_normalized': False, 'mention': 'IL-4', 'obj': 'gene', 'prob': 0.9756038784980774, 'span': {'begin': 36, 'end': 40}}, {'id': ['NCBIGene:3567'], 'is_neural_normalized': False, 'mention': 'IL-5', 'obj': 'gene', 'prob': 0.9845430254936218, 'span': {'begin': 45, 'end': 49}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'women', 'obj': 'species', 'prob': 0.8643378615379333, 'span': {'begin': 53, 'end': 58}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.8272078633308411, 'span': {'begin': 69, 'end': 74}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999960660934448, 'span': {'begin': 80, 'end': 86}}], 'text': 'Increased midgestational IFN-gamma, IL-4 and IL-5 in women bearing a child with autism: a case-control study.', 'timestamp': 'Thu Feb 15 20:44:11 +0000 2024'}\n",
            "Annotations for Sentence 225: {'annotations': [], 'text': 'Mol Autism.', 'timestamp': 'Thu Feb 15 20:44:11 +0000 2024'}\n",
            "Annotations for Sentence 226: {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:44:12 +0000 2024'}\n",
            "Annotations for Sentence 227: {'annotations': [], 'text': \"Carter M, Casey $, O'Keeffe GW, Gibson L, Murray DM.\", 'timestamp': 'Thu Feb 15 20:44:13 +0000 2024'}\n",
            "Annotations for Sentence 228: {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9581453800201416, 'span': {'begin': 39, 'end': 47}}, {'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorder', 'obj': 'disease', 'prob': 0.9999992847442627, 'span': {'begin': 60, 'end': 84}}], 'text': 'Mid- gestation cytokine profiles in of children affected by autism spectrum disorder: a case-control study.', 'timestamp': 'Thu Feb 15 20:44:15 +0000 2024'}\n",
            "Annotations for Sentence 229: {'annotations': [], 'text': 'Sci Rep. (2021) 27.', 'timestamp': 'Thu Feb 15 20:44:16 +0000 2024'}\n",
            "Annotations for Sentence 230: {'annotations': [], 'text': 'Ghassabian A, Albert PS, Hornig M, Yeung E, Cherkerzian $, Goldstein RB, et al.', 'timestamp': 'Thu Feb 15 20:44:17 +0000 2024'}\n",
            "Annotations for Sentence 231: {'annotations': [], 'text': 'Gestational cytokine concentrations and neurocognitive development at 7 years.', 'timestamp': 'Thu Feb 15 20:44:18 +0000 2024'}\n",
            "Annotations for Sentence 232: {'annotations': [], 'text': 'Transl Psychiatry.', 'timestamp': 'Thu Feb 15 20:44:18 +0000 2024'}\n",
            "Annotations for Sentence 233: {'annotations': [], 'text': '(2018) 8:64. doi: 10.1038/s41398-018-0112-z Frontiers in Psychiatry | www.frontiersin.org June 2022 | Volume 13 | Article 834910', 'timestamp': 'Thu Feb 15 20:44:19 +0000 2024'}\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(annotations)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "61pd7rBqeN-V",
        "outputId": "79a93dca-0c2e-4d28-8e55-97ff7e35855c"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[{'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'Autism spectrum disorder', 'obj': 'disease', 'prob': 0.9999997019767761, 'span': {'begin': 0, 'end': 24}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999947547912598, 'span': {'begin': 26, 'end': 29}}, {'id': ['mesh:D065886'], 'is_neural_normalized': False, 'mention': 'neurodevelopmental disorder', 'obj': 'disease', 'prob': 0.9999985098838806, 'span': {'begin': 95, 'end': 122}}], 'text': 'Autism spectrum disorder (ASD) is acknowledged as a highly heterogeneous, behaviorally defined neurodevelopmental disorder with multiple etiologies.', 'timestamp': 'Thu Feb 15 20:20:58 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998526573181152, 'span': {'begin': 162, 'end': 165}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.9401512742042542, 'span': {'begin': 173, 'end': 178}}], 'text': 'In addition to its high heritability, we have come to recognize a role for maternal immune system dysregulation as a prominent risk factor for the development of ASD in the child.', 'timestamp': 'Thu Feb 15 20:20:59 +0000 2024'}, {'annotations': [], 'text': 'Examples of these risk factors include altered cytokine/chemokine activity and the presence of autoantibodies in mothers that are reactive to proteins in the developing brain.', 'timestamp': 'Thu Feb 15 20:21:00 +0000 2024'}, {'annotations': [], 'text': 'In addition to large clinical studies, the development of pre-clinical models enables the ability to evaluate the cellular and molecular underpinnings of immune-related pathology.', 'timestamp': 'Thu Feb 15 20:21:01 +0000 2024'}, {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'maternal autoantibody- related (MAR) ASD', 'obj': 'disease', 'prob': 0.9991886615753174, 'span': {'begin': 40, 'end': 80}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998546838760376, 'span': {'begin': 199, 'end': 202}}], 'text': 'For example, the novel animal models of maternal autoantibody- related (MAR) ASD described herein will serve as a preclinical platform for the future testing of targeted therapeutics for one type of ASD.', 'timestamp': 'Thu Feb 15 20:21:02 +0000 2024'}, {'annotations': [], 'text': 'Identification of the cellular targets will advance Frontiers in Psychiatry | www.frontiersin.org 1 June 2022 | Volume 13 | Article 834910   McLellan et al.', 'timestamp': 'Thu Feb 15 20:21:03 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9997811913490295, 'span': {'begin': 25, 'end': 28}}], 'text': 'Maternal Risk Factors in ASD precision medicine efforts toward tailored therapeutics and prevention.', 'timestamp': 'Thu Feb 15 20:21:04 +0000 2024'}, {'annotations': [{'id': ['mesh:D007154'], 'is_neural_normalized': True, 'mention': 'maternal immune dysregulation', 'obj': 'disease', 'prob': 0.9331035017967224, 'span': {'begin': 61, 'end': 90}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998258948326111, 'span': {'begin': 187, 'end': 190}}], 'text': 'This minireview highlights emerging evidence for the role of maternal immune dysregulation as a potential biomarker, as well as a pathologically relevant mechanism for the development of ASD in offspring.', 'timestamp': 'Thu Feb 15 20:21:05 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999520778656006, 'span': {'begin': 155, 'end': 158}}, {'id': ['mesh:D007154'], 'is_neural_normalized': True, 'mention': 'maternal immune dysregulation', 'obj': 'disease', 'prob': 0.9525726437568665, 'span': {'begin': 252, 'end': 281}}], 'text': 'Further, we will discuss the current limitations of these models as well as potential avenues THE ROLE OF THE MATERNAL IMMUNE SYSTEM IN THE DEVELOPMENT OF ASD In the past two decades, an increasingly large number of studies have provided evidence that maternal immune dysregulation can impact offspring neurodevelopment (1-11).', 'timestamp': 'Thu Feb 15 20:21:06 +0000 2024'}, {'annotations': [], 'text': 'For example, it is now well-understood that the maternal immune system plays a critical role in the healthy development of the fetus.', 'timestamp': 'Thu Feb 15 20:21:07 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:3500'], 'is_neural_normalized': True, 'mention': 'maternal immunoglobulin G', 'obj': 'gene', 'prob': 0.9953225255012512, 'span': {'begin': 9, 'end': 34}}, {'id': ['NCBIGene:8857'], 'is_neural_normalized': True, 'mention': 'IgG', 'obj': 'gene', 'prob': 0.9908105134963989, 'span': {'begin': 36, 'end': 39}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'infant', 'obj': 'species', 'prob': 0.5590081810951233, 'span': {'begin': 153, 'end': 159}}], 'text': 'In fact, maternal immunoglobulin G (IgG) can cross the placenta and enter the fetal compartment, thereby providing early immunological protection to the infant during the perinatal stage (12, 13).', 'timestamp': 'Thu Feb 15 20:21:08 +0000 2024'}, {'annotations': [], 'text': 'However, this protective mechanism is not selective and harmful antibodies reactive to self proteins can also cross the placenta (14).', 'timestamp': 'Thu Feb 15 20:21:09 +0000 2024'}, {'annotations': [], 'text': 'Once within the fetal compartment, these maternal autoantibodies may bind to their protein targets, potentially impacting protein function.', 'timestamp': 'Thu Feb 15 20:21:10 +0000 2024'}, {'annotations': [], 'text': 'This is especially dangerous during the perinatal period given the permissiveness of the blood- brain barrier (BBB) and vulnerability of the developing central nervous system (CNS) (15).', 'timestamp': 'Thu Feb 15 20:21:11 +0000 2024'}, {'annotations': [], 'text': 'In addition to the production of autoantibodies, other perturbations of the maternal immune system can result in harmful effects on the developing fetus.', 'timestamp': 'Thu Feb 15 20:21:12 +0000 2024'}, {'annotations': [], 'text': 'It has been shown that alterations in the maternal cytokine/chemokine profile can result in changes in the inflammatory state, skewed cellular signaling, and altered neurodevelopment (16, 17).', 'timestamp': 'Thu Feb 15 20:21:12 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9994564652442932, 'span': {'begin': 144, 'end': 147}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9628236889839172, 'span': {'begin': 161, 'end': 169}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999626874923706, 'span': {'begin': 175, 'end': 178}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999051094055176, 'span': {'begin': 223, 'end': 226}}], 'text': 'CYTOKINES AND CHEMOKINES AS In recent years, several researchers have reported on specific cytokines and/or chemokines that are associated with ASD risk both in children with ASD and mothers that have ildren diagnosed with ASD.', 'timestamp': 'Thu Feb 15 20:21:14 +0000 2024'}, {'annotations': [], 'text': 'Interestingly, several cytokines nd chemokines are constitutively expressed throughout the developing CNS (18, 19).', 'timestamp': 'Thu Feb 15 20:21:15 +0000 2024'}, {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'neuronal and non-neuronal cells', 'obj': 'cell_type', 'prob': 0.8246024250984192, 'span': {'begin': 176, 'end': 207}}], 'text': 'Cytokines in the brain perform functions similar to those seen in the periphery, acting as cues in cell development and differentiation, and regulating the types and number of neuronal and non-neuronal cells (20, 21).', 'timestamp': 'Thu Feb 15 20:21:16 +0000 2024'}, {'annotations': [], 'text': 'Together, these complex processes contribute to early neurodevelopment and homeostasis.', 'timestamp': 'Thu Feb 15 20:21:16 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:3569'], 'is_neural_normalized': False, 'mention': 'IL-6', 'obj': 'gene', 'prob': 0.9753560423851013, 'span': {'begin': 77, 'end': 81}}], 'text': 'In the context of maternal- fetal interaction, some cytokines, in particular IL-6, can be transported from the mother to the offspring and access e developing CNS (17).', 'timestamp': 'Thu Feb 15 20:21:18 +0000 2024'}, {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'neonatal blood samples', 'obj': 'cell_type', 'prob': 0.7486866116523743, 'span': {'begin': 315, 'end': 337}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9997453093528748, 'span': {'begin': 372, 'end': 375}}], 'text': 'Although the source of abnormal cytokine levels in mothers during gestation may differ, this could alter placental production and overall levels of cytokines and chemokines in the fetal compartment, impacting the cascade To date, a variety of clinical studies have demonstrated tered cytokine levels in mothers and neonatal blood samples that are strongly associated with ASD (Table 1), increasing the potential for cytokines/chemokines to serve as biomarkers for risk of abnormal neurodevelopment.', 'timestamp': 'Thu Feb 15 20:21:18 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.999893069267273, 'span': {'begin': 47, 'end': 50}}], 'text': 'Most of the reported cytokines associated with ASD induce the BBB to become more permissive (22) increasing the vulnerability and altering the homeostatic levels of cytokines in the developing CNS.', 'timestamp': 'Thu Feb 15 20:21:19 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998290538787842, 'span': {'begin': 139, 'end': 142}}, {'id': ['mesh:D011225', 'mim:189800'], 'is_neural_normalized': True, 'mention': 'maternal/fetal infection', 'obj': 'disease', 'prob': 0.999851405620575, 'span': {'begin': 178, 'end': 202}}], 'text': 'Numerous researchers have corroborated the concept that significant changes in maternal cytokine/chemokine homeostasis are correlated with ASD development even in the absence of maternal/fetal infection.', 'timestamp': 'Thu Feb 15 20:21:20 +0000 2024'}, {'annotations': [], 'text': 'Such changes in maternal cytokines and chemokines can not only directly impact the fetus but can also stimulate placental production of pro-inflammatory cytokines within the fetal compartment (17, 23, 24).', 'timestamp': 'Thu Feb 15 20:21:21 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:215', '81693'], 'is_neural_normalized': True, 'mention': 'amniotic', 'obj': 'gene', 'prob': 0.6666468977928162, 'span': {'begin': 43, 'end': 51}}, {'id': ['NCBIGene:3565'], 'is_neural_normalized': False, 'mention': 'IL-4', 'obj': 'gene', 'prob': 0.7701614499092102, 'span': {'begin': 58, 'end': 62}}, {'id': ['NCBIGene:3569'], 'is_neural_normalized': False, 'mention': 'IL-6', 'obj': 'gene', 'prob': 0.9902611374855042, 'span': {'begin': 64, 'end': 68}}, {'id': ['NCBIGene:3576'], 'is_neural_normalized': False, 'mention': 'IL- 8', 'obj': 'gene', 'prob': 0.9871503114700317, 'span': {'begin': 74, 'end': 79}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.8173210620880127, 'span': {'begin': 114, 'end': 122}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.999924898147583, 'span': {'begin': 128, 'end': 131}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9794467687606812, 'span': {'begin': 256, 'end': 264}}], 'text': 'For example, dysregulation of serum and/or amniotic fluid IL-4, IL-6, and IL- 8 have been described in mothers of children with ASD and were associated with altered behavioral outcomes including non- verbal cognitive ability and stereotypical behaviors in children (25-28).', 'timestamp': 'Thu Feb 15 20:21:23 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:3605'], 'is_neural_normalized': True, 'mention': 'cytokine IL-17', 'obj': 'gene', 'prob': 0.6681621670722961, 'span': {'begin': 4, 'end': 18}}, {'id': ['mesh:D065886'], 'is_neural_normalized': False, 'mention': 'neurodevelopmental disorders', 'obj': 'disease', 'prob': 0.9995962381362915, 'span': {'begin': 57, 'end': 85}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999783039093018, 'span': {'begin': 97, 'end': 100}}], 'text': 'The cytokine IL-17, which has been implicated in several neurodevelopmental disorders, including ASD, has been shown to promote inflammation and disrupt the BBB postnatally (29, 30).', 'timestamp': 'Thu Feb 15 20:21:24 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:3458'], 'is_neural_normalized': False, 'mention': 'IFN-y', 'obj': 'gene', 'prob': 0.9915488958358765, 'span': {'begin': 13, 'end': 18}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9744454026222229, 'span': {'begin': 127, 'end': 135}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999674558639526, 'span': {'begin': 141, 'end': 144}}], 'text': 'In addition, IFN-y, which is involved in neuronal differentiation and synaptic formation, was shown to be higher in mothers of children with ASD during the second trimester (25, 28), potentially suggesting disrupted synaptic connectivity.', 'timestamp': 'Thu Feb 15 20:21:26 +0000 2024'}, {'annotations': [{'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999977350234985, 'span': {'begin': 106, 'end': 112}}], 'text': 'Studies have also observed altered cytokine and chemokine levels in neonates who are later diagnosed with autism.', 'timestamp': 'Thu Feb 15 20:21:27 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999656677246094, 'span': {'begin': 66, 'end': 69}}, {'id': ['NCBIGene:3603'], 'is_neural_normalized': False, 'mention': 'IL-16', 'obj': 'gene', 'prob': 0.994965672492981, 'span': {'begin': 103, 'end': 108}}], 'text': 'For example, researchers found that newborns later diagnosed with ASD have higher peripheral levels of IL-16, which is expressed throughout the CNS particularly during the early neurodevelopmental period (16, 21).', 'timestamp': 'Thu Feb 15 20:21:28 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:10850'], 'is_neural_normalized': False, 'mention': 'CCL27', 'obj': 'gene', 'prob': 0.9837304353713989, 'span': {'begin': 24, 'end': 29}}, {'id': ['NCBIGene:10850'], 'is_neural_normalized': False, 'mention': 'CTACK', 'obj': 'gene', 'prob': 0.9465448260307312, 'span': {'begin': 45, 'end': 50}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999552965164185, 'span': {'begin': 109, 'end': 112}}], 'text': 'In our recent findings, CCL27, also known as CTACK, was significantly lower in newborns later diagnosed with ASD.', 'timestamp': 'Thu Feb 15 20:21:30 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999957084655762, 'span': {'begin': 66, 'end': 69}}, {'id': ['mesh:D008607'], 'is_neural_normalized': False, 'mention': 'intellectual disability', 'obj': 'disease', 'prob': 0.9999973177909851, 'span': {'begin': 87, 'end': 110}}, {'id': ['mesh:D002658'], 'is_neural_normalized': False, 'mention': 'developmental delay', 'obj': 'disease', 'prob': 0.9999982118606567, 'span': {'begin': 142, 'end': 161}}], 'text': 'This decrease was associated with an increase in the risk of both ASD with and without intellectual disability when compared to newborns with developmental delay or those with typical development (31).', 'timestamp': 'Thu Feb 15 20:21:31 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:6347'], 'is_neural_normalized': False, 'mention': 'monocyte chemoattractant protein-1', 'obj': 'gene', 'prob': 0.9976604580879211, 'span': {'begin': 19, 'end': 53}}, {'id': ['NCBIGene:6347'], 'is_neural_normalized': False, 'mention': 'MCP- 1', 'obj': 'gene', 'prob': 0.996988832950592, 'span': {'begin': 55, 'end': 61}}, {'id': ['NCBIGene:6367'], 'is_neural_normalized': False, 'mention': 'macrophage-derived chemokine', 'obj': 'gene', 'prob': 0.9942678809165955, 'span': {'begin': 67, 'end': 95}}, {'id': ['NCBIGene:6367'], 'is_neural_normalized': False, 'mention': 'MDC', 'obj': 'gene', 'prob': 0.9877848029136658, 'span': {'begin': 97, 'end': 100}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9334511160850525, 'span': {'begin': 183, 'end': 191}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999099969863892, 'span': {'begin': 197, 'end': 200}}], 'text': 'Elevated levels of monocyte chemoattractant protein-1 (MCP- 1) and macrophage-derived chemokine (MDC) were found in the amniotic fluid, plasma, cerebellum, and cerebrospinal fluid of children with ASD (10, 32, 33), implying involvement of these chemokines in neurodevelopment.', 'timestamp': 'Thu Feb 15 20:21:32 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:6348'], 'is_neural_normalized': True, 'mention': 'macrophage inflammatory protein-1', 'obj': 'gene', 'prob': 0.9729967713356018, 'span': {'begin': 35, 'end': 68}}, {'id': ['NCBIGene:3842'], 'is_neural_normalized': False, 'mention': 'MIP-1', 'obj': 'gene', 'prob': 0.995566725730896, 'span': {'begin': 70, 'end': 75}}, {'id': ['NCBIGene:6356'], 'is_neural_normalized': True, 'mention': 'eotaxin', 'obj': 'gene', 'prob': 0.728026270866394, 'span': {'begin': 81, 'end': 88}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9049980640411377, 'span': {'begin': 113, 'end': 121}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999443292617798, 'span': {'begin': 127, 'end': 130}}], 'text': 'Increased levels of the chemokines macrophage inflammatory protein-1 (MIP-1) and eotaxin are also often noted in children with ASD, and have been associated with behavioral deficits (10, 34-36).', 'timestamp': 'Thu Feb 15 20:21:34 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999014139175415, 'span': {'begin': 90, 'end': 93}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999974966049194, 'span': {'begin': 212, 'end': 218}}], 'text': 'It is unlikely that one specific cytokine or chemokine plays a role in the development of ASD, but rather a combination of cytokines/chemokines are more likely to contribute to the neuropathology associated with autism.', 'timestamp': 'Thu Feb 15 20:21:35 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9997778534889221, 'span': {'begin': 94, 'end': 97}}], 'text': 'The exact consequences of altered cytokine/chemokine levels during pregnancy that lead to the ASD phenotype is an important area of research.', 'timestamp': 'Thu Feb 15 20:21:36 +0000 2024'}, {'annotations': [], 'text': 'Furthermore, the trigger(s) for changes in maternal cytokine and chemokine levels, and how other aspects of the maternal immune system may also be affected are essential questions to address.', 'timestamp': 'Thu Feb 15 20:21:37 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'infant', 'obj': 'species', 'prob': 0.845718264579773, 'span': {'begin': 110, 'end': 116}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9482090473175049, 'span': {'begin': 258, 'end': 266}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999017715454102, 'span': {'begin': 272, 'end': 275}}], 'text': 'Although the number of research studies that include time-specific/longitudinal examination as well as mother-infant pair-matched studies are lacking, it is promising that similar groups of cytokines and chemokines are frequently shown to be altered in both children with ASD and their mothers, increasing Frontiers in Psychiatry | www.frontiersin.org June 2022 | Volume 13 | Article 834910   McLellan et al.', 'timestamp': 'Thu Feb 15 20:21:38 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999369382858276, 'span': {'begin': 25, 'end': 28}}, {'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'maternal autoantibody targets', 'obj': 'DNA', 'prob': 0.5790223479270935, 'span': {'begin': 73, 'end': 102}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999796152114868, 'span': {'begin': 117, 'end': 120}}], 'text': 'Maternal Risk Factors in ASD TABLE 1 | Maternal cytokines/chemokines and maternal autoantibody targets implicated in ASD.', 'timestamp': 'Thu Feb 15 20:21:39 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:3552'], 'is_neural_normalized': False, 'mention': 'IL-1', 'obj': 'gene', 'prob': 0.99137282371521, 'span': {'begin': 45, 'end': 49}}, {'id': ['NCBIGene:3565'], 'is_neural_normalized': False, 'mention': 'IL-4', 'obj': 'gene', 'prob': 0.9811803102493286, 'span': {'begin': 51, 'end': 55}}, {'id': ['NCBIGene:3567'], 'is_neural_normalized': False, 'mention': 'IL-5', 'obj': 'gene', 'prob': 0.9802108407020569, 'span': {'begin': 57, 'end': 61}}, {'id': ['NCBIGene:3576'], 'is_neural_normalized': False, 'mention': 'IL-8', 'obj': 'gene', 'prob': 0.9743618965148926, 'span': {'begin': 63, 'end': 67}}, {'id': ['NCBIGene:3574'], 'is_neural_normalized': True, 'mention': 'IL-7A', 'obj': 'gene', 'prob': 0.9953019618988037, 'span': {'begin': 69, 'end': 74}}, {'id': ['NCBIGene:3458'], 'is_neural_normalized': False, 'mention': 'IFN-y', 'obj': 'gene', 'prob': 0.9906409382820129, 'span': {'begin': 76, 'end': 81}}, {'id': ['NCBIGene:3565'], 'is_neural_normalized': False, 'mention': 'IL-4', 'obj': 'gene', 'prob': 0.9942848086357117, 'span': {'begin': 134, 'end': 138}}, {'id': ['NCBIGene:3587'], 'is_neural_normalized': True, 'mention': 'IL-10MCP-1TNF-a', 'obj': 'gene', 'prob': 0.9929863810539246, 'span': {'begin': 140, 'end': 155}}, {'id': ['NCBIGene:4049'], 'is_neural_normalized': False, 'mention': 'TNF-B', 'obj': 'gene', 'prob': 0.99400395154953, 'span': {'begin': 157, 'end': 162}}, {'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'CRMP1', 'obj': 'gene', 'prob': 0.9900533556938171, 'span': {'begin': 219, 'end': 224}}, {'id': ['NCBIGene:1808'], 'is_neural_normalized': False, 'mention': 'CRMP2', 'obj': 'gene', 'prob': 0.9846120476722717, 'span': {'begin': 226, 'end': 231}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'STIP1', 'obj': 'gene', 'prob': 0.9933784604072571, 'span': {'begin': 233, 'end': 238}}, {'id': ['NCBIGene:4904'], 'is_neural_normalized': True, 'mention': 'YBOX', 'obj': 'gene', 'prob': 0.9891681671142578, 'span': {'begin': 240, 'end': 244}}, {'id': ['NCBIGene:3939'], 'is_neural_normalized': False, 'mention': 'LDH-A', 'obj': 'gene', 'prob': 0.9970669150352478, 'span': {'begin': 322, 'end': 327}}, {'id': ['NCBIGene:3945'], 'is_neural_normalized': False, 'mention': 'LDH-B', 'obj': 'gene', 'prob': 0.996402382850647, 'span': {'begin': 329, 'end': 334}}, {'id': ['NCBIGene:9615'], 'is_neural_normalized': False, 'mention': 'GDA', 'obj': 'gene', 'prob': 0.9944157600402832, 'span': {'begin': 336, 'end': 339}}, {'id': ['NCBIGene:2026'], 'is_neural_normalized': False, 'mention': 'NSE', 'obj': 'gene', 'prob': 0.9953380823135376, 'span': {'begin': 341, 'end': 344}}, {'id': ['NCBIGene:26047'], 'is_neural_normalized': False, 'mention': 'CASPR2', 'obj': 'gene', 'prob': 0.9425560832023621, 'span': {'begin': 378, 'end': 384}}, {'id': ['NCBIGene:9247'], 'is_neural_normalized': True, 'mention': 'maternal IgG', 'obj': 'gene', 'prob': 0.9910596609115601, 'span': {'begin': 585, 'end': 597}}, {'id': ['mesh:D065886'], 'is_neural_normalized': False, 'mention': 'neurodevelopmental impairments', 'obj': 'disease', 'prob': 0.9999959468841553, 'span': {'begin': 617, 'end': 647}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.716987669467926, 'span': {'begin': 655, 'end': 660}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.999992847442627, 'span': {'begin': 672, 'end': 675}}], 'text': 'Cytokines/chemokines Sample source Reference IL-1, IL-4, IL-5, IL-8, IL-7A, IFN-y Maternal serum collected mid-gestation (25, 26, 28) IL-4, IL-10MCP-1TNF-a, TNF-B Amniotic fluid (27, 32) Target antigen Protein function CRMP1, CRMP2, STIP1, YBOX Microtubule dynamics, protein chaperone, transcription factor (12-14, 42-44) LDH-A, LDH-B, GDA, NSE Metabolic enzymes (14-16, 37-41) CASPR2 Cell adhesion (45, 52) the promise of cytokines and chemokines as biomarkers for risk MATERNAL AUTOANTIBODY TARGETS IN Several groups have now identified multiple brain antigens that cross-react with maternal IgG and are related to neurodevelopmental impairments in the child, including ASD (37-45).', 'timestamp': 'Thu Feb 15 20:21:44 +0000 2024'}, {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'maternal plasma', 'obj': 'cell_type', 'prob': 0.573803186416626, 'span': {'begin': 49, 'end': 64}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999656677246094, 'span': {'begin': 162, 'end': 165}}], 'text': 'Early studies used fetal brain extracts to probe maternal plasma by western blot (WB) and reported reactivity to bands at ~36 kDa that were present in 10% of the ASD samples vs. only 2% of controls.', 'timestamp': 'Thu Feb 15 20:21:45 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:9247'], 'is_neural_normalized': True, 'mention': 'maternal IgG', 'obj': 'gene', 'prob': 0.9775835275650024, 'span': {'begin': 37, 'end': 49}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998959302902222, 'span': {'begin': 112, 'end': 115}}], 'text': 'In addition, they observed increased maternal IgG cross-reactivity to multiple bands at 27, 36, at 73 kD in the ASD-positive mothers (46).', 'timestamp': 'Thu Feb 15 20:21:46 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999517202377319, 'span': {'begin': 102, 'end': 105}}], 'text': 'Concurrent studies reported similar band patterns of reactivity at 37/73 kDa and 39/73 kDa which were ASD specific and not present in controls (47-50).', 'timestamp': 'Thu Feb 15 20:21:47 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:54828'], 'is_neural_normalized': True, 'mention': 'maternal autoantibody', 'obj': 'gene', 'prob': 0.7877233624458313, 'span': {'begin': 110, 'end': 131}}, {'id': ['NCBIGene:3659'], 'is_neural_normalized': False, 'mention': 'MAR', 'obj': 'gene', 'prob': 0.710262656211853, 'span': {'begin': 141, 'end': 144}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999457597732544, 'span': {'begin': 146, 'end': 149}}, {'id': ['NCBIGene:414'], 'is_neural_normalized': True, 'mention': 'ASD antigens', 'obj': 'gene', 'prob': 0.5137134194374084, 'span': {'begin': 146, 'end': 158}}], 'text': 'Several groups, including our own, conducted a series of experiments that lead to the identification of eight maternal autoantibody-related (MAR) ASD antigens and their pathogenic epitopes (51-54).', 'timestamp': 'Thu Feb 15 20:21:48 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:1400'], 'is_neural_normalized': True, 'mention': 'collapsin response mediator proteins 1 and 2', 'obj': 'gene', 'prob': 0.9983932375907898, 'span': {'begin': 32, 'end': 76}}, {'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'CRMP1', 'obj': 'gene', 'prob': 0.9858659505844116, 'span': {'begin': 78, 'end': 83}}, {'id': ['NCBIGene:1808'], 'is_neural_normalized': False, 'mention': 'CRMP2', 'obj': 'gene', 'prob': 0.9871776103973389, 'span': {'begin': 85, 'end': 90}}, {'id': ['mesh:D006147'], 'is_neural_normalized': False, 'mention': 'guanine', 'obj': 'drug', 'prob': 0.9984839558601379, 'span': {'begin': 93, 'end': 100}}, {'id': ['NCBIGene:9615'], 'is_neural_normalized': False, 'mention': 'guanine deaminase', 'obj': 'gene', 'prob': 0.9783497452735901, 'span': {'begin': 93, 'end': 110}}, {'id': ['NCBIGene:9615'], 'is_neural_normalized': False, 'mention': 'cypin', 'obj': 'gene', 'prob': 0.9633235335350037, 'span': {'begin': 114, 'end': 119}}, {'id': ['NCBIGene:9615'], 'is_neural_normalized': False, 'mention': 'GDA', 'obj': 'gene', 'prob': 0.9967974424362183, 'span': {'begin': 121, 'end': 124}}, {'id': ['mesh:D019344'], 'is_neural_normalized': False, 'mention': 'lactate', 'obj': 'drug', 'prob': 0.9954426288604736, 'span': {'begin': 127, 'end': 134}}, {'id': ['NCBIGene:3939'], 'is_neural_normalized': False, 'mention': 'lactate dehydrogenase A', 'obj': 'gene', 'prob': 0.981489896774292, 'span': {'begin': 127, 'end': 150}}, {'id': ['NCBIGene:3939'], 'is_neural_normalized': False, 'mention': 'LDHA', 'obj': 'gene', 'prob': 0.9975763559341431, 'span': {'begin': 158, 'end': 162}}, {'id': ['NCBIGene:3945'], 'is_neural_normalized': False, 'mention': 'LDHB', 'obj': 'gene', 'prob': 0.9959751963615417, 'span': {'begin': 164, 'end': 168}}, {'id': ['NCBIGene:2026'], 'is_neural_normalized': False, 'mention': 'neuron-specific enolase', 'obj': 'gene', 'prob': 0.9964224696159363, 'span': {'begin': 171, 'end': 194}}, {'id': ['NCBIGene:2026'], 'is_neural_normalized': False, 'mention': 'NSE', 'obj': 'gene', 'prob': 0.9927749037742615, 'span': {'begin': 196, 'end': 199}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'stress-induced phosphoprotein-1', 'obj': 'gene', 'prob': 0.9960516691207886, 'span': {'begin': 202, 'end': 233}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'STIP1', 'obj': 'gene', 'prob': 0.9951144456863403, 'span': {'begin': 235, 'end': 240}}, {'id': ['NCBIGene:4904'], 'is_neural_normalized': False, 'mention': 'YBX1', 'obj': 'gene', 'prob': 0.9972219467163086, 'span': {'begin': 272, 'end': 276}}], 'text': 'The proteins were identified as collapsin response mediator proteins 1 and 2 (CRMP1, CRMP2), guanine deaminase or cypin (GDA), lactate dehydrogenase A and B (LDHA, LDHB), neuron-specific enolase (NSE), stress-induced phosphoprotein-1 (STIP1), and Y-box binding protein 1 (YBX1) (functions are summarized in Table 1).', 'timestamp': 'Thu Feb 15 20:21:57 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999120235443115, 'span': {'begin': 214, 'end': 217}}], 'text': 'In this early study, instances of maternal seroreactivity to at least one of the proteins in both the case and control groups was observed, indicating that reactivity to any single antigen is not enough to predict ASD risk.', 'timestamp': 'Thu Feb 15 20:21:58 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9322324395179749, 'span': {'begin': 75, 'end': 78}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.9590169787406921, 'span': {'begin': 113, 'end': 118}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999744892120361, 'span': {'begin': 130, 'end': 133}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998156428337097, 'span': {'begin': 167, 'end': 170}}, {'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9258397817611694, 'span': {'begin': 220, 'end': 227}}, {'id': ['NCBIGene:3939'], 'is_neural_normalized': False, 'mention': 'LDHA', 'obj': 'gene', 'prob': 0.9976282715797424, 'span': {'begin': 246, 'end': 250}}, {'id': ['NCBIGene:3945'], 'is_neural_normalized': False, 'mention': 'LDHB', 'obj': 'gene', 'prob': 0.9982452392578125, 'span': {'begin': 251, 'end': 255}}, {'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'CRMP1', 'obj': 'gene', 'prob': 0.9974269866943359, 'span': {'begin': 256, 'end': 261}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'STIP1', 'obj': 'gene', 'prob': 0.9981192350387573, 'span': {'begin': 262, 'end': 267}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999300241470337, 'span': {'begin': 273, 'end': 276}}, {'id': ['mesh:D010900'], 'is_neural_normalized': True, 'mention': 'TD', 'obj': 'disease', 'prob': nan, 'span': {'begin': 284, 'end': 286}}], 'text': 'Instead, reactivity to a combination of two or more specific antigens (MAR ASD patterns) increased the risk of a child developing ASD with high accuracy: up to 20% of ASD cases and <1% of the controls; the most relevant MAR ASD pattern found was LDHA+LDHB+CRMP1+STIP1 (23% ASD vs. 1% TD) (51).', 'timestamp': 'Thu Feb 15 20:22:00 +0000 2024'}, {'annotations': [], 'text': 'In a more recent study using machine learning techniques, Ramiz-Celis et al.', 'timestamp': 'Thu Feb 15 20:22:00 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'CRMP1', 'obj': 'gene', 'prob': 0.9960671067237854, 'span': {'begin': 56, 'end': 61}}, {'id': ['NCBIGene:1808'], 'is_neural_normalized': False, 'mention': 'CRMP2', 'obj': 'gene', 'prob': 0.9976612329483032, 'span': {'begin': 62, 'end': 67}}, {'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'CRMP1', 'obj': 'gene', 'prob': 0.9948980212211609, 'span': {'begin': 69, 'end': 74}}, {'id': ['NCBIGene:9615'], 'is_neural_normalized': False, 'mention': 'GDA', 'obj': 'gene', 'prob': 0.998193085193634, 'span': {'begin': 75, 'end': 78}}, {'id': ['NCBIGene:2026'], 'is_neural_normalized': False, 'mention': 'NSE', 'obj': 'gene', 'prob': 0.997380793094635, 'span': {'begin': 84, 'end': 87}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'STIP1', 'obj': 'gene', 'prob': 0.9986073970794678, 'span': {'begin': 88, 'end': 93}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9997978806495667, 'span': {'begin': 117, 'end': 120}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999234676361084, 'span': {'begin': 219, 'end': 222}}], 'text': 'demonstrated that autoantibody combinations composed of CRMP1+CRMP2, CRMP1+GDA, and NSE+STIP1 predicted up to 20% of ASD cases with 100% accuracy, suggesting a significant potential for these patterns as biomarkers for ASD risk (52).', 'timestamp': 'Thu Feb 15 20:22:03 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:9247'], 'is_neural_normalized': True, 'mention': 'maternal IgG', 'obj': 'gene', 'prob': 0.9053129553794861, 'span': {'begin': 33, 'end': 45}}, {'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'brain', 'obj': 'DNA', 'prob': 0.46132969856262207, 'span': {'begin': 71, 'end': 76}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999372959136963, 'span': {'begin': 99, 'end': 102}}], 'text': 'Other groups have also looked at maternal IgG reactivity to individual brain antigens as potential ASD predictors.', 'timestamp': 'Thu Feb 15 20:22:04 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:26047'], 'is_neural_normalized': True, 'mention': 'contactin associated protein 2', 'obj': 'gene', 'prob': 0.9972642064094543, 'span': {'begin': 89, 'end': 119}}, {'id': ['NCBIGene:26047'], 'is_neural_normalized': False, 'mention': 'CASPR2', 'obj': 'gene', 'prob': 0.9953427910804749, 'span': {'begin': 121, 'end': 127}}, {'id': ['mesh:D016202'], 'is_neural_normalized': False, 'mention': 'N- methyl-D-aspartate', 'obj': 'drug', 'prob': 0.9991720914840698, 'span': {'begin': 146, 'end': 167}}, {'id': ['NCBIGene:2902'], 'is_neural_normalized': True, 'mention': 'N- methyl-D-aspartate receptor', 'obj': 'gene', 'prob': 0.9530954360961914, 'span': {'begin': 146, 'end': 176}}, {'id': ['mesh:D016202'], 'is_neural_normalized': False, 'mention': 'NMDA', 'obj': 'drug', 'prob': 0.9997475147247314, 'span': {'begin': 178, 'end': 182}}, {'id': ['NCBIGene:2902'], 'is_neural_normalized': True, 'mention': 'NMDA receptor', 'obj': 'gene', 'prob': 0.9870545268058777, 'span': {'begin': 178, 'end': 191}}], 'text': 'Due to their pivotal roles in neurodevelopment, the two most well-studied candidates are contactin associated protein 2 (CASPR2) (43, 44, 55) and N- methyl-D-aspartate receptor (NMDA receptor) (56).', 'timestamp': 'Thu Feb 15 20:22:06 +0000 2024'}, {'annotations': [{'id': ['mesh:D009422'], 'is_neural_normalized': True, 'mention': 'neurological alterations', 'obj': 'disease', 'prob': 0.999948263168335, 'span': {'begin': 104, 'end': 128}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.999984622001648, 'span': {'begin': 157, 'end': 160}}], 'text': 'Further, several groups have reported that maternal seroreactivity to these proteins is associated with neurological alterations in the offspring, including ASD (37, 38, 40, 57, 58).', 'timestamp': 'Thu Feb 15 20:22:07 +0000 2024'}, {'annotations': [], 'text': 'For example, Brimberg et al.', 'timestamp': 'Thu Feb 15 20:22:07 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:26047'], 'is_neural_normalized': True, 'mention': 'anti- CASPR2 antibodies', 'obj': 'gene', 'prob': 0.9898569583892822, 'span': {'begin': 14, 'end': 37}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.8592066168785095, 'span': {'begin': 68, 'end': 73}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999979734420776, 'span': {'begin': 79, 'end': 85}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9996733665466309, 'span': {'begin': 121, 'end': 124}}], 'text': 'reported that anti- CASPR2 antibodies were elevated in mothers of a child with autism when compared to the controls (37% ASD vs. 8% TD) (44, 59).', 'timestamp': 'Thu Feb 15 20:22:09 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:9247'], 'is_neural_normalized': True, 'mention': 'maternal IgG', 'obj': 'gene', 'prob': 0.9856336116790771, 'span': {'begin': 58, 'end': 70}}, {'id': ['NCBIGene:26047'], 'is_neural_normalized': False, 'mention': 'CASPR2', 'obj': 'gene', 'prob': 0.9740037322044373, 'span': {'begin': 130, 'end': 136}}, {'id': ['mesh:D016202'], 'is_neural_normalized': False, 'mention': 'NMDA', 'obj': 'drug', 'prob': 0.9994372725486755, 'span': {'begin': 141, 'end': 145}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.901480495929718, 'span': {'begin': 151, 'end': 156}}, {'id': ['mesh:D008607'], 'is_neural_normalized': False, 'mention': 'intellectual disability', 'obj': 'disease', 'prob': 0.9999987483024597, 'span': {'begin': 233, 'end': 256}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999923706054688, 'span': {'begin': 270, 'end': 273}}], 'text': 'However, results from a recent Danish study that examined maternal IgG cross-reactivity against several brain proteins (including CASPR2 and NMDA) and child outcomes concluded that seroreactivity to both proteins was associated with intellectual disability but not with ASD specifically (43, 60).', 'timestamp': 'Thu Feb 15 20:22:10 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:26047'], 'is_neural_normalized': False, 'mention': 'CASPR2', 'obj': 'gene', 'prob': 0.9802144765853882, 'span': {'begin': 87, 'end': 93}}, {'id': ['mesh:D016202'], 'is_neural_normalized': False, 'mention': 'NMDA', 'obj': 'drug', 'prob': 0.9988634586334229, 'span': {'begin': 98, 'end': 102}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999508857727051, 'span': {'begin': 166, 'end': 169}}], 'text': 'However, experiments using animal models suggests that maternal autoantibodies against CASPR2 and NMDA can disrupt proper neuronal function/development and result in ASD-like manifestations in the offspring (43-45, 56).', 'timestamp': 'Thu Feb 15 20:22:11 +0000 2024'}, {'annotations': [], 'text': 'Given data from the various studies, the pathologic significance of gestational exposure to maternal autoantibodies is clearly complex and future analyses will be needed to determine how their presence leads to specific changes in neurodevelopment.', 'timestamp': 'Thu Feb 15 20:22:12 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9813899397850037, 'span': {'begin': 31, 'end': 39}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999244213104248, 'span': {'begin': 45, 'end': 48}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.957843005657196, 'span': {'begin': 71, 'end': 79}}, {'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'maternal blood', 'obj': 'cell_type', 'prob': 0.5321471691131592, 'span': {'begin': 122, 'end': 136}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.999728262424469, 'span': {'begin': 165, 'end': 168}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.9294071793556213, 'span': {'begin': 337, 'end': 342}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999080896377563, 'span': {'begin': 354, 'end': 357}}], 'text': 'In one study of 450 mothers of children with ASD and 342 mothers of TD children, the presence of select autoantibodies in maternal blood was associated with ~20% of ASD cases compared to <1% of the typically developing (TD) controls, suggesting that these autoantibodies appear to be highly specific in their ability to detect risk of a child getting an ASD diagnosis (51, 52).', 'timestamp': 'Thu Feb 15 20:22:13 +0000 2024'}, {'annotations': [{'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999973773956299, 'span': {'begin': 53, 'end': 59}}, {'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'single gene mutation', 'obj': 'DNA', 'prob': 0.721057116985321, 'span': {'begin': 140, 'end': 160}}], 'text': 'Therefore, at this point in time, the association of autism with maternal autoantibodies to proteins in developing brain is higher than any single gene mutation described thus far (61, 62).', 'timestamp': 'Thu Feb 15 20:22:14 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9997871518135071, 'span': {'begin': 20, 'end': 23}}], 'text': 'This MAR subtype of ASD is now a focus of intense clinical and pre-clinical research.', 'timestamp': 'Thu Feb 15 20:22:15 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999113082885742, 'span': {'begin': 24, 'end': 27}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.8521215915679932, 'span': {'begin': 50, 'end': 58}}], 'text': 'It is believed that the ASD phenotype observed in children of mothers with these autoantibodies is the result of gestational exposure to these pathologically significant autoantibodies (47, 63-68).', 'timestamp': 'Thu Feb 15 20:22:16 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.8464388251304626, 'span': {'begin': 164, 'end': 169}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999940395355225, 'span': {'begin': 191, 'end': 197}}], 'text': 'While rigorous clinical validation is still necessary, maternal autoantibodies have the potential to be used as a precision medicine tool to evaluate the risk of a child being diagnosed with autism.', 'timestamp': 'Thu Feb 15 20:22:16 +0000 2024'}, {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9988762140274048, 'span': {'begin': 29, 'end': 36}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.8766207695007324, 'span': {'begin': 138, 'end': 143}}, {'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9999220967292786, 'span': {'begin': 246, 'end': 253}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'women', 'obj': 'species', 'prob': 0.8597068786621094, 'span': {'begin': 282, 'end': 287}}], 'text': 'The etiological relevance of MAR ASD was supported by multiple clinical studies in diverse populations and by experimental rodent and non-human primate animal models [reviewed in (37, 40, 58)], that in the future could lead to the development of MAR ASD prophylactic treatments for women at risk.', 'timestamp': 'Thu Feb 15 20:22:18 +0000 2024'}, {'annotations': [], 'text': 'Frontiers in Psychiatry | www.frontiersin.org June 2022 | Volume 13 | Article 834910   McLellan et al.', 'timestamp': 'Thu Feb 15 20:22:18 +0000 2024'}, {'annotations': [{'id': ['mesh:D000757', 'mim:206500'], 'is_neural_normalized': True, 'mention': 'ASD of the fetal brain', 'obj': 'disease', 'prob': 0.9774920344352722, 'span': {'begin': 25, 'end': 47}}], 'text': 'Maternal Risk Factors in ASD of the fetal brain FIGURE 1 | Schematic of maternal cytokines and autoantibodies affecting fetal brain development as studied using animal models.', 'timestamp': 'Thu Feb 15 20:22:19 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999264478683472, 'span': {'begin': 87, 'end': 90}}], 'text': 'Dysregulation of maternal immune system is a strong risk factor for the development of ASD.', 'timestamp': 'Thu Feb 15 20:22:20 +0000 2024'}, {'annotations': [], 'text': 'Alterations in the production of maternal cytokines and chemokines can impact the neurodevelopmental process, and the presence of maternal autoantibodies reactive to critical proteins can alter how the developmental trajectory of the brain.', 'timestamp': 'Thu Feb 15 20:22:21 +0000 2024'}, {'annotations': [], 'text': 'Pre-clinical models are used to better understand the underlying mechanisms for both proposed pathways to altered neurodevelopment.', 'timestamp': 'Thu Feb 15 20:22:22 +0000 2024'}, {'annotations': [], 'text': 'The figure was generated by Biorender.', 'timestamp': 'Thu Feb 15 20:22:23 +0000 2024'}, {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'MAR ASD profiles', 'obj': 'DNA', 'prob': 0.5918079018592834, 'span': {'begin': 9, 'end': 25}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9716665148735046, 'span': {'begin': 13, 'end': 16}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999064207077026, 'span': {'begin': 40, 'end': 43}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999983310699463, 'span': {'begin': 77, 'end': 83}}], 'text': 'Although MAR ASD profiles are promising ASD-risk biomarkers for a subtype of autism, substantial analytical and clinical validation is still needed before they can be introduced into clinical practice.', 'timestamp': 'Thu Feb 15 20:22:23 +0000 2024'}, {'annotations': [], 'text': 'Meanwhile, the use of in vitro and in vivo animal models will allow us to better understand the pathogenic mechanisms of maternal autoantibodies in neurodevelopment.', 'timestamp': 'Thu Feb 15 20:22:24 +0000 2024'}, {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9999203085899353, 'span': {'begin': 154, 'end': 161}}], 'text': 'In addition, they will have the potential to facilitate development of prophylactic treatments to mitigate the neurodevelopmental changes associated with MAR ASD.', 'timestamp': 'Thu Feb 15 20:22:25 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9307954907417297, 'span': {'begin': 21, 'end': 24}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998507499694824, 'span': {'begin': 103, 'end': 106}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999523162841797, 'span': {'begin': 208, 'end': 211}}], 'text': 'ANIMAL MODELS OF MAR ASD While strong correlations between the presence of maternal autoantibodies and ASD diagnosis have been observed, the pathological role of maternal autoantibodies in the development of ASD is the focus of ongoing research.', 'timestamp': 'Thu Feb 15 20:22:26 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:10095'], 'is_neural_normalized': False, 'mention': 'mice', 'obj': 'species', 'prob': 0.9878788590431213, 'span': {'begin': 39, 'end': 43}}, {'id': ['NCBITaxon:10116'], 'is_neural_normalized': False, 'mention': 'rats', 'obj': 'species', 'prob': 0.9822346568107605, 'span': {'begin': 45, 'end': 49}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.6242618560791016, 'span': {'begin': 59, 'end': 64}}], 'text': 'Multiple preclinical models, including mice, rats, and non-human primates have been utilized to understand the underlying pathology associated with the presence of these maternal autoantibodies (Figure 1).', 'timestamp': 'Thu Feb 15 20:22:27 +0000 2024'}, {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.999980628490448, 'span': {'begin': 23, 'end': 30}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9740291833877563, 'span': {'begin': 123, 'end': 131}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999924898147583, 'span': {'begin': 137, 'end': 143}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.948393702507019, 'span': {'begin': 184, 'end': 192}}], 'text': 'Early animal models of MAR ASD relied on a passive transfer method, utilizing purified antibodies isolated from mothers of children with autism or from mothers of typically developing children that were transferred to an otherwise healthy animal during gestation.', 'timestamp': 'Thu Feb 15 20:22:29 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:10095'], 'is_neural_normalized': False, 'mention': 'mice', 'obj': 'species', 'prob': 0.9801454544067383, 'span': {'begin': 19, 'end': 23}}], 'text': 'First conducted in mice, and subsequently in non-human primates, the passive transfer models yielded two main findings: (1) They confirmed that maternal antibodies do cross the placenta and can be detected in fetal tissues, including the brain, and (2) they confirmed that exposure to maternal autoantibodies results in changes in offspring behavior and brain development.', 'timestamp': 'Thu Feb 15 20:22:30 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:10090'], 'is_neural_normalized': False, 'mention': 'mouse', 'obj': 'species', 'prob': 0.9445799589157104, 'span': {'begin': 38, 'end': 43}}, {'id': ['NCBIGene:8857'], 'is_neural_normalized': True, 'mention': 'IgG', 'obj': 'gene', 'prob': 0.9953233599662781, 'span': {'begin': 63, 'end': 66}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9677581787109375, 'span': {'begin': 83, 'end': 91}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999326467514038, 'span': {'begin': 97, 'end': 100}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999603033065796, 'span': {'begin': 215, 'end': 218}}], 'text': 'More specifically, the offspring from mouse dams that received IgG from mothers of children with ASD spent more time in self-grooming and marble-burying behavior, reflective of the stereotypic behaviors observed in ASD.', 'timestamp': 'Thu Feb 15 20:22:31 +0000 2024'}, {'annotations': [{'id': ['mesh:D001008', 'mim:607834'], 'is_neural_normalized': False, 'mention': 'anxiety', 'obj': 'disease', 'prob': 0.9460899829864502, 'span': {'begin': 37, 'end': 44}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9344565272331238, 'span': {'begin': 65, 'end': 73}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999786615371704, 'span': {'begin': 79, 'end': 82}}], 'text': 'They also showed increased levels of anxiety, a comorbidity many children with ASD experience (69, 70).', 'timestamp': 'Thu Feb 15 20:22:32 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:8857'], 'is_neural_normalized': True, 'mention': 'IgG', 'obj': 'gene', 'prob': 0.9935850501060486, 'span': {'begin': 13, 'end': 16}}, {'id': ['NCBIGene:8857'], 'is_neural_normalized': True, 'mention': 'IgG', 'obj': 'gene', 'prob': 0.9950403571128845, 'span': {'begin': 91, 'end': 94}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9565671682357788, 'span': {'begin': 111, 'end': 119}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999264478683472, 'span': {'begin': 125, 'end': 128}}], 'text': 'Furthermore, IgG deposition was observed in the brains of offspring from dams treated with IgG from mothers of children with ASD, but not in controls (69, 70).', 'timestamp': 'Thu Feb 15 20:22:33 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:26047'], 'is_neural_normalized': False, 'mention': 'CASPR2', 'obj': 'gene', 'prob': 0.9702601432800293, 'span': {'begin': 55, 'end': 61}}, {'id': ['mesh:D016202'], 'is_neural_normalized': False, 'mention': 'NMDA', 'obj': 'drug', 'prob': 0.9982113838195801, 'span': {'begin': 66, 'end': 70}}], 'text': 'Similar passive transfer models studying antibodies to CASPR2 and NMDA have also yielded important findings.', 'timestamp': 'Thu Feb 15 20:22:34 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:10090'], 'is_neural_normalized': False, 'mention': 'mouse', 'obj': 'species', 'prob': 0.9756489396095276, 'span': {'begin': 14, 'end': 19}}, {'id': ['NCBIGene:26047'], 'is_neural_normalized': True, 'mention': 'anti-CASPR2 antibodies', 'obj': 'gene', 'prob': 0.9893642663955688, 'span': {'begin': 41, 'end': 63}}, {'id': ['NCBITaxon:10090'], 'is_neural_normalized': False, 'mention': 'mouse', 'obj': 'species', 'prob': 0.9755010008811951, 'span': {'begin': 215, 'end': 220}}], 'text': 'In one study, mouse offspring exposed to anti-CASPR2 antibodies at gestational day 13.5 had differences in sociability, as determined by the amount of time spent with an unfamiliar object vs. an unfamiliar stimulus mouse.', 'timestamp': 'Thu Feb 15 20:22:35 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:26047'], 'is_neural_normalized': True, 'mention': 'anti-CASPR2 antibodies', 'obj': 'gene', 'prob': 0.9924180507659912, 'span': {'begin': 55, 'end': 77}}], 'text': 'In addition, fetuses examined 2 days after exposure to anti-CASPR2 antibodies showed reduced cortical thickness and changes in cell proliferation (44).', 'timestamp': 'Thu Feb 15 20:22:37 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:2902', '27158'], 'is_neural_normalized': True, 'mention': 'NR1 subunit', 'obj': 'gene', 'prob': 0.9828261137008667, 'span': {'begin': 16, 'end': 27}}, {'id': ['mesh:D016202'], 'is_neural_normalized': False, 'mention': 'NMDA', 'obj': 'drug', 'prob': 0.9993700385093689, 'span': {'begin': 31, 'end': 35}}, {'id': ['NCBIGene:2902'], 'is_neural_normalized': True, 'mention': 'NMDA receptor', 'obj': 'gene', 'prob': 0.964963972568512, 'span': {'begin': 31, 'end': 44}}], 'text': 'Exposure to the NR1 subunit of NMDA receptor at gestational days 13 and 17 resulted in offspring who displayed impaired early postnatal reflexes and decreased prepulse inhibition (56).', 'timestamp': 'Thu Feb 15 20:22:38 +0000 2024'}, {'annotations': [], 'text': 'In non-human primate passive transfer studies, the results were similar, with offspring from treated dams displaying increased stereotypic behaviors with both novel and familiar social partners (47).', 'timestamp': 'Thu Feb 15 20:22:39 +0000 2024'}, {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'offspring', 'obj': 'cell_type', 'prob': 0.5227325558662415, 'span': {'begin': 29, 'end': 38}}], 'text': 'When examining the brains of offspring Frontiers in Psychiatry | www.frontiersin.org 4 June 2022 | Volume 13 | Article 834910   McLellan et al.', 'timestamp': 'Thu Feb 15 20:22:40 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999769926071167, 'span': {'begin': 25, 'end': 28}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9995729327201843, 'span': {'begin': 203, 'end': 206}}], 'text': 'Maternal Risk Factors in ASD from treated dams, investigators noted that male offspring had a higher rate of brain growth between 3 and 6 months of age, a finding that has been observed in some clinical ASD cases and may be correlated with atypical connectivity and altered brain maturation (71, 72).', 'timestamp': 'Thu Feb 15 20:22:41 +0000 2024'}, {'annotations': [], 'text': 'Together, these studies were essential in validating the hypothesis that maternal autoantibodies have pathologic significance and the potential to alter neurodevelopment (47, 69-71, 73).', 'timestamp': 'Thu Feb 15 20:22:42 +0000 2024'}, {'annotations': [], 'text': 'The passive transfer model was an essential first step in advancing the understanding of maternal autoantibody pathogenesis.', 'timestamp': 'Thu Feb 15 20:22:43 +0000 2024'}, {'annotations': [], 'text': 'However, this route of administration does not reflect the true exposure a fetus would experience during pregnancy.', 'timestamp': 'Thu Feb 15 20:22:43 +0000 2024'}, {'annotations': [], 'text': 'Thus, to create a more appropriate mimic of the gestational environment where a fetus would be exposed to maternal autoantibodies throughout pregnancy, we generated an antigen-driven model of endogenous exposure.', 'timestamp': 'Thu Feb 15 20:22:44 +0000 2024'}, {'annotations': [], 'text': 'In contrast to the passive transfer model, the antigen-driven model involves immunizing experimental dams with specific protein combinations prior to pregnancy, to induce selective, endogenous autoantibody production (64).', 'timestamp': 'Thu Feb 15 20:22:45 +0000 2024'}, {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'epitopes', 'obj': 'DNA', 'prob': 0.49439477920532227, 'span': {'begin': 98, 'end': 106}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.9834879040718079, 'span': {'begin': 152, 'end': 157}}], 'text': 'Clinical studies had previously identified specific patterns of antigen reactivity as well as the epitopes recognized by the maternal autoantibodies in human samples (51, 53).', 'timestamp': 'Thu Feb 15 20:22:46 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:10090'], 'is_neural_normalized': False, 'mention': 'mouse', 'obj': 'species', 'prob': 0.9757382273674011, 'span': {'begin': 43, 'end': 48}}, {'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9999598860740662, 'span': {'begin': 100, 'end': 107}}], 'text': 'This knowledge was then used to generate a mouse model with reliable construct validity to clinical MAR ASD.', 'timestamp': 'Thu Feb 15 20:22:47 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:10090'], 'is_neural_normalized': False, 'mention': 'mouse', 'obj': 'species', 'prob': 0.9806675910949707, 'span': {'begin': 19, 'end': 24}}, {'id': ['mesh:D019344'], 'is_neural_normalized': False, 'mention': 'lactate', 'obj': 'drug', 'prob': 0.9905713796615601, 'span': {'begin': 80, 'end': 87}}, {'id': ['NCBIGene:3945'], 'is_neural_normalized': True, 'mention': 'lactate dehydrogenase A and B', 'obj': 'gene', 'prob': 0.9942095279693604, 'span': {'begin': 80, 'end': 109}}, {'id': ['NCBIGene:3945'], 'is_neural_normalized': True, 'mention': 'LDH-A and B', 'obj': 'gene', 'prob': 0.994158923625946, 'span': {'begin': 111, 'end': 122}}, {'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'collapsin response mediator protein 1', 'obj': 'gene', 'prob': 0.9981132745742798, 'span': {'begin': 125, 'end': 162}}, {'id': ['NCBIGene:1400'], 'is_neural_normalized': False, 'mention': 'CRMP1', 'obj': 'gene', 'prob': 0.994620680809021, 'span': {'begin': 164, 'end': 169}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'stress induced phosphoprotein 1', 'obj': 'gene', 'prob': 0.9963170886039734, 'span': {'begin': 176, 'end': 207}}, {'id': ['NCBIGene:10963'], 'is_neural_normalized': False, 'mention': 'STIP1', 'obj': 'gene', 'prob': 0.9952114224433899, 'span': {'begin': 209, 'end': 214}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.923226535320282, 'span': {'begin': 300, 'end': 308}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999514818191528, 'span': {'begin': 314, 'end': 317}}], 'text': 'Described briefly, mouse dams were injected with synthetic peptide epitopes for lactate dehydrogenase A and B (LDH-A and B), collapsin response mediator protein 1 (CRMP1), and stress induced phosphoprotein 1 (STIP1), a protein reactivity pattern identified in clinical samples specific to mothers of children with ASD (53).', 'timestamp': 'Thu Feb 15 20:22:54 +0000 2024'}, {'annotations': [{'id': ['mesh:D007249'], 'is_neural_normalized': False, 'mention': 'inflammation', 'obj': 'disease', 'prob': 0.9850060343742371, 'span': {'begin': 159, 'end': 171}}], 'text': 'Once immune tolerance to the self-proteins was bypassed, these dams continuously produced autoantibodies to the protein epitopes of interest in the absence of inflammation and other immune perturbations that are also thought to impact offspring development.', 'timestamp': 'Thu Feb 15 20:22:54 +0000 2024'}, {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9999671578407288, 'span': {'begin': 166, 'end': 173}}], 'text': 'This approach resulted in offspring that were exposed to the autoantibodies throughout the gestational period, more closely resembling the exposure noted in clinical MAR ASD (64).', 'timestamp': 'Thu Feb 15 20:22:55 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:10090'], 'is_neural_normalized': False, 'mention': 'mouse', 'obj': 'species', 'prob': 0.9768286943435669, 'span': {'begin': 26, 'end': 31}}], 'text': 'Using the antigen- driven mouse model, researchers were able to test the behavioral and neurological impacts of constant gestational exposure to maternal autoantibodies.', 'timestamp': 'Thu Feb 15 20:22:56 +0000 2024'}, {'annotations': [], 'text': 'Offspring from treated dams had reduced social behaviors, including fewer bouts of nose-to-nose sniffing and front approaches.', 'timestamp': 'Thu Feb 15 20:22:57 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:10116'], 'is_neural_normalized': False, 'mention': 'rat', 'obj': 'species', 'prob': 0.9778521060943604, 'span': {'begin': 313, 'end': 316}}], 'text': 'In addition, researchers observed elevated repetitive behaviors, decreased ultrasonic vocalizations, and differences in neuroanatomical development; specifically increased brain volume in the offspring from treated dams (64, Our current studies seek to build upon this foundation through use of an antigen-driven rat model with an expanded repertoire of maternal antibody combinations recently identified in a large clinical study (52).', 'timestamp': 'Thu Feb 15 20:22:58 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:10116'], 'is_neural_normalized': False, 'mention': 'rat', 'obj': 'species', 'prob': 0.9581597447395325, 'span': {'begin': 133, 'end': 136}}], 'text': 'Recent work identifying the consequences of acute peripheral immune activation of offspring neurodevelopment (75), suggests that the rat model is a promising next step in understanding the pathology of maternal autoantibodies.', 'timestamp': 'Thu Feb 15 20:22:59 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:10116'], 'is_neural_normalized': False, 'mention': 'rat', 'obj': 'species', 'prob': 0.9754912257194519, 'span': {'begin': 19, 'end': 22}}], 'text': 'The antigen-driven rat model will allow for a more thorough identification of the behavioral and social impacts of maternal autoantibody exposure, thanks to their more complex neuroanatomy and social interactions.', 'timestamp': 'Thu Feb 15 20:23:00 +0000 2024'}, {'annotations': [], 'text': 'Additionally, utilizing the specific autoantibody combinations identified in clinical research will allow us to identify the consequences of exposure to select autoantibodies, providing researchers with a better understanding of which autoantibody combinations result in more severe pathology, and which can be used as risk- biomarkers.', 'timestamp': 'Thu Feb 15 20:23:01 +0000 2024'}, {'annotations': [], 'text': 'Since the development of this model yields dams that produce autoantibodies in the absence of inflammation, we can directly test how skewing of one arm of the maternal immune system impacts offspring behavior and neuroanatomy.', 'timestamp': 'Thu Feb 15 20:23:02 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:10116'], 'is_neural_normalized': False, 'mention': 'rat', 'obj': 'species', 'prob': 0.9773371815681458, 'span': {'begin': 4, 'end': 7}}], 'text': 'The rat model will not only be more translationally specific, but it will also provide researchers with a pre-clinical model in which to test future therapeutic interventions.', 'timestamp': 'Thu Feb 15 20:23:03 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.8369669914245605, 'span': {'begin': 68, 'end': 73}}], 'text': 'In the future, we hope to be able to generate an antigen-driven non-human primate model to further advance our preclinical model.', 'timestamp': 'Thu Feb 15 20:23:04 +0000 2024'}, {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9902240037918091, 'span': {'begin': 20, 'end': 27}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998918771743774, 'span': {'begin': 166, 'end': 169}}], 'text': 'Clinical studies of MAR ASD have revealed the critical protein targets for maternal autoantibodies and drawn links between the specific autoantibody combinations and ASD severity.', 'timestamp': 'Thu Feb 15 20:23:04 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998979568481445, 'span': {'begin': 178, 'end': 181}}], 'text': 'In addition, they have begun to elucidate other immunological factors, such as variances in maternal cytokine/chemokine profile, that can also be used as predictive measures for ASD risk.', 'timestamp': 'Thu Feb 15 20:23:05 +0000 2024'}, {'annotations': [], 'text': 'The use of animal models has helped to confirm the pathologic significance of at least some of the maternal autoantibodies, as well as provided researchers with a means to better understand the downstream molecular consequences and mechanisms involved in these effects.', 'timestamp': 'Thu Feb 15 20:23:06 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'humans', 'obj': 'species', 'prob': 0.9901012182235718, 'span': {'begin': 318, 'end': 324}}], 'text': 'Despite the advances made thus far, many questions remain which, once answered, will aid in the creation of more precise diagnostic tools, preventative treatments, There are several questions we are unable to answer using the animal model, such as: What is the triggering event for maternal autoantibody production in humans?', 'timestamp': 'Thu Feb 15 20:23:07 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9892298579216003, 'span': {'begin': 59, 'end': 67}}], 'text': 'What are the longstanding immunological impacts on exposed children?', 'timestamp': 'Thu Feb 15 20:23:08 +0000 2024'}, {'annotations': [{'id': ['mesh:D001327', 'mim:109100'], 'is_neural_normalized': False, 'mention': 'autoimmune disease', 'obj': 'disease', 'prob': 0.999987006187439, 'span': {'begin': 29, 'end': 47}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999896287918091, 'span': {'begin': 58, 'end': 61}}, {'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'MAR', 'obj': 'DNA', 'prob': 0.8635894060134888, 'span': {'begin': 79, 'end': 82}}], 'text': 'How does previous history of autoimmune disease influence ASD risk through the MAR mechanism?', 'timestamp': 'Thu Feb 15 20:23:09 +0000 2024'}, {'annotations': [], 'text': 'How do autoantibody and cytokine/chemokine levels prior to pregnancy compare to those present during and after pregnancy?', 'timestamp': 'Thu Feb 15 20:23:10 +0000 2024'}, {'annotations': [], 'text': 'To develop targeted therapeutics, it will also be important to further identify when offspring are most vulnerable to autoantibody and/or cytokine/chemokine exposure.', 'timestamp': 'Thu Feb 15 20:23:11 +0000 2024'}, {'annotations': [], 'text': 'To answer these questions, continued clinical studies and use of our pre-clinical models will be necessary.', 'timestamp': 'Thu Feb 15 20:23:12 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.6483522057533264, 'span': {'begin': 56, 'end': 61}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999978542327881, 'span': {'begin': 150, 'end': 156}}], 'text': 'The development of a more sophisticated model using non-human primates would increase the translational ability to the more complex behaviors seen in autism.', 'timestamp': 'Thu Feb 15 20:23:13 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.908327043056488, 'span': {'begin': 18, 'end': 23}}, {'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'antigen', 'obj': 'cell_line', 'prob': 0.5355033874511719, 'span': {'begin': 64, 'end': 71}}], 'text': 'Although some non-human primate studies have been completed, an antigen-driven model is currently under development, and we remain hopeful that this will soon be another model for researchers to utilize.', 'timestamp': 'Thu Feb 15 20:23:14 +0000 2024'}, {'annotations': [], 'text': 'Future research will continue to elucidate the mechanisms by which maternal autoantibodies impact their target proteins, and the optimal intervention strategies to mitigate damage.', 'timestamp': 'Thu Feb 15 20:23:14 +0000 2024'}, {'annotations': [], 'text': 'In addition, we will aim to identify connections between maternal cytokine/chemokine changes and Frontiers in Psychiatry | www.frontiersin.org June 2022 | Volume 13 | Article 834910   McLellan et al.', 'timestamp': 'Thu Feb 15 20:23:15 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999856948852539, 'span': {'begin': 25, 'end': 28}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'Autism', 'obj': 'disease', 'prob': 0.9999972581863403, 'span': {'begin': 29, 'end': 35}}], 'text': 'Maternal Risk Factors in ASD Autism is an incredibly complex disorder with a wide range of behavioral and cognitive phenotypes.', 'timestamp': 'Thu Feb 15 20:23:16 +0000 2024'}, {'annotations': [], 'text': 'Despite multiple known etiologies, a preventative strategy for the disorder remains to be discovered.', 'timestamp': 'Thu Feb 15 20:23:17 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999479055404663, 'span': {'begin': 56, 'end': 59}}], 'text': 'Furthermore, testing for specific phenotypic subsets of ASD are also lacking.', 'timestamp': 'Thu Feb 15 20:23:18 +0000 2024'}, {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9999834895133972, 'span': {'begin': 0, 'end': 7}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999951124191284, 'span': {'begin': 26, 'end': 32}}], 'text': 'MAR ASD is one subtype of autism in which the maternal immune system plays a critical role.', 'timestamp': 'Thu Feb 15 20:23:19 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9943702816963196, 'span': {'begin': 65, 'end': 68}}], 'text': 'We now know that specific risk factors exist for immune mediated ASD, including maternal autoantibody production, and skewed maternal and fetal chemokine/cytokine profile.', 'timestamp': 'Thu Feb 15 20:23:20 +0000 2024'}, {'annotations': [{'id': ['mesh:C564433', 'mim:304500'], 'is_neural_normalized': True, 'mention': 'MAR ASD', 'obj': 'disease', 'prob': 0.9999322295188904, 'span': {'begin': 138, 'end': 145}}], 'text': 'While much is left to be discovered, we continue to use clinical studies and refined animal models to tease apart the mechanisms by which MAR ASD develops.', 'timestamp': 'Thu Feb 15 20:23:21 +0000 2024'}, {'annotations': [{'id': ['mesh:D007154'], 'is_neural_normalized': True, 'mention': 'maternal immune dysregulation', 'obj': 'disease', 'prob': 0.9988955855369568, 'span': {'begin': 145, 'end': 174}}], 'text': 'Further, studies are underway to understand how neonatal cytokines and chemokines influence symptom severity as well as the relationship between maternal immune dysregulation during gestation and changes in the brain of affected offspring.', 'timestamp': 'Thu Feb 15 20:23:21 +0000 2024'}, {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:23:22 +0000 2024'}, {'annotations': [], 'text': 'Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke $, Abdallah M, et al.', 'timestamp': 'Thu Feb 15 20:23:23 +0000 2024'}, {'annotations': [{'id': ['mesh:D011645'], 'is_neural_normalized': True, 'mention': 'Maternal infection', 'obj': 'disease', 'prob': 0.9649432897567749, 'span': {'begin': 0, 'end': 18}}, {'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorders', 'obj': 'disease', 'prob': 0.9999992847442627, 'span': {'begin': 66, 'end': 91}}], 'text': 'Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders.', 'timestamp': 'Thu Feb 15 20:23:24 +0000 2024'}, {'annotations': [], 'text': 'J Autism Dev Disord.', 'timestamp': 'Thu Feb 15 20:23:25 +0000 2024'}, {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:23:26 +0000 2024'}, {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:23:27 +0000 2024'}, {'annotations': [], 'text': 'Shi L, Fatemi SH, Sidwell RW, Patterson PH.', 'timestamp': 'Thu Feb 15 20:23:28 +0000 2024'}, {'annotations': [{'id': ['mesh:D007251'], 'is_neural_normalized': True, 'mention': 'Maternal influenza infection', 'obj': 'disease', 'prob': 0.9814167022705078, 'span': {'begin': 0, 'end': 28}}], 'text': 'Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring[[/i]].', 'timestamp': 'Thu Feb 15 20:23:29 +0000 2024'}, {'annotations': [], 'text': 'J Neurosci.', 'timestamp': 'Thu Feb 15 20:23:30 +0000 2024'}, {'annotations': [], 'text': '(2003) 23:297. doi: 10.1523/JNEUROSCI.23-01-00297.2003 3.', 'timestamp': 'Thu Feb 15 20:23:31 +0000 2024'}, {'annotations': [], 'text': 'Stubbs EG, Crawford ML.', 'timestamp': 'Thu Feb 15 20:23:31 +0000 2024'}, {'annotations': [{'id': ['CL:0000542'], 'is_neural_normalized': False, 'mention': 'lymphocyte', 'obj': 'cell_type', 'prob': 0.8063668012619019, 'span': {'begin': 10, 'end': 20}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autistic', 'obj': 'disease', 'prob': 0.9999948740005493, 'span': {'begin': 39, 'end': 47}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9225614666938782, 'span': {'begin': 48, 'end': 56}}], 'text': 'Depressed lymphocyte responsiveness in autistic children.', 'timestamp': 'Thu Feb 15 20:23:32 +0000 2024'}, {'annotations': [], 'text': 'J Autism Child Schizophr.', 'timestamp': 'Thu Feb 15 20:23:33 +0000 2024'}, {'annotations': [], 'text': '(1977) 7:49. doi: 10.1007/BF01531114 4.', 'timestamp': 'Thu Feb 15 20:23:34 +0000 2024'}, {'annotations': [{'id': ['CL:0000542'], 'is_neural_normalized': False, 'mention': 'Lymphocyte', 'obj': 'cell_type', 'prob': 0.7759126424789429, 'span': {'begin': 47, 'end': 57}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999985694885254, 'span': {'begin': 70, 'end': 76}}, {'id': ['mesh:D015518', 'mim:312750'], 'is_neural_normalized': False, 'mention': 'Rett syndrome', 'obj': 'disease', 'prob': 0.9999986886978149, 'span': {'begin': 81, 'end': 94}}], 'text': 'Plioplys AV, Greaves A, Kazemi K, Silverman E. Lymphocyte function in autism and Rett syndrome.', 'timestamp': 'Thu Feb 15 20:23:35 +0000 2024'}, {'annotations': [], 'text': 'Neuropsychobiology.', 'timestamp': 'Thu Feb 15 20:23:36 +0000 2024'}, {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:23:37 +0000 2024'}, {'annotations': [], 'text': 'Warren RP, Foster A, Margaretten NC.', 'timestamp': 'Thu Feb 15 20:23:38 +0000 2024'}, {'annotations': [{'id': ['CL:0000623'], 'is_neural_normalized': False, 'mention': 'natural killer cell', 'obj': 'cell_type', 'prob': 0.9017917513847351, 'span': {'begin': 13, 'end': 32}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.999996542930603, 'span': {'begin': 45, 'end': 51}}], 'text': '[[i]]Reduced natural killer cell activity in autism[[/i]].', 'timestamp': 'Thu Feb 15 20:23:38 +0000 2024'}, {'annotations': [], 'text': 'Journal for the American Academy of Child e& Adolescent Psychiatry.', 'timestamp': 'Thu Feb 15 20:23:39 +0000 2024'}, {'annotations': [], 'text': '(1987) 26:333. doi: 10.1097/00004583-198705000-00008 6.', 'timestamp': 'Thu Feb 15 20:23:40 +0000 2024'}, {'annotations': [], 'text': 'Sweeten TL, Posey DJ, McDougle CJ.', 'timestamp': 'Thu Feb 15 20:23:41 +0000 2024'}, {'annotations': [{'id': ['CUI-less'], 'is_neural_normalized': False, 'mention': 'blood monocyte', 'obj': 'cell_type', 'prob': 0.8414391279220581, 'span': {'begin': 5, 'end': 19}}, {'id': ['mesh:D019798'], 'is_neural_normalized': False, 'mention': 'neopterin', 'obj': 'drug', 'prob': 0.9659011363983154, 'span': {'begin': 31, 'end': 40}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9142366051673889, 'span': {'begin': 51, 'end': 59}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autistic disorder', 'obj': 'disease', 'prob': 0.9999994039535522, 'span': {'begin': 65, 'end': 82}}], 'text': 'High blood monocyte counts and neopterin levels in children with autistic disorder.', 'timestamp': 'Thu Feb 15 20:23:42 +0000 2024'}, {'annotations': [], 'text': 'Am J Psychiatry.', 'timestamp': 'Thu Feb 15 20:23:43 +0000 2024'}, {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:23:44 +0000 2024'}, {'annotations': [{'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999289512634277, 'span': {'begin': 68, 'end': 71}}], 'text': 'MeadJ, Ashwood P. Evidence supporting an altered immune response in ASD.', 'timestamp': 'Thu Feb 15 20:23:45 +0000 2024'}, {'annotations': [], 'text': 'Immunol Lett.', 'timestamp': 'Thu Feb 15 20:23:46 +0000 2024'}, {'annotations': [], 'text': '(2015) 163:49. doi: 10.1016/j.imlet.2014.11.006 8.', 'timestamp': 'Thu Feb 15 20:23:47 +0000 2024'}, {'annotations': [], 'text': 'Abdallah MW, Larsen N, Grove J, Bonefeld-Jorgensen EC, Norgaard- Pedersen B, Hougaard DM, et al.', 'timestamp': 'Thu Feb 15 20:23:48 +0000 2024'}, {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorders', 'obj': 'disease', 'prob': 0.9999992251396179, 'span': {'begin': 38, 'end': 63}}], 'text': 'Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study.', 'timestamp': 'Thu Feb 15 20:23:49 +0000 2024'}, {'annotations': [], 'text': 'Cytokine.', 'timestamp': 'Thu Feb 15 20:23:50 +0000 2024'}, {'annotations': [], 'text': '(2013) 61:370. doi: 10.1016/j.cyto.2012.11.015 9.', 'timestamp': 'Thu Feb 15 20:23:50 +0000 2024'}, {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorders', 'obj': 'disease', 'prob': 0.9999992251396179, 'span': {'begin': 108, 'end': 133}}, {'id': ['mesh:D007154'], 'is_neural_normalized': False, 'mention': 'immune dysfunction', 'obj': 'disease', 'prob': 0.9997198581695557, 'span': {'begin': 154, 'end': 172}}], 'text': 'Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.', 'timestamp': 'Thu Feb 15 20:23:54 +0000 2024'}, {'annotations': [], 'text': 'Brain Behav Immun.', 'timestamp': 'Thu Feb 15 20:23:55 +0000 2024'}, {'annotations': [], 'text': '(2011) 25:40. doi: 10.1016/j.bbi.2010.08.003 10.', 'timestamp': 'Thu Feb 15 20:23:55 +0000 2024'}, {'annotations': [], 'text': 'Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J.', 'timestamp': 'Thu Feb 15 20:23:56 +0000 2024'}, {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorders', 'obj': 'disease', 'prob': 0.9999993443489075, 'span': {'begin': 70, 'end': 95}}], 'text': 'Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.', 'timestamp': 'Thu Feb 15 20:23:57 +0000 2024'}, {'annotations': [], 'text': 'J Neuroimmunol.', 'timestamp': 'Thu Feb 15 20:23:58 +0000 2024'}, {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:23:59 +0000 2024'}, {'annotations': [], 'text': 'Zerbo O, Yoshida C, Grether JK, Van de Water J, Ashwood P, Delorenze GN, et al.', 'timestamp': 'Thu Feb 15 20:24:00 +0000 2024'}, {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'Autism Spectrum Disorder', 'obj': 'disease', 'prob': 0.9999990463256836, 'span': {'begin': 46, 'end': 70}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'Autism', 'obj': 'disease', 'prob': 0.9998787641525269, 'span': {'begin': 94, 'end': 100}}], 'text': 'Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study.', 'timestamp': 'Thu Feb 15 20:24:01 +0000 2024'}, {'annotations': [], 'text': 'J Neuroinflammation.', 'timestamp': 'Thu Feb 15 20:24:02 +0000 2024'}, {'annotations': [], 'text': '(2014) 11:113. doi: 10.1186/1742-2094-11-113 12.', 'timestamp': 'Thu Feb 15 20:24:03 +0000 2024'}, {'annotations': [], 'text': 'Garty BZ, Ludomirsky A, Danon YL, Peter JB, Douglas SD.', 'timestamp': 'Thu Feb 15 20:24:04 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:7057'], 'is_neural_normalized': True, 'mention': 'immunoglobulin G', 'obj': 'gene', 'prob': 0.9951131939888, 'span': {'begin': 22, 'end': 38}}], 'text': 'Placental transfer of immunoglobulin G subclasses.', 'timestamp': 'Thu Feb 15 20:24:05 +0000 2024'}, {'annotations': [], 'text': 'Clin Diagn Lab Immunol.', 'timestamp': 'Thu Feb 15 20:24:06 +0000 2024'}, {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:24:07 +0000 2024'}, {'annotations': [], 'text': 'Roopenian DC, Akilesh $.', 'timestamp': 'Thu Feb 15 20:24:08 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:2217'], 'is_neural_normalized': False, 'mention': 'FcRn', 'obj': 'gene', 'prob': 0.9936323761940002, 'span': {'begin': 0, 'end': 4}}, {'id': ['NCBIGene:2217'], 'is_neural_normalized': False, 'mention': 'neonatal Fc receptor', 'obj': 'gene', 'prob': 0.9971632957458496, 'span': {'begin': 10, 'end': 30}}], 'text': 'FcRn: the neonatal Fc receptor comes of age.', 'timestamp': 'Thu Feb 15 20:24:09 +0000 2024'}, {'annotations': [], 'text': 'Nat Rev Immunol.', 'timestamp': 'Thu Feb 15 20:24:10 +0000 2024'}, {'annotations': [], 'text': '(2007) 7:715. doi: 10.1038/nri2155 We hope this knowledge will yield future preventatives This mini-review contains review of research performed by each of the authors.', 'timestamp': 'Thu Feb 15 20:24:11 +0000 2024'}, {'annotations': [], 'text': 'JV is the senior author and oversaw all aspects of this mini-review.', 'timestamp': 'Thu Feb 15 20:24:12 +0000 2024'}, {'annotations': [], 'text': 'JM is the first author and compiled all of the information from the other authors as well as wrote the animal model section.', 'timestamp': 'Thu Feb 15 20:24:13 +0000 2024'}, {'annotations': [], 'text': 'DK wrote the section on maternal immune activation.', 'timestamp': 'Thu Feb 15 20:24:14 +0000 2024'}, {'annotations': [], 'text': 'MB developed the animal models and edited the entire review.', 'timestamp': 'Thu Feb 15 20:24:15 +0000 2024'}, {'annotations': [], 'text': 'AR-C wrote the section on maternal autoantibodies.', 'timestamp': 'Thu Feb 15 20:24:15 +0000 2024'}, {'annotations': [], 'text': 'All authors contributed to the article and approved the submitted version.', 'timestamp': 'Thu Feb 15 20:24:16 +0000 2024'}, {'annotations': [], 'text': 'NICHD funded IDDRC P50 (P50HD103526).', 'timestamp': 'Thu Feb 15 20:24:17 +0000 2024'}, {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:24:18 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'women', 'obj': 'species', 'prob': 0.9427354335784912, 'span': {'begin': 112, 'end': 117}}, {'id': ['mesh:D008180', 'mim:152700'], 'is_neural_normalized': False, 'mention': 'systemic lupus erythematosus', 'obj': 'disease', 'prob': 0.9999992251396179, 'span': {'begin': 123, 'end': 151}}], 'text': 'Pakhathirathien P, Janjindamai W, Dissaneevate $, Thatrimontrichai A, Maneenil G. Neonatal outcomes in pregnant women with systemic lupus erythematosus: a 13-year experience in Southern Thailand.', 'timestamp': 'Thu Feb 15 20:24:19 +0000 2024'}, {'annotations': [], 'text': 'J Trop Pediatr.', 'timestamp': 'Thu Feb 15 20:24:20 +0000 2024'}, {'annotations': [], 'text': '(2021) 67:58. doi: 10.1093/tropej/fmab058 15.', 'timestamp': 'Thu Feb 15 20:24:21 +0000 2024'}, {'annotations': [], 'text': 'Saunders NR,  Liddelow $A, Dziegielewska KM.', 'timestamp': 'Thu Feb 15 20:24:22 +0000 2024'}, {'annotations': [], 'text': 'mechanisms in the developing brain.', 'timestamp': 'Thu Feb 15 20:24:23 +0000 2024'}, {'annotations': [], 'text': 'Front 16.', 'timestamp': 'Thu Feb 15 20:24:23 +0000 2024'}, {'annotations': [], 'text': 'Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL, Hertz-Picciotto I, et al.', 'timestamp': 'Thu Feb 15 20:24:24 +0000 2024'}, {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorder', 'obj': 'disease', 'prob': 0.9999993443489075, 'span': {'begin': 43, 'end': 67}}], 'text': 'Neonatal cytokine profiles associated with autism spectrum disorder.', 'timestamp': 'Thu Feb 15 20:24:25 +0000 2024'}, {'annotations': [], 'text': 'Biol Psychiatry.', 'timestamp': 'Thu Feb 15 20:24:26 +0000 2024'}, {'annotations': [], 'text': '(2017) 81:442. doi: 10.1016/j.biopsych.2015.08.007 17.', 'timestamp': 'Thu Feb 15 20:24:27 +0000 2024'}, {'annotations': [{'id': ['mesh:D011251'], 'is_neural_normalized': True, 'mention': 'Maternal intrauterine infection', 'obj': 'disease', 'prob': 0.9912474751472473, 'span': {'begin': 22, 'end': 53}}, {'id': ['mesh:D001930'], 'is_neural_normalized': True, 'mention': 'brain damage', 'obj': 'disease', 'prob': 0.9999803304672241, 'span': {'begin': 70, 'end': 82}}], 'text': 'Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn.', 'timestamp': 'Thu Feb 15 20:24:28 +0000 2024'}, {'annotations': [], 'text': 'Pediatr Res.', 'timestamp': 'Thu Feb 15 20:24:29 +0000 2024'}, {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:24:30 +0000 2024'}, {'annotations': [], 'text': 'Deverman BE, Patterson PH.', 'timestamp': 'Thu Feb 15 20:24:31 +0000 2024'}, {'annotations': [], 'text': 'Cytokines and CNS development.', 'timestamp': 'Thu Feb 15 20:24:32 +0000 2024'}, {'annotations': [], 'text': 'Neuron.', 'timestamp': 'Thu Feb 15 20:24:33 +0000 2024'}, {'annotations': [], 'text': '(2009) 64:61. doi: 10.1016/j.neuron.2009.09.002 19.', 'timestamp': 'Thu Feb 15 20:24:34 +0000 2024'}, {'annotations': [], 'text': 'Mousa A, Bakhiet M. Role of cytokine signaling during nervous system development.', 'timestamp': 'Thu Feb 15 20:24:35 +0000 2024'}, {'annotations': [], 'text': 'Int J Mol Sci.', 'timestamp': 'Thu Feb 15 20:24:35 +0000 2024'}, {'annotations': [], 'text': '(2013) 14:13931. doi: 10.3390/ijms140713931 20.', 'timestamp': 'Thu Feb 15 20:24:36 +0000 2024'}, {'annotations': [], 'text': 'Ramesh G, MacLean AG, Philipp MT.', 'timestamp': 'Thu Feb 15 20:24:37 +0000 2024'}, {'annotations': [{'id': ['mesh:D020078'], 'is_neural_normalized': True, 'mention': 'neuro-inflammation', 'obj': 'disease', 'prob': 0.999734103679657, 'span': {'begin': 46, 'end': 64}}, {'id': ['mesh:D009410'], 'is_neural_normalized': False, 'mention': 'neurodegeneration', 'obj': 'disease', 'prob': 0.9999966621398926, 'span': {'begin': 66, 'end': 83}}, {'id': ['mesh:D009437'], 'is_neural_normalized': False, 'mention': 'neuropathic pain', 'obj': 'disease', 'prob': 0.9999893307685852, 'span': {'begin': 89, 'end': 105}}], 'text': 'Cytokines and chemokines at the crossroads of neuro-inflammation, neurodegeneration, and neuropathic pain.', 'timestamp': 'Thu Feb 15 20:24:38 +0000 2024'}, {'annotations': [], 'text': 'Mediators Inflamm.', 'timestamp': 'Thu Feb 15 20:24:39 +0000 2024'}, {'annotations': [], 'text': '(2013) 2013:480739. doi: 10.1155/2013/480739 21.', 'timestamp': 'Thu Feb 15 20:24:40 +0000 2024'}, {'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorders', 'obj': 'disease', 'prob': 0.9999995231628418, 'span': {'begin': 48, 'end': 73}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.999997615814209, 'span': {'begin': 75, 'end': 78}}], 'text': 'Goines PE, Ashwood P. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.', 'timestamp': 'Thu Feb 15 20:24:41 +0000 2024'}, {'annotations': [], 'text': 'Neurotoxicol Teratol.', 'timestamp': 'Thu Feb 15 20:24:41 +0000 2024'}, {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:24:42 +0000 2024'}, {'annotations': [{'id': ['mesh:D000083242'], 'is_neural_normalized': False, 'mention': 'ischemic stroke', 'obj': 'disease', 'prob': 0.9999961256980896, 'span': {'begin': 110, 'end': 125}}], 'text': 'Yang C, Hawkins KE, Dore $, Candelario-Jalil E. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.', 'timestamp': 'Thu Feb 15 20:24:43 +0000 2024'}, {'annotations': [], 'text': 'Am J Physiol Cell Physiol.', 'timestamp': 'Thu Feb 15 20:24:44 +0000 2024'}, {'annotations': [], 'text': '(2019) 316:C135.', 'timestamp': 'Thu Feb 15 20:24:45 +0000 2024'}, {'annotations': [], 'text': 'doi: 10.1152/ajpcell.00136.2018 23.', 'timestamp': 'Thu Feb 15 20:24:46 +0000 2024'}, {'annotations': [], 'text': 'Hauguel-de Mouzon $, Guerre-Millo M. The placenta network and inflammatory signals.', 'timestamp': 'Thu Feb 15 20:24:47 +0000 2024'}, {'annotations': [], 'text': 'Placenta.', 'timestamp': 'Thu Feb 15 20:24:48 +0000 2024'}, {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:24:48 +0000 2024'}, {'annotations': [], 'text': 'Siwetz M, Blaschitz A, El-Heliebi A, Hiden U, Desoye G, Huppertz B, et al.', 'timestamp': 'Thu Feb 15 20:24:52 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:7124'], 'is_neural_normalized': False, 'mention': 'TNF-alpha', 'obj': 'gene', 'prob': 0.9898688197135925, 'span': {'begin': 0, 'end': 9}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'human', 'obj': 'species', 'prob': 0.9918531775474548, 'span': {'begin': 55, 'end': 60}}], 'text': 'TNF-alpha alters the inflammatory secretion profile of human first trimester placenta.', 'timestamp': 'Thu Feb 15 20:24:53 +0000 2024'}, {'annotations': [], 'text': 'Lab Invest.', 'timestamp': 'Thu Feb 15 20:24:54 +0000 2024'}, {'annotations': [], 'text': '(2016) 96:428. doi: 10.1038/labinvest.2015.159 25.', 'timestamp': 'Thu Feb 15 20:24:55 +0000 2024'}, {'annotations': [], 'text': 'Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen R, et al.', 'timestamp': 'Thu Feb 15 20:24:56 +0000 2024'}, {'annotations': [{'id': ['NCBIGene:3458'], 'is_neural_normalized': False, 'mention': 'IFN-gamma', 'obj': 'gene', 'prob': 0.9894703030586243, 'span': {'begin': 25, 'end': 34}}, {'id': ['NCBIGene:3565'], 'is_neural_normalized': False, 'mention': 'IL-4', 'obj': 'gene', 'prob': 0.9756038784980774, 'span': {'begin': 36, 'end': 40}}, {'id': ['NCBIGene:3567'], 'is_neural_normalized': False, 'mention': 'IL-5', 'obj': 'gene', 'prob': 0.9845430254936218, 'span': {'begin': 45, 'end': 49}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'women', 'obj': 'species', 'prob': 0.8643378615379333, 'span': {'begin': 53, 'end': 58}}, {'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'child', 'obj': 'species', 'prob': 0.8272078633308411, 'span': {'begin': 69, 'end': 74}}, {'id': ['mim:209850', 'mesh:D001321'], 'is_neural_normalized': False, 'mention': 'autism', 'obj': 'disease', 'prob': 0.9999960660934448, 'span': {'begin': 80, 'end': 86}}], 'text': 'Increased midgestational IFN-gamma, IL-4 and IL-5 in women bearing a child with autism: a case-control study.', 'timestamp': 'Thu Feb 15 20:24:57 +0000 2024'}, {'annotations': [], 'text': 'Mol Autism.', 'timestamp': 'Thu Feb 15 20:24:58 +0000 2024'}, {'annotations': [], 'text': 'No ascii letters. Please enter your text in English.', 'timestamp': 'Thu Feb 15 20:24:59 +0000 2024'}, {'annotations': [], 'text': \"Carter M, Casey $, O'Keeffe GW, Gibson L, Murray DM.\", 'timestamp': 'Thu Feb 15 20:25:00 +0000 2024'}, {'annotations': [{'id': ['NCBITaxon:9606'], 'is_neural_normalized': False, 'mention': 'children', 'obj': 'species', 'prob': 0.9581453800201416, 'span': {'begin': 39, 'end': 47}}, {'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'autism spectrum disorder', 'obj': 'disease', 'prob': 0.9999992847442627, 'span': {'begin': 60, 'end': 84}}], 'text': 'Mid- gestation cytokine profiles in of children affected by autism spectrum disorder: a case-control study.', 'timestamp': 'Thu Feb 15 20:25:02 +0000 2024'}, {'annotations': [], 'text': 'Sci Rep. (2021) 27.', 'timestamp': 'Thu Feb 15 20:25:03 +0000 2024'}, {'annotations': [], 'text': 'Ghassabian A, Albert PS, Hornig M, Yeung E, Cherkerzian $, Goldstein RB, et al.', 'timestamp': 'Thu Feb 15 20:25:04 +0000 2024'}, {'annotations': [], 'text': 'Gestational cytokine concentrations and neurocognitive development at 7 years.', 'timestamp': 'Thu Feb 15 20:25:04 +0000 2024'}, {'annotations': [], 'text': 'Transl Psychiatry.', 'timestamp': 'Thu Feb 15 20:25:05 +0000 2024'}, {'annotations': [], 'text': '(2018) 8:64. doi: 10.1038/s41398-018-0112-z Frontiers in Psychiatry | www.frontiersin.org June 2022 | Volume 13 | Article 834910', 'timestamp': 'Thu Feb 15 20:25:06 +0000 2024'}]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#syntax for retreiving the annotations through pubmed pmids\n",
        "import requests\n",
        "\n",
        "def query_pmid(pmids, url=\"http://bern2.korea.ac.kr/pubmed\"):\n",
        "    response = requests.get(url + \"/\" + \",\".join(pmids)).json()\n",
        "    return response\n",
        "\n",
        "if __name__ == '__main__':\n",
        "    pmids = [\"33271759\"]\n",
        "    print(query_pmid(pmids))\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "W_pXauFf-qSn",
        "outputId": "1bd74144-1c2d-4740-a184-ae2abed90014"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[{'_id': '33271759', 'annotations': [{'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'Autism Spectrum Disorder', 'obj': 'disease', 'prob': 0.9999995231628418, 'span': {'begin': 67, 'end': 91}}, {'id': ['mesh:D002659'], 'is_neural_normalized': True, 'mention': 'Autism spectrum disorders', 'obj': 'disease', 'prob': 0.9999992251396179, 'span': {'begin': 93, 'end': 118}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999881386756897, 'span': {'begin': 120, 'end': 123}}, {'id': ['mesh:D065886'], 'is_neural_normalized': False, 'mention': 'neurodevelopmental disorders', 'obj': 'disease', 'prob': 0.9999894499778748, 'span': {'begin': 140, 'end': 168}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999032020568848, 'span': {'begin': 341, 'end': 344}}, {'id': ['mesh:D007154'], 'is_neural_normalized': True, 'mention': 'maternal immune system dysfunctions', 'obj': 'disease', 'prob': 0.9997987151145935, 'span': {'begin': 735, 'end': 770}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9999524354934692, 'span': {'begin': 925, 'end': 928}}, {'id': ['NCBIGene:2487'], 'is_neural_normalized': True, 'mention': 'foetal brain-reactive antibodies', 'obj': 'gene', 'prob': 0.8846524357795715, 'span': {'begin': 1112, 'end': 1144}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998840093612671, 'span': {'begin': 1267, 'end': 1270}}, {'id': ['mesh:D006344'], 'is_neural_normalized': False, 'mention': 'ASD', 'obj': 'disease', 'prob': 0.9998852014541626, 'span': {'begin': 1499, 'end': 1502}}, {'id': ['mesh:D018805'], 'is_neural_normalized': True, 'mention': 'life', 'obj': 'disease', 'prob': 0.9668667912483215, 'span': {'begin': 1656, 'end': 1660}}], 'pmid': '33271759', 'text': 'Critical Role of the Maternal Immune System in the Pathogenesis of Autism Spectrum Disorder. Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders characterised by impairments in communication, social interaction, and the presence of restrictive and repetitive behaviours. Over the past decade, most of the research in ASD has focused on the contribution of genetics, with the identification of a variety of different genes and mutations. However, the vast heterogeneity in clinical presentations associated with this disorder suggests that environmental factors may be involved, acting as a \"second hit\" in already genetically susceptible individuals. To this regard, emerging evidence points towards a role for maternal immune system dysfunctions. This literature review considered evidence from epidemiological studies and aimed to discuss the pathological relevance of the maternal immune system in ASD by looking at the proposed mechanisms by which it alters the prenatal environment. In particular, this review focuses on the effects of maternal immune activation (MIA) by looking at foetal brain-reactive antibodies, cytokines and the microbiome. Despite the arguments presented here that strongly implicate MIA in the pathophysiology of ASD, further research is needed to fully understand the precise mechanisms by which they alter brain structure and behaviour. Overall, this review has not only shown the importance of the maternal immune system as a risk factor for ASD, but more importantly, has highlighted new promising pathways to target for the discovery of novel therapeutic interventions for the treatment of such a life-changing disorder.', 'timestamp': 'Fri Apr 15 05:40:25 +0000 2022'}]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "article_txt.split(\"\\n\")[57:61] #the author"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 35
        },
        "id": "dSrv4qEWNttq",
        "outputId": "27468556-f7e2-434f-c5f8-ff0757937ddc"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'Judy Van de Water'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 72
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import hashlib\n",
        "\n",
        "parsed_entities = []\n",
        "for entities in annotations:\n",
        "  e = []\n",
        "  # If there are not entities in the text\n",
        "  if not entities.get('denotations'):\n",
        "    parsed_entities.append({'text':entities['text'], 'text_sha256': hashlib.sha256(entities['text'].encode('utf-8')).hexdigest()})\n",
        "    continue\n",
        "  for entity in entities['denotations']:\n",
        "    other_ids = [id for id in entity['id'] if not id.startswith(\"BERN\")]\n",
        "    entity_type = entity['obj']\n",
        "    entity_name = entities['text'][entity['span']['begin']:entity['span']['end']]\n",
        "    try:\n",
        "      entity_id = [id for id in entity['id'] if id.startswith(\"BERN\")][0]\n",
        "    except IndexError:\n",
        "      entity_id = entity_name\n",
        "    e.append({'entity_id': entity_id, 'other_ids': other_ids, 'entity_type': entity_type, 'entity': entity_name})\n",
        "  parsed_entities.append({'entities':e, 'text':entities['text'], 'text_sha256': hashlib.sha256(entities['text'].encode('utf-8')).hexdigest()})\n",
        "parsed_entities"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "emLRhPirgqDO",
        "outputId": "bacc7422-1985-47c4-f6f3-40f149f4d00b"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[{'text': 'Autism spectrum disorder (ASD) is acknowledged as a highly heterogeneous, behaviorally defined neurodevelopmental disorder with multiple etiologies.',\n",
              "  'text_sha256': '9ce333cccb2dc919b84303b8d4144a371b8c7e8b9ed6904039b96066d099c566'},\n",
              " {'text': 'In addition to its high heritability, we have come to recognize a role for maternal immune system dysregulation as a prominent risk factor for the development of ASD in the child.',\n",
              "  'text_sha256': 'ae2a776c6bdbbc3740431f9b4358ba11d3e406299922f55518cf92e9aaaf713f'},\n",
              " {'text': 'Examples of these risk factors include altered cytokine/chemokine activity and the presence of autoantibodies in mothers that are reactive to proteins in the developing brain.',\n",
              "  'text_sha256': '66ea6110260d17536308f61ed682d0340a35ac3c2452b8a61b4c54634a3f630f'},\n",
              " {'text': 'In addition to large clinical studies, the development of pre-clinical models enables the ability to evaluate the cellular and molecular underpinnings of immune-related pathology.',\n",
              "  'text_sha256': '3de708a52ffc59718c3048c330d75fd0372ce25e0b0f8c1ad0ccfd2173d247b2'},\n",
              " {'text': 'For example, the novel animal models of maternal autoantibody- related (MAR) ASD described herein will serve as a preclinical platform for the future testing of targeted therapeutics for one type of ASD.',\n",
              "  'text_sha256': '88309583037259e1963f3f92bc0bb2cfdf994ffd097a689cb6511a40cd1cd5aa'},\n",
              " {'text': 'Identification of the cellular targets will advance Frontiers in Psychiatry | www.frontiersin.org 1 June 2022 | Volume 13 | Article 834910   McLellan et al.',\n",
              "  'text_sha256': '5c23ce90511cba2a39fe616ffcfa976d6814bcdd39ec23b10bd5257f353d34cb'},\n",
              " {'text': 'Maternal Risk Factors in ASD precision medicine efforts toward tailored therapeutics and prevention.',\n",
              "  'text_sha256': '99d460a99dfbb90962289e63b10fab58bebcede264de5572e54ed210e13cae93'},\n",
              " {'text': 'This minireview highlights emerging evidence for the role of maternal immune dysregulation as a potential biomarker, as well as a pathologically relevant mechanism for the development of ASD in offspring.',\n",
              "  'text_sha256': 'a6961774e26f8b3e9205d0537b2778863ffbe5693a8885a3411f093c003e284a'},\n",
              " {'text': 'Further, we will discuss the current limitations of these models as well as potential avenues THE ROLE OF THE MATERNAL IMMUNE SYSTEM IN THE DEVELOPMENT OF ASD In the past two decades, an increasingly large number of studies have provided evidence that maternal immune dysregulation can impact offspring neurodevelopment (1-11).',\n",
              "  'text_sha256': '351574a100ed6150fe7fd0d91923fa35163d2566b1c407450265be8f788b225e'},\n",
              " {'text': 'For example, it is now well-understood that the maternal immune system plays a critical role in the healthy development of the fetus.',\n",
              "  'text_sha256': 'e1f58302c5f17c6f5902992a71865d7a67aaba394d082bd6c09ad4c3dc49e319'},\n",
              " {'text': 'In fact, maternal immunoglobulin G (IgG) can cross the placenta and enter the fetal compartment, thereby providing early immunological protection to the infant during the perinatal stage (12, 13).',\n",
              "  'text_sha256': 'a50d296175b786b0f571ca0522f3f6f7f45fecce15124c56006e1193742ebd39'},\n",
              " {'text': 'However, this protective mechanism is not selective and harmful antibodies reactive to self proteins can also cross the placenta (14).',\n",
              "  'text_sha256': '993d17ba8c6d22ac082527a5310d5e383c8c89ff5532bafc03fc3a4c6d58ef05'},\n",
              " {'text': 'Once within the fetal compartment, these maternal autoantibodies may bind to their protein targets, potentially impacting protein function.',\n",
              "  'text_sha256': 'c377344d27eb843894f9f8ef33aaf5e15ce9ce19758695c5eb2e12e1cc80038f'},\n",
              " {'text': 'This is especially dangerous during the perinatal period given the permissiveness of the blood- brain barrier (BBB) and vulnerability of the developing central nervous system (CNS) (15).',\n",
              "  'text_sha256': 'f342f2a55cf2f905e5d0f1582c7ec4246493d8bb24d2bbf3eebf42a0bf330764'},\n",
              " {'text': 'In addition to the production of autoantibodies, other perturbations of the maternal immune system can result in harmful effects on the developing fetus.',\n",
              "  'text_sha256': 'cdbe0d4f61c3b4583ceacfbfed45c745aabd042d11ac6f825f18ae00fbfd50db'},\n",
              " {'text': 'It has been shown that alterations in the maternal cytokine/chemokine profile can result in changes in the inflammatory state, skewed cellular signaling, and altered neurodevelopment (16, 17).',\n",
              "  'text_sha256': 'c1f03a35547506117acedbf1e447eb907f69b8ab83c6ea1cf828b839e5b9b706'},\n",
              " {'text': 'CYTOKINES AND CHEMOKINES AS In recent years, several researchers have reported on specific cytokines and/or chemokines that are associated with ASD risk both in children with ASD and mothers that have ildren diagnosed with ASD.',\n",
              "  'text_sha256': 'fec0251c5fee18375fbafdddfcc752f8b6adacb98edfa44f791cf13788caa004'},\n",
              " {'text': 'Interestingly, several cytokines nd chemokines are constitutively expressed throughout the developing CNS (18, 19).',\n",
              "  'text_sha256': 'c968703e71133239f89e7010964c872bd7dae2562b37fb41bc926957789f156a'},\n",
              " {'text': 'Cytokines in the brain perform functions similar to those seen in the periphery, acting as cues in cell development and differentiation, and regulating the types and number of neuronal and non-neuronal cells (20, 21).',\n",
              "  'text_sha256': 'f23f81e64edd91d210d84995edd4cae40a4b1da9a70be5d4f201a0cf88e13aa3'},\n",
              " {'text': 'Together, these complex processes contribute to early neurodevelopment and homeostasis.',\n",
              "  'text_sha256': 'b72a06f008f9f5a176a6327a49ffa4e88618197f22c5ba708dcc171ea1ae44a0'},\n",
              " {'text': 'In the context of maternal- fetal interaction, some cytokines, in particular IL-6, can be transported from the mother to the offspring and access e developing CNS (17).',\n",
              "  'text_sha256': '94683ca7b2c20e467aebf59602d532962b2f701538c28209dc0747573a17a79a'},\n",
              " {'text': 'Although the source of abnormal cytokine levels in mothers during gestation may differ, this could alter placental production and overall levels of cytokines and chemokines in the fetal compartment, impacting the cascade To date, a variety of clinical studies have demonstrated tered cytokine levels in mothers and neonatal blood samples that are strongly associated with ASD (Table 1), increasing the potential for cytokines/chemokines to serve as biomarkers for risk of abnormal neurodevelopment.',\n",
              "  'text_sha256': 'a97faf6a6eb4ade2ac84a2c26f0b89e455a7dac68de56d4fec884c03681ff39b'},\n",
              " {'text': 'Most of the reported cytokines associated with ASD induce the BBB to become more permissive (22) increasing the vulnerability and altering the homeostatic levels of cytokines in the developing CNS.',\n",
              "  'text_sha256': '82d29fe6b73aeb1ddb510b48645d5a0e1a762283b4b2fead204a25eb9399ca85'},\n",
              " {'text': 'Numerous researchers have corroborated the concept that significant changes in maternal cytokine/chemokine homeostasis are correlated with ASD development even in the absence of maternal/fetal infection.',\n",
              "  'text_sha256': '442e2c6d4b8f4aa5df1cb545ef26892d420e094c052861a48753581759392ffe'},\n",
              " {'text': 'Such changes in maternal cytokines and chemokines can not only directly impact the fetus but can also stimulate placental production of pro-inflammatory cytokines within the fetal compartment (17, 23, 24).',\n",
              "  'text_sha256': '6eb6d5cecf874476327586e90b398bb543d174dffa1d6534f65557e9d08378cc'},\n",
              " {'text': 'For example, dysregulation of serum and/or amniotic fluid IL-4, IL-6, and IL- 8 have been described in mothers of children with ASD and were associated with altered behavioral outcomes including non- verbal cognitive ability and stereotypical behaviors in children (25-28).',\n",
              "  'text_sha256': '4062a5e469134f7b8a23cbf1ef2b68622034bebfc2acabd8ea0370da7a588c2a'},\n",
              " {'text': 'The cytokine IL-17, which has been implicated in several neurodevelopmental disorders, including ASD, has been shown to promote inflammation and disrupt the BBB postnatally (29, 30).',\n",
              "  'text_sha256': '04fac74a51016279564dd279f9cb7b08066bcd3d28a93e7696cffcb85fb34305'},\n",
              " {'text': 'In addition, IFN-y, which is involved in neuronal differentiation and synaptic formation, was shown to be higher in mothers of children with ASD during the second trimester (25, 28), potentially suggesting disrupted synaptic connectivity.',\n",
              "  'text_sha256': '6549ba117496f6e6f5830b9c7090f28a8eda5850a39605ef4713c52daed46df0'},\n",
              " {'text': 'Studies have also observed altered cytokine and chemokine levels in neonates who are later diagnosed with autism.',\n",
              "  'text_sha256': 'cc9868db924ae381aee5d4b96a8e8360e3a6feca3f40037e43ec7396d23c3901'},\n",
              " {'text': 'For example, researchers found that newborns later diagnosed with ASD have higher peripheral levels of IL-16, which is expressed throughout the CNS particularly during the early neurodevelopmental period (16, 21).',\n",
              "  'text_sha256': 'a34b5af6aab7a30e532fcc2f9462b7022baea73357fa752ab7299d03366a63ce'},\n",
              " {'text': 'In our recent findings, CCL27, also known as CTACK, was significantly lower in newborns later diagnosed with ASD.',\n",
              "  'text_sha256': '67429e0281eb60fa92e91dc7c5edc4b28f4a0e4254ecaecc1c3404efc8db3e98'},\n",
              " {'text': 'This decrease was associated with an increase in the risk of both ASD with and without intellectual disability when compared to newborns with developmental delay or those with typical development (31).',\n",
              "  'text_sha256': '7cd8fd54b9de1c83ff15bdd62d1b41e9cb5cd681db948d03832933e2c42044ab'},\n",
              " {'text': 'Elevated levels of monocyte chemoattractant protein-1 (MCP- 1) and macrophage-derived chemokine (MDC) were found in the amniotic fluid, plasma, cerebellum, and cerebrospinal fluid of children with ASD (10, 32, 33), implying involvement of these chemokines in neurodevelopment.',\n",
              "  'text_sha256': '292662a29680b283f1e486a6d8508ee3388899626f8d0e6dbe0d6bbe465db488'},\n",
              " {'text': 'Increased levels of the chemokines macrophage inflammatory protein-1 (MIP-1) and eotaxin are also often noted in children with ASD, and have been associated with behavioral deficits (10, 34-36).',\n",
              "  'text_sha256': '5be6a12602cc9a63fd972c6869d3382ac110533e443697e530c169bb74a2f7f3'},\n",
              " {'text': 'It is unlikely that one specific cytokine or chemokine plays a role in the development of ASD, but rather a combination of cytokines/chemokines are more likely to contribute to the neuropathology associated with autism.',\n",
              "  'text_sha256': '242533e6507915dfb5f78b1a732286eb8bda842940179816262d66ce3fc0b459'},\n",
              " {'text': 'The exact consequences of altered cytokine/chemokine levels during pregnancy that lead to the ASD phenotype is an important area of research.',\n",
              "  'text_sha256': '1bc002d8c2da03bd9210223454fb92db7e46d012157d49b74491732c5ebdcbee'},\n",
              " {'text': 'Furthermore, the trigger(s) for changes in maternal cytokine and chemokine levels, and how other aspects of the maternal immune system may also be affected are essential questions to address.',\n",
              "  'text_sha256': '10ba36594222f9aab421f74d151ebef19f35e95f43e2413c8af7069bb72d6691'},\n",
              " {'text': 'Although the number of research studies that include time-specific/longitudinal examination as well as mother-infant pair-matched studies are lacking, it is promising that similar groups of cytokines and chemokines are frequently shown to be altered in both children with ASD and their mothers, increasing Frontiers in Psychiatry | www.frontiersin.org June 2022 | Volume 13 | Article 834910   McLellan et al.',\n",
              "  'text_sha256': 'de09a2cd3399adbf6c882844eecec55f09b651029aa196e53359b43cfc19ef9f'},\n",
              " {'text': 'Maternal Risk Factors in ASD TABLE 1 | Maternal cytokines/chemokines and maternal autoantibody targets implicated in ASD.',\n",
              "  'text_sha256': 'b9f47ab0e2e4b3bc308d661f7d54e2bac2442cba95869d0f9dd435cda43bff99'},\n",
              " {'text': 'Cytokines/chemokines Sample source Reference IL-1, IL-4, IL-5, IL-8, IL-7A, IFN-y Maternal serum collected mid-gestation (25, 26, 28) IL-4, IL-10MCP-1TNF-a, TNF-B Amniotic fluid (27, 32) Target antigen Protein function CRMP1, CRMP2, STIP1, YBOX Microtubule dynamics, protein chaperone, transcription factor (12-14, 42-44) LDH-A, LDH-B, GDA, NSE Metabolic enzymes (14-16, 37-41) CASPR2 Cell adhesion (45, 52) the promise of cytokines and chemokines as biomarkers for risk MATERNAL AUTOANTIBODY TARGETS IN Several groups have now identified multiple brain antigens that cross-react with maternal IgG and are related to neurodevelopmental impairments in the child, including ASD (37-45).',\n",
              "  'text_sha256': 'a2afac6dda84f950a0a34c8b8f450d6704ea486a6a5d5a0983c6df25715d3b85'},\n",
              " {'text': 'Early studies used fetal brain extracts to probe maternal plasma by western blot (WB) and reported reactivity to bands at ~36 kDa that were present in 10% of the ASD samples vs. only 2% of controls.',\n",
              "  'text_sha256': 'f31099f074a78d231f9d88c224cd8bfa78f61b05bbd237c2d0918fc5abe05f32'},\n",
              " {'text': 'In addition, they observed increased maternal IgG cross-reactivity to multiple bands at 27, 36, at 73 kD in the ASD-positive mothers (46).',\n",
              "  'text_sha256': 'fc9a5620cda240b65b72c1d9b79e8b0af08092dba76958d01ffbc95c87f78ca9'},\n",
              " {'text': 'Concurrent studies reported similar band patterns of reactivity at 37/73 kDa and 39/73 kDa which were ASD specific and not present in controls (47-50).',\n",
              "  'text_sha256': 'cb017b7d05a4a44fa907dd31a6f4f0380af3ac4da350c514894fe47160a68aea'},\n",
              " {'text': 'Several groups, including our own, conducted a series of experiments that lead to the identification of eight maternal autoantibody-related (MAR) ASD antigens and their pathogenic epitopes (51-54).',\n",
              "  'text_sha256': '3d5c19121dcefe0f3fa442470d9dd65d4b09b378e24ba4b455ffce592d08db30'},\n",
              " {'text': 'The proteins were identified as collapsin response mediator proteins 1 and 2 (CRMP1, CRMP2), guanine deaminase or cypin (GDA), lactate dehydrogenase A and B (LDHA, LDHB), neuron-specific enolase (NSE), stress-induced phosphoprotein-1 (STIP1), and Y-box binding protein 1 (YBX1) (functions are summarized in Table 1).',\n",
              "  'text_sha256': 'febcaa61c3efa2624feb45c80cbb34c769ef9e0158aa181c3435ca4d423f6de7'},\n",
              " {'text': 'In this early study, instances of maternal seroreactivity to at least one of the proteins in both the case and control groups was observed, indicating that reactivity to any single antigen is not enough to predict ASD risk.',\n",
              "  'text_sha256': 'c3e8db4f660ac147782c8227c2e6e91350509f5098fd89068747f67b3cf0a3aa'},\n",
              " {'text': 'Instead, reactivity to a combination of two or more specific antigens (MAR ASD patterns) increased the risk of a child developing ASD with high accuracy: up to 20% of ASD cases and <1% of the controls; the most relevant MAR ASD pattern found was LDHA+LDHB+CRMP1+STIP1 (23% ASD vs. 1% TD) (51).',\n",
              "  'text_sha256': '0f1fa8795aaf7f458f7d1378eba7810e4a69f8458a6855012f26a5934bf9332f'},\n",
              " {'text': 'In a more recent study using machine learning techniques, Ramiz-Celis et al.',\n",
              "  'text_sha256': 'ce4deee9738c0dca71e7cad106b6818c28fd8f7159a47e4c82154d306bdf7333'},\n",
              " {'text': 'demonstrated that autoantibody combinations composed of CRMP1+CRMP2, CRMP1+GDA, and NSE+STIP1 predicted up to 20% of ASD cases with 100% accuracy, suggesting a significant potential for these patterns as biomarkers for ASD risk (52).',\n",
              "  'text_sha256': '539510ba442cadbc62bc8d29b709cc3c96d17f4126bc1ffc1ca5d0354cde31d1'},\n",
              " {'text': 'Other groups have also looked at maternal IgG reactivity to individual brain antigens as potential ASD predictors.',\n",
              "  'text_sha256': 'a00ba6ebc6c58ea8acc72a15474cca4a0734721b52ea50c18461e0b44a426407'},\n",
              " {'text': 'Due to their pivotal roles in neurodevelopment, the two most well-studied candidates are contactin associated protein 2 (CASPR2) (43, 44, 55) and N- methyl-D-aspartate receptor (NMDA receptor) (56).',\n",
              "  'text_sha256': 'c0e0f0ce94fe024bba73fe41cd669b520a83eed1d65110073fbda3592a5aecdb'},\n",
              " {'text': 'Further, several groups have reported that maternal seroreactivity to these proteins is associated with neurological alterations in the offspring, including ASD (37, 38, 40, 57, 58).',\n",
              "  'text_sha256': '6435f9f6351220c8754a1ad2e7736cc404865188c1e573f10df50fdfd6df097a'},\n",
              " {'text': 'For example, Brimberg et al.',\n",
              "  'text_sha256': '0c568687cba6dc350214d3ab1cc6cecee9625a903517fb401ea17eb568e4eb83'},\n",
              " {'text': 'reported that anti- CASPR2 antibodies were elevated in mothers of a child with autism when compared to the controls (37% ASD vs. 8% TD) (44, 59).',\n",
              "  'text_sha256': 'f3ccd8fae13cdfd9f5bb6dd21e496f01cf789976b7b32d9a47f3203dd8edee6f'},\n",
              " {'text': 'However, results from a recent Danish study that examined maternal IgG cross-reactivity against several brain proteins (including CASPR2 and NMDA) and child outcomes concluded that seroreactivity to both proteins was associated with intellectual disability but not with ASD specifically (43, 60).',\n",
              "  'text_sha256': 'b0fc3a8333c00669e298b6cfd3462169cc8d1f780eb8958644673e327dca93c5'},\n",
              " {'text': 'However, experiments using animal models suggests that maternal autoantibodies against CASPR2 and NMDA can disrupt proper neuronal function/development and result in ASD-like manifestations in the offspring (43-45, 56).',\n",
              "  'text_sha256': '31495b44aee52fb53e6d5d39a4a17fbb40b80ac9d0ec174fbcf08850463dd5a4'},\n",
              " {'text': 'Given data from the various studies, the pathologic significance of gestational exposure to maternal autoantibodies is clearly complex and future analyses will be needed to determine how their presence leads to specific changes in neurodevelopment.',\n",
              "  'text_sha256': '18e809642c96052b701701026035b426d0c64257054f3befe87c22dbcbca5161'},\n",
              " {'text': 'In one study of 450 mothers of children with ASD and 342 mothers of TD children, the presence of select autoantibodies in maternal blood was associated with ~20% of ASD cases compared to <1% of the typically developing (TD) controls, suggesting that these autoantibodies appear to be highly specific in their ability to detect risk of a child getting an ASD diagnosis (51, 52).',\n",
              "  'text_sha256': '0d8578c807631b919b6cf806cfd2788988b7e44e17cde6f2b554af503a5862a5'},\n",
              " {'text': 'Therefore, at this point in time, the association of autism with maternal autoantibodies to proteins in developing brain is higher than any single gene mutation described thus far (61, 62).',\n",
              "  'text_sha256': '0abde24abb3cc4715ab318e62ee566e2384bec7dc1d60301a0aed914946f677b'},\n",
              " {'text': 'This MAR subtype of ASD is now a focus of intense clinical and pre-clinical research.',\n",
              "  'text_sha256': '8c436aa6c7c86355f0cbcfb36f533c73772bac99ec5bfcf807cf34a481a60343'},\n",
              " {'text': 'It is believed that the ASD phenotype observed in children of mothers with these autoantibodies is the result of gestational exposure to these pathologically significant autoantibodies (47, 63-68).',\n",
              "  'text_sha256': '57432baad8cbeb898dae7e9cc7d676265c6a8bc2e409f73fa3e5a3665b6cac71'},\n",
              " {'text': 'While rigorous clinical validation is still necessary, maternal autoantibodies have the potential to be used as a precision medicine tool to evaluate the risk of a child being diagnosed with autism.',\n",
              "  'text_sha256': 'fc5070fb220b67a0a3807603f5d18c68501bf3fde5b3177cf9faaf6f21d0f7ec'},\n",
              " {'text': 'The etiological relevance of MAR ASD was supported by multiple clinical studies in diverse populations and by experimental rodent and non-human primate animal models [reviewed in (37, 40, 58)], that in the future could lead to the development of MAR ASD prophylactic treatments for women at risk.',\n",
              "  'text_sha256': '145613ac5bf86ad2c5c873d8dfe926ef0e7d6effc26a4be0d93ba4162a729d21'},\n",
              " {'text': 'Frontiers in Psychiatry | www.frontiersin.org June 2022 | Volume 13 | Article 834910   McLellan et al.',\n",
              "  'text_sha256': 'cca445815df9543054f646167cecf7c01ec3da7590eb79febb803d9bf8e8190f'},\n",
              " {'text': 'Maternal Risk Factors in ASD of the fetal brain FIGURE 1 | Schematic of maternal cytokines and autoantibodies affecting fetal brain development as studied using animal models.',\n",
              "  'text_sha256': '929457b50c3cdc82f4d91594da7f9995f4215fd70652a0d2de88f91c96f487fc'},\n",
              " {'text': 'Dysregulation of maternal immune system is a strong risk factor for the development of ASD.',\n",
              "  'text_sha256': '4901abe77fe0b80600a323bafd40fa3b36b9ebff7e20298ef0317b6a9dabeeb2'},\n",
              " {'text': 'Alterations in the production of maternal cytokines and chemokines can impact the neurodevelopmental process, and the presence of maternal autoantibodies reactive to critical proteins can alter how the developmental trajectory of the brain.',\n",
              "  'text_sha256': '26112cd042a923c90e3cf776cf4ce1c9e5e38208a8ca2e39f54b7b7ba5936f19'},\n",
              " {'text': 'Pre-clinical models are used to better understand the underlying mechanisms for both proposed pathways to altered neurodevelopment.',\n",
              "  'text_sha256': '787ed684603ff22f9e9cb5c6de72b72414a124f7d813a691262dafbae0bd843e'},\n",
              " {'text': 'The figure was generated by Biorender.',\n",
              "  'text_sha256': '30eac147ff5ff1318b7fbf47c0be30aa6ce0a09c1c4cc46d47c0b6ced3fdf068'},\n",
              " {'text': 'Although MAR ASD profiles are promising ASD-risk biomarkers for a subtype of autism, substantial analytical and clinical validation is still needed before they can be introduced into clinical practice.',\n",
              "  'text_sha256': 'f3d2b511cd2734df39bf3e1811f16306d19c01e28b1486895c267ceaca7dbe78'},\n",
              " {'text': 'Meanwhile, the use of in vitro and in vivo animal models will allow us to better understand the pathogenic mechanisms of maternal autoantibodies in neurodevelopment.',\n",
              "  'text_sha256': '7316fc6adc7f08c1edfddebb9a92a580027911cc5b114af6f3dffdc0658d189a'},\n",
              " {'text': 'In addition, they will have the potential to facilitate development of prophylactic treatments to mitigate the neurodevelopmental changes associated with MAR ASD.',\n",
              "  'text_sha256': '9a3ba6f07c424101547d393dc237b6b128ebb5cbb7e702ee855b5146fc30f0bf'},\n",
              " {'text': 'ANIMAL MODELS OF MAR ASD While strong correlations between the presence of maternal autoantibodies and ASD diagnosis have been observed, the pathological role of maternal autoantibodies in the development of ASD is the focus of ongoing research.',\n",
              "  'text_sha256': 'a477658f02fe1203244c9628e4a1659abfbf10ed6207a19f02f59bd12efc5ef8'},\n",
              " {'text': 'Multiple preclinical models, including mice, rats, and non-human primates have been utilized to understand the underlying pathology associated with the presence of these maternal autoantibodies (Figure 1).',\n",
              "  'text_sha256': 'fe7a46dd387ac9e51c523399074d68780b3c6adff862ad67d3412e45a137db25'},\n",
              " {'text': 'Early animal models of MAR ASD relied on a passive transfer method, utilizing purified antibodies isolated from mothers of children with autism or from mothers of typically developing children that were transferred to an otherwise healthy animal during gestation.',\n",
              "  'text_sha256': 'f4fba80dc6bde5987d8d35ea100a09e2b7b8de187202906013478dc50b70ec74'},\n",
              " {'text': 'First conducted in mice, and subsequently in non-human primates, the passive transfer models yielded two main findings: (1) They confirmed that maternal antibodies do cross the placenta and can be detected in fetal tissues, including the brain, and (2) they confirmed that exposure to maternal autoantibodies results in changes in offspring behavior and brain development.',\n",
              "  'text_sha256': '81b792d1559858b0f38a16ceff6105c777fa2cda863bfd8c326104539b27fd09'},\n",
              " {'text': 'More specifically, the offspring from mouse dams that received IgG from mothers of children with ASD spent more time in self-grooming and marble-burying behavior, reflective of the stereotypic behaviors observed in ASD.',\n",
              "  'text_sha256': 'f07a86de194c5f07d5cecf6317f2a907bcf9fde5cbed686e529f4d585afb5f8a'},\n",
              " {'text': 'They also showed increased levels of anxiety, a comorbidity many children with ASD experience (69, 70).',\n",
              "  'text_sha256': 'd5b8ae17efc02ea96ded05549187cf163854c0eee6092a653c692c940d80522c'},\n",
              " {'text': 'Furthermore, IgG deposition was observed in the brains of offspring from dams treated with IgG from mothers of children with ASD, but not in controls (69, 70).',\n",
              "  'text_sha256': '3c874facfbbfdb9853234fc217f0585cf916de9606b89e508ee1cf4c2849df93'},\n",
              " {'text': 'Similar passive transfer models studying antibodies to CASPR2 and NMDA have also yielded important findings.',\n",
              "  'text_sha256': '31f1da9255fc176b4e6dc52918b8a9d944cb50d9bb7500d10b2f53fd7fde3cf8'},\n",
              " {'text': 'In one study, mouse offspring exposed to anti-CASPR2 antibodies at gestational day 13.5 had differences in sociability, as determined by the amount of time spent with an unfamiliar object vs. an unfamiliar stimulus mouse.',\n",
              "  'text_sha256': '5e55e41439fd5d52f88f9373ca738ba1b227a83d41f07b02542c5a28723b68c4'},\n",
              " {'text': 'In addition, fetuses examined 2 days after exposure to anti-CASPR2 antibodies showed reduced cortical thickness and changes in cell proliferation (44).',\n",
              "  'text_sha256': '41756f399904ad2b6e9b2eb81cf0f3c935ada92a096b288804631f18cefc73b5'},\n",
              " {'text': 'Exposure to the NR1 subunit of NMDA receptor at gestational days 13 and 17 resulted in offspring who displayed impaired early postnatal reflexes and decreased prepulse inhibition (56).',\n",
              "  'text_sha256': '26c29f04055524c0b6dc812d8cbb0883455a585eda0033f47d7eeaab04392db4'},\n",
              " {'text': 'In non-human primate passive transfer studies, the results were similar, with offspring from treated dams displaying increased stereotypic behaviors with both novel and familiar social partners (47).',\n",
              "  'text_sha256': '9817e275c66a63f09e68b401cf7dff4b0f389d968eca71207aaed94e69cc61db'},\n",
              " {'text': 'When examining the brains of offspring Frontiers in Psychiatry | www.frontiersin.org 4 June 2022 | Volume 13 | Article 834910   McLellan et al.',\n",
              "  'text_sha256': '7fc3095a30632ebab87bb070362d1ef34d06da1889c9673cbd7296f2644dc2a1'},\n",
              " {'text': 'Maternal Risk Factors in ASD from treated dams, investigators noted that male offspring had a higher rate of brain growth between 3 and 6 months of age, a finding that has been observed in some clinical ASD cases and may be correlated with atypical connectivity and altered brain maturation (71, 72).',\n",
              "  'text_sha256': '88ca563a6f4b23ced140786e1f5508578641df132baddea94233355372ed24cb'},\n",
              " {'text': 'Together, these studies were essential in validating the hypothesis that maternal autoantibodies have pathologic significance and the potential to alter neurodevelopment (47, 69-71, 73).',\n",
              "  'text_sha256': 'c49fc591a06dc41f3f1a85983b19545ca7c2da4b1d9dedb073f1437181f8e73c'},\n",
              " {'text': 'The passive transfer model was an essential first step in advancing the understanding of maternal autoantibody pathogenesis.',\n",
              "  'text_sha256': 'd123464a22b455bd28fb9f646f8610217607c3c23511601690bb2f09670e1645'},\n",
              " {'text': 'However, this route of administration does not reflect the true exposure a fetus would experience during pregnancy.',\n",
              "  'text_sha256': 'c63a59d925e798499673812df9656670d2634e7e2e4bb7411bbb7cbdb91f36b0'},\n",
              " {'text': 'Thus, to create a more appropriate mimic of the gestational environment where a fetus would be exposed to maternal autoantibodies throughout pregnancy, we generated an antigen-driven model of endogenous exposure.',\n",
              "  'text_sha256': 'acfeffa2e6c8cbc4ca405ceaed5960bc49b4d46009aae1a5b5ea9560c9a13293'},\n",
              " {'text': 'In contrast to the passive transfer model, the antigen-driven model involves immunizing experimental dams with specific protein combinations prior to pregnancy, to induce selective, endogenous autoantibody production (64).',\n",
              "  'text_sha256': '7168e57009c20c2be6854765b3b465f6b9467c5ecca6fce6311095e3b5016b1b'},\n",
              " {'text': 'Clinical studies had previously identified specific patterns of antigen reactivity as well as the epitopes recognized by the maternal autoantibodies in human samples (51, 53).',\n",
              "  'text_sha256': '2fcad2277ac658202c6e4af3a5cbd37fccca9d3947020f0d9c8c25ec002195a7'},\n",
              " {'text': 'This knowledge was then used to generate a mouse model with reliable construct validity to clinical MAR ASD.',\n",
              "  'text_sha256': '8d3e26dd9341e9a497e5bdabffb44c955535881ad0335010921ceebc3acc3b40'},\n",
              " {'text': 'Described briefly, mouse dams were injected with synthetic peptide epitopes for lactate dehydrogenase A and B (LDH-A and B), collapsin response mediator protein 1 (CRMP1), and stress induced phosphoprotein 1 (STIP1), a protein reactivity pattern identified in clinical samples specific to mothers of children with ASD (53).',\n",
              "  'text_sha256': '4179ba4c42485d9c3e286a4e8fcf2ea84300b73c11c59c69476331f43194589f'},\n",
              " {'text': 'Once immune tolerance to the self-proteins was bypassed, these dams continuously produced autoantibodies to the protein epitopes of interest in the absence of inflammation and other immune perturbations that are also thought to impact offspring development.',\n",
              "  'text_sha256': '4af65519ac17ef6d09d185d2d73d22ec59969f2d554afa16d5e355f3c153e2a9'},\n",
              " {'text': 'This approach resulted in offspring that were exposed to the autoantibodies throughout the gestational period, more closely resembling the exposure noted in clinical MAR ASD (64).',\n",
              "  'text_sha256': 'ff3c9a0bb354ea0b472ef2cd3d1cc3b063e2172733a78c2fdf4a2b0a544e728e'},\n",
              " {'text': 'Using the antigen- driven mouse model, researchers were able to test the behavioral and neurological impacts of constant gestational exposure to maternal autoantibodies.',\n",
              "  'text_sha256': '7e5450a559a99fbb839e018d6838722f0f442813cbec03f8aa1b1eb7231a96e0'},\n",
              " {'text': 'Offspring from treated dams had reduced social behaviors, including fewer bouts of nose-to-nose sniffing and front approaches.',\n",
              "  'text_sha256': '558cc7ee62399146c572e508b702423b8adeb4ac2d32a513ccf7a72c5cf921b9'},\n",
              " {'text': 'In addition, researchers observed elevated repetitive behaviors, decreased ultrasonic vocalizations, and differences in neuroanatomical development; specifically increased brain volume in the offspring from treated dams (64, Our current studies seek to build upon this foundation through use of an antigen-driven rat model with an expanded repertoire of maternal antibody combinations recently identified in a large clinical study (52).',\n",
              "  'text_sha256': '50543a24a848e9bf75361f17f989f8e023b5e6c8751b4933296470feed85c980'},\n",
              " {'text': 'Recent work identifying the consequences of acute peripheral immune activation of offspring neurodevelopment (75), suggests that the rat model is a promising next step in understanding the pathology of maternal autoantibodies.',\n",
              "  'text_sha256': '10066bee84527390d97980a5330ddc3b2f3ca1e1dcf68db6840b4f3d0e9aa961'},\n",
              " {'text': 'The antigen-driven rat model will allow for a more thorough identification of the behavioral and social impacts of maternal autoantibody exposure, thanks to their more complex neuroanatomy and social interactions.',\n",
              "  'text_sha256': '6d796696f61c02f235979161efecb45477ccee6c3dd9da9b652199c621072c21'},\n",
              " {'text': 'Additionally, utilizing the specific autoantibody combinations identified in clinical research will allow us to identify the consequences of exposure to select autoantibodies, providing researchers with a better understanding of which autoantibody combinations result in more severe pathology, and which can be used as risk- biomarkers.',\n",
              "  'text_sha256': '8f3c0f20d00555bb27d07620a1f1e06c3936f2d9b96979aa837c432ab6cf4405'},\n",
              " {'text': 'Since the development of this model yields dams that produce autoantibodies in the absence of inflammation, we can directly test how skewing of one arm of the maternal immune system impacts offspring behavior and neuroanatomy.',\n",
              "  'text_sha256': 'ce284d72deacd6ae0356eba4cf5966e49ffaa7ec231d319b181691b223b94127'},\n",
              " {'text': 'The rat model will not only be more translationally specific, but it will also provide researchers with a pre-clinical model in which to test future therapeutic interventions.',\n",
              "  'text_sha256': '69c1616b0b564dce7886b663ac64667ae171c8974e05880d3551a6df98788161'},\n",
              " {'text': 'In the future, we hope to be able to generate an antigen-driven non-human primate model to further advance our preclinical model.',\n",
              "  'text_sha256': 'dfd403c2caa2d91bf2702d32e7a4b7103a09c383f159c7b48041ba62e01e3cd9'},\n",
              " {'text': 'Clinical studies of MAR ASD have revealed the critical protein targets for maternal autoantibodies and drawn links between the specific autoantibody combinations and ASD severity.',\n",
              "  'text_sha256': '869ffdfdba4b7cce5e7b746b7314a1813584be53a8a98f01a73591cfe9326fa4'},\n",
              " {'text': 'In addition, they have begun to elucidate other immunological factors, such as variances in maternal cytokine/chemokine profile, that can also be used as predictive measures for ASD risk.',\n",
              "  'text_sha256': '3881282e584748d9c03c89a599d641f843b933d7ab249c0839d38169bda317ad'},\n",
              " {'text': 'The use of animal models has helped to confirm the pathologic significance of at least some of the maternal autoantibodies, as well as provided researchers with a means to better understand the downstream molecular consequences and mechanisms involved in these effects.',\n",
              "  'text_sha256': '8d5fe0ff91db1b4d22132965d4305cfd7e52d42f8bda2acbe94f7e39001d3e4e'},\n",
              " {'text': 'Despite the advances made thus far, many questions remain which, once answered, will aid in the creation of more precise diagnostic tools, preventative treatments, There are several questions we are unable to answer using the animal model, such as: What is the triggering event for maternal autoantibody production in humans?',\n",
              "  'text_sha256': 'ed139fb840e055119b343b1979cc0898f17298bf94f4f482b572e77a4e80afe9'},\n",
              " {'text': 'What are the longstanding immunological impacts on exposed children?',\n",
              "  'text_sha256': '66c32abeb2492df80b606e8b2f4089ec053c73b13e1f55d775e38c023d5d874d'},\n",
              " {'text': 'How does previous history of autoimmune disease influence ASD risk through the MAR mechanism?',\n",
              "  'text_sha256': 'bf31f0412062b04cca6fa09236708c760435bb7d6ac24c05569bf03d8a9a2924'},\n",
              " {'text': 'How do autoantibody and cytokine/chemokine levels prior to pregnancy compare to those present during and after pregnancy?',\n",
              "  'text_sha256': 'c819f6ff7068b298bbf0ce976f802658ac0a712b601fcf68fa52b7eef26e00f4'},\n",
              " {'text': 'To develop targeted therapeutics, it will also be important to further identify when offspring are most vulnerable to autoantibody and/or cytokine/chemokine exposure.',\n",
              "  'text_sha256': 'c28ae934054dbd19be685b0491ed20aacfda6ebe3e1ba0f0c22c6faf359b0ee9'},\n",
              " {'text': 'To answer these questions, continued clinical studies and use of our pre-clinical models will be necessary.',\n",
              "  'text_sha256': 'f83f0994b3d6b5dfa15152ffc952bea1835cb0ebc664539d5437c075309091a1'},\n",
              " {'text': 'The development of a more sophisticated model using non-human primates would increase the translational ability to the more complex behaviors seen in autism.',\n",
              "  'text_sha256': 'a886e3014db878361363f36f164c7d6c6b88f226b0b5cf8068523514c3172444'},\n",
              " {'text': 'Although some non-human primate studies have been completed, an antigen-driven model is currently under development, and we remain hopeful that this will soon be another model for researchers to utilize.',\n",
              "  'text_sha256': '56f26b170945a7940dc4173c274ae0e6d75d7d80979e0704a3df0fb7fc727f2c'},\n",
              " {'text': 'Future research will continue to elucidate the mechanisms by which maternal autoantibodies impact their target proteins, and the optimal intervention strategies to mitigate damage.',\n",
              "  'text_sha256': 'eb4e84a7ffb5e5b0a687d6984750a30475670e4f1392d11e2e4ad23f5e3a9673'},\n",
              " {'text': 'In addition, we will aim to identify connections between maternal cytokine/chemokine changes and Frontiers in Psychiatry | www.frontiersin.org June 2022 | Volume 13 | Article 834910   McLellan et al.',\n",
              "  'text_sha256': 'de6bffc93a227f42a74073304bd158ecb2ac241cb7d4302d18038d4b649840ba'},\n",
              " {'text': 'Maternal Risk Factors in ASD Autism is an incredibly complex disorder with a wide range of behavioral and cognitive phenotypes.',\n",
              "  'text_sha256': '3eb934923d0d16f8d8fa9e3db255e2699003123913ec180653bd014f5ce402d9'},\n",
              " {'text': 'Despite multiple known etiologies, a preventative strategy for the disorder remains to be discovered.',\n",
              "  'text_sha256': '41156cb89cadd8a19250bc3de51ad07657de2a862f4e6224a5129c9e27047297'},\n",
              " {'text': 'Furthermore, testing for specific phenotypic subsets of ASD are also lacking.',\n",
              "  'text_sha256': 'c8c9275c87bdee6ec5408894fef7714cbac407dbaa982341a1370bc4fdeac476'},\n",
              " {'text': 'MAR ASD is one subtype of autism in which the maternal immune system plays a critical role.',\n",
              "  'text_sha256': 'fb1a994d500994073a16c00af2fce867451fb22f45ac3bca2be4b92ac4bfcaa4'},\n",
              " {'text': 'We now know that specific risk factors exist for immune mediated ASD, including maternal autoantibody production, and skewed maternal and fetal chemokine/cytokine profile.',\n",
              "  'text_sha256': '154ccdb2c8abb16b90aca9451bcdb7dc8a781d3fbd1c2c8bf5bccbde71bf45b2'},\n",
              " {'text': 'While much is left to be discovered, we continue to use clinical studies and refined animal models to tease apart the mechanisms by which MAR ASD develops.',\n",
              "  'text_sha256': 'dc6457395347894c1846e454f2be643e694fc209722274ac88259fbc53112bb5'},\n",
              " {'text': 'Further, studies are underway to understand how neonatal cytokines and chemokines influence symptom severity as well as the relationship between maternal immune dysregulation during gestation and changes in the brain of affected offspring.',\n",
              "  'text_sha256': 'e6628c4b6dd6c7942576d0551df9be506c6e78f811e96a08711662c4ed61183c'},\n",
              " {'text': 'No ascii letters. Please enter your text in English.',\n",
              "  'text_sha256': '55e18657adb0ea0cd6f084024889719072612e5ba463c51df1aea0b14241dd24'},\n",
              " {'text': 'Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke $, Abdallah M, et al.',\n",
              "  'text_sha256': '2d11d4dfb5f34edae6a5ced955668e638518568795fde72313545c09bc679c81'},\n",
              " {'text': 'Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders.',\n",
              "  'text_sha256': 'df0a345057f7a249b2fa60ebf4678a1d58b60a06ba9d976dc479461742ef7958'},\n",
              " {'text': 'J Autism Dev Disord.',\n",
              "  'text_sha256': '4c07268bbb1108ad5528fe54dcd8109709d17bed9af2ff8d13f7230d555832f3'},\n",
              " {'text': 'No ascii letters. Please enter your text in English.',\n",
              "  'text_sha256': '55e18657adb0ea0cd6f084024889719072612e5ba463c51df1aea0b14241dd24'},\n",
              " {'text': 'No ascii letters. Please enter your text in English.',\n",
              "  'text_sha256': '55e18657adb0ea0cd6f084024889719072612e5ba463c51df1aea0b14241dd24'},\n",
              " {'text': 'Shi L, Fatemi SH, Sidwell RW, Patterson PH.',\n",
              "  'text_sha256': '37c9e1991cc546a99ef85030eeddae69837117210fc1263d12a823dd6178da82'},\n",
              " {'text': 'Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring[[/i]].',\n",
              "  'text_sha256': 'c457ba9d1c2827cd1b564489d25291237a5d97c0b27f1c94a4be48a3c860034b'},\n",
              " {'text': 'J Neurosci.',\n",
              "  'text_sha256': 'd0e6c84e95b5d02800f34dd430394fc1528f63d6ad7ac61fe3aee3aaaa0cd851'},\n",
              " {'text': '(2003) 23:297. doi: 10.1523/JNEUROSCI.23-01-00297.2003 3.',\n",
              "  'text_sha256': 'e420c651afb7ce7e77d02239e133cd0e25b713cc62f00aa7f17516754a9bbe43'},\n",
              " {'text': 'Stubbs EG, Crawford ML.',\n",
              "  'text_sha256': '64b0ade22633bf1f91a42b1ed7abe226d21bca17220a3ec8553721d3a27c292f'},\n",
              " {'text': 'Depressed lymphocyte responsiveness in autistic children.',\n",
              "  'text_sha256': '9fdd91354f115ac31ca81b9c8b571c8249282a74e6eb19f1d46b6d0f95325c15'},\n",
              " {'text': 'J Autism Child Schizophr.',\n",
              "  'text_sha256': '5dbad05d1fcec0d1b56fd5985c7e5399c64668d504e30ad552d0133e7aaad507'},\n",
              " {'text': '(1977) 7:49. doi: 10.1007/BF01531114 4.',\n",
              "  'text_sha256': '6ef2cee5211f0c054f09e6e9c55eca57b1c1326004be1ea9655b60e3a4c236b6'},\n",
              " {'text': 'Plioplys AV, Greaves A, Kazemi K, Silverman E. Lymphocyte function in autism and Rett syndrome.',\n",
              "  'text_sha256': '043b549b90a70f51c77db9ec81f60b3e2e091f104a46504368ec7481bce0dee0'},\n",
              " {'text': 'Neuropsychobiology.',\n",
              "  'text_sha256': 'b81419c038b5957d01dd0004585436cfaf55ea1304b5f806ffcb63c7d509d8e9'},\n",
              " {'text': 'No ascii letters. Please enter your text in English.',\n",
              "  'text_sha256': '55e18657adb0ea0cd6f084024889719072612e5ba463c51df1aea0b14241dd24'},\n",
              " {'text': 'Warren RP, Foster A, Margaretten NC.',\n",
              "  'text_sha256': 'c70293fd1f98b3e84977c23291c8c4a25acce940e76810467d7383a7fa5012ab'},\n",
              " {'text': '[[i]]Reduced natural killer cell activity in autism[[/i]].',\n",
              "  'text_sha256': '3e1523bef62d46a9ae608386cb166ba48c90b7129a89a4a981118d1fc1daaff9'},\n",
              " {'text': 'Journal for the American Academy of Child e& Adolescent Psychiatry.',\n",
              "  'text_sha256': '6ee8c2970ab926e61517aa4d8780dec22465e370c3c68c1e40787add32a883f8'},\n",
              " {'text': '(1987) 26:333. doi: 10.1097/00004583-198705000-00008 6.',\n",
              "  'text_sha256': '439b9620676f92645cfe6548cb0d7f38ecfffd3c35fb85cb73fe5dd6f1fa1459'},\n",
              " {'text': 'Sweeten TL, Posey DJ, McDougle CJ.',\n",
              "  'text_sha256': '24af8282fc0a94b16f814313de51e661b9408ff1db550128dcbe9e7a0bfcd175'},\n",
              " {'text': 'High blood monocyte counts and neopterin levels in children with autistic disorder.',\n",
              "  'text_sha256': 'ad90b5a8ef2d91195291880dd9f10ed49775a6e74af9911ba39ca727bf37eba4'},\n",
              " {'text': 'Am J Psychiatry.',\n",
              "  'text_sha256': 'cb026a488b4fe12b62d97f756cb4dd277bb75ebd4bbd425b67623d76455fce79'},\n",
              " {'text': 'No ascii letters. Please enter your text in English.',\n",
              "  'text_sha256': '55e18657adb0ea0cd6f084024889719072612e5ba463c51df1aea0b14241dd24'},\n",
              " {'text': 'MeadJ, Ashwood P. Evidence supporting an altered immune response in ASD.',\n",
              "  'text_sha256': 'c60634d972d4f5f91894a509a32be7c1b4516db103777c4baa56616b91e6ad27'},\n",
              " {'text': 'Immunol Lett.',\n",
              "  'text_sha256': '95e09bf2d4c54053ee0b33c181538637b9968453857604d4b53184bd50a40084'},\n",
              " {'text': '(2015) 163:49. doi: 10.1016/j.imlet.2014.11.006 8.',\n",
              "  'text_sha256': 'd05d130b2638005a1d2f45535ca4fab630e688e1f0e85d2798f081cf81a9ed3d'},\n",
              " {'text': 'Abdallah MW, Larsen N, Grove J, Bonefeld-Jorgensen EC, Norgaard- Pedersen B, Hougaard DM, et al.',\n",
              "  'text_sha256': 'c12afd028d9a155dc6b39d4b08a84665ac7ce5462ad1039ea36680e84748c509'},\n",
              " {'text': 'Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study.',\n",
              "  'text_sha256': '3efdebb0c16078dfd46b2b1a6754eafc819023f54224f739205fd2050f45118e'},\n",
              " {'text': 'Cytokine.',\n",
              "  'text_sha256': '24697ff51df1aee26ae96fd41aaef530fb4fdeb82daa670fba63add954dd6226'},\n",
              " {'text': '(2013) 61:370. doi: 10.1016/j.cyto.2012.11.015 9.',\n",
              "  'text_sha256': '95465a3d18a9aaf487bf23a788c513027474fe48c5fbc404797383f0cdbbb7e7'},\n",
              " {'text': 'Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.',\n",
              "  'text_sha256': '79348e91c11c5f8128498d4e6d72d8ac830a2901d500b555c62c89195c152e61'},\n",
              " {'text': 'Brain Behav Immun.',\n",
              "  'text_sha256': '4c4c06a521bf538523f20b596eed6ff54f79722b6163f479b39971b694f83675'},\n",
              " {'text': '(2011) 25:40. doi: 10.1016/j.bbi.2010.08.003 10.',\n",
              "  'text_sha256': 'c15dc6ed2fb317d8c3d3831a2f78f9ff438b9b41010b61f7be901046552676f4'},\n",
              " {'text': 'Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J.',\n",
              "  'text_sha256': 'e545a836feceddd35859a4ff3bd1192ff9c80af993aace96075846bb498459f0'},\n",
              " {'text': 'Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.',\n",
              "  'text_sha256': '1d195da07e3597aa99193039d73cf343f9cc54b7dfbf4bab82bf8faca59532bf'},\n",
              " {'text': 'J Neuroimmunol.',\n",
              "  'text_sha256': '8213845a5a0562281d03212cc7a86cc54311ba6be8985abbc5fb4b1cbc463a7e'},\n",
              " {'text': 'No ascii letters. Please enter your text in English.',\n",
              "  'text_sha256': '55e18657adb0ea0cd6f084024889719072612e5ba463c51df1aea0b14241dd24'},\n",
              " {'text': 'Zerbo O, Yoshida C, Grether JK, Van de Water J, Ashwood P, Delorenze GN, et al.',\n",
              "  'text_sha256': '192d17a3340347d4d715b0988c334372164c7cbe37102d106395c254c6c24479'},\n",
              " {'text': 'Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study.',\n",
              "  'text_sha256': 'e1ecf2c8c50395dda1fdb9f6884bf706caf2bcebcb0972fede56e4ff9686f6e5'},\n",
              " {'text': 'J Neuroinflammation.',\n",
              "  'text_sha256': '7537c3d742e0c8a304a2a87195c793b2235e9ed11858c8cef9bc8fc922d90729'},\n",
              " {'text': '(2014) 11:113. doi: 10.1186/1742-2094-11-113 12.',\n",
              "  'text_sha256': '074feb2d9427a57d9c773dbd3f38303bc69a7ab568cf2d4ee257c9126dc88638'},\n",
              " {'text': 'Garty BZ, Ludomirsky A, Danon YL, Peter JB, Douglas SD.',\n",
              "  'text_sha256': '0a81bb4467b17ae194c5d854a5256f86d26b472495a1d0ba9485e2959eebee05'},\n",
              " {'text': 'Placental transfer of immunoglobulin G subclasses.',\n",
              "  'text_sha256': '937e13f0a5b5a15a7a1b98f15961f893c03f98f4f6f1239b09a65b0435511924'},\n",
              " {'text': 'Clin Diagn Lab Immunol.',\n",
              "  'text_sha256': '8e531beefb68091d9171f26a79b6f304cbe07ad6fb12e7850d32e28005f051ea'},\n",
              " {'text': 'No ascii letters. Please enter your text in English.',\n",
              "  'text_sha256': '55e18657adb0ea0cd6f084024889719072612e5ba463c51df1aea0b14241dd24'},\n",
              " {'text': 'Roopenian DC, Akilesh $.',\n",
              "  'text_sha256': '6a33b12726bd5ed5696db58cdd4ba18fbd8ea372b65858c47672fdb1c2d73400'},\n",
              " {'text': 'FcRn: the neonatal Fc receptor comes of age.',\n",
              "  'text_sha256': '2cff79c2d7b8a70b434067f0c55dbaea598041fca17bb8ce470f7c38cc92216d'},\n",
              " {'text': 'Nat Rev Immunol.',\n",
              "  'text_sha256': '099007f5ab5ae534f14377b9096ac059961335d05cc5f6438a3718b1d3357caf'},\n",
              " {'text': '(2007) 7:715. doi: 10.1038/nri2155 We hope this knowledge will yield future preventatives This mini-review contains review of research performed by each of the authors.',\n",
              "  'text_sha256': 'fd60dd70218daf23c045560f5bfb7c1708d24cdbf0eb3b08b0b1acd4c327ab86'},\n",
              " {'text': 'JV is the senior author and oversaw all aspects of this mini-review.',\n",
              "  'text_sha256': '21052bbfccd16ac8c009552487e326a5d59d6d4758160d95c21138749c291602'},\n",
              " {'text': 'JM is the first author and compiled all of the information from the other authors as well as wrote the animal model section.',\n",
              "  'text_sha256': 'a1fcd5b3f3e6a96b5a6100d2fa169dccdb302302acdc1e75ab4a8d893f9e6d77'},\n",
              " {'text': 'DK wrote the section on maternal immune activation.',\n",
              "  'text_sha256': '2eb37e1415308b5bf278b7d44a37160ccc8a39f26619e00f0ae45ccca4612f0b'},\n",
              " {'text': 'MB developed the animal models and edited the entire review.',\n",
              "  'text_sha256': 'de14e35399c19a6cea4785ba0d8a8fd6bf19b9e18bfe1a9941f26b1919b0f330'},\n",
              " {'text': 'AR-C wrote the section on maternal autoantibodies.',\n",
              "  'text_sha256': '32fa7f2c096037a3e1f294248b308fd443983e331c121e4e6438ebd13b9457bb'},\n",
              " {'text': 'All authors contributed to the article and approved the submitted version.',\n",
              "  'text_sha256': 'de1f6137f8a5b1faf7c336a2e443337207fec9817aaeec90ce09009049eec055'},\n",
              " {'text': 'NICHD funded IDDRC P50 (P50HD103526).',\n",
              "  'text_sha256': 'addbde1271bc7a3f83b70fff099ba275bab6475a5b8214d27a3e9f9a9120908a'},\n",
              " {'text': 'No ascii letters. Please enter your text in English.',\n",
              "  'text_sha256': '55e18657adb0ea0cd6f084024889719072612e5ba463c51df1aea0b14241dd24'},\n",
              " {'text': 'Pakhathirathien P, Janjindamai W, Dissaneevate $, Thatrimontrichai A, Maneenil G. Neonatal outcomes in pregnant women with systemic lupus erythematosus: a 13-year experience in Southern Thailand.',\n",
              "  'text_sha256': '95078478e1ed359858f5f8ba920f7bc7bb12a4439c871fba102dca25b351e0fe'},\n",
              " {'text': 'J Trop Pediatr.',\n",
              "  'text_sha256': 'ed5d7f3c49ba9d4221fea4e71da5322ecccdef1bb613239ca8377416df758d3d'},\n",
              " {'text': '(2021) 67:58. doi: 10.1093/tropej/fmab058 15.',\n",
              "  'text_sha256': 'c087779628060c41bb6faeb9641777ffb78dcce688536f52fc086d6428e75ce2'},\n",
              " {'text': 'Saunders NR,  Liddelow $A, Dziegielewska KM.',\n",
              "  'text_sha256': '4b654c06c0c99763d7115d64b49cd99e82ba9da0caefd29c1f5ea8d862530891'},\n",
              " {'text': 'mechanisms in the developing brain.',\n",
              "  'text_sha256': '5c42c7260db36f013fb9a64214c7a0d51798a7cceddaab93f63e5f1cc37ff669'},\n",
              " {'text': 'Front 16.',\n",
              "  'text_sha256': '9b8c9503ecce2d219478a53b7acc7b10baaa74636e4f04c5b6d400f880d0229b'},\n",
              " {'text': 'Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL, Hertz-Picciotto I, et al.',\n",
              "  'text_sha256': '9c3d2b3e15efeefa69c89eafb3897c8ff48a11d9bcee3e39869726270f55d1d8'},\n",
              " {'text': 'Neonatal cytokine profiles associated with autism spectrum disorder.',\n",
              "  'text_sha256': 'c3ad50274b1507c041c7321c99552470a1440b7c9e872e6870ed0fc383019305'},\n",
              " {'text': 'Biol Psychiatry.',\n",
              "  'text_sha256': 'b4ca086d63c3f72d54c4dab40cfb39d263e4dad75bbf5e70c71ffee3c5906606'},\n",
              " {'text': '(2017) 81:442. doi: 10.1016/j.biopsych.2015.08.007 17.',\n",
              "  'text_sha256': '26ad72b8dbe03a616f7eb18a6013f32a2809ed95ed04e3f96093b911cd1258ec'},\n",
              " {'text': 'Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn.',\n",
              "  'text_sha256': '52f42c63daed42e8813b77ece0d0d5a11cca4a8fe2911b19ed3ebdf626f98deb'},\n",
              " {'text': 'Pediatr Res.',\n",
              "  'text_sha256': '87fe5a7828a4218cf48545a3f2a2c09c55811098f41356b3d27e9f7fbaaad383'},\n",
              " {'text': 'No ascii letters. Please enter your text in English.',\n",
              "  'text_sha256': '55e18657adb0ea0cd6f084024889719072612e5ba463c51df1aea0b14241dd24'},\n",
              " {'text': 'Deverman BE, Patterson PH.',\n",
              "  'text_sha256': 'eb650e51b0a9bd94a5905d74718627008ffc95de644c528867892cc6183b611d'},\n",
              " {'text': 'Cytokines and CNS development.',\n",
              "  'text_sha256': '2754b4d02b0955cc04f08d29a3a91f2b710184c718d822598506d67f9b2f9176'},\n",
              " {'text': 'Neuron.',\n",
              "  'text_sha256': '7eda312b7483ca7b0ba286470c952fbe4bb8184990f2e547144fa5525898ada2'},\n",
              " {'text': '(2009) 64:61. doi: 10.1016/j.neuron.2009.09.002 19.',\n",
              "  'text_sha256': '75314541f146391056b4081ba441df91baa0a5bfd562129b1eec4fd8777aae30'},\n",
              " {'text': 'Mousa A, Bakhiet M. Role of cytokine signaling during nervous system development.',\n",
              "  'text_sha256': '5fe6dc3a6e678b5e5eba437d06b03e17dfadd28e676f1e24e928224d8fd343d5'},\n",
              " {'text': 'Int J Mol Sci.',\n",
              "  'text_sha256': 'c43b264e7346e9ec698dcf2576f27221f5a9f6d0465227cf66f66a648d56f459'},\n",
              " {'text': '(2013) 14:13931. doi: 10.3390/ijms140713931 20.',\n",
              "  'text_sha256': '5e40a3dc16906eaf21c4169958c7dce7e0124568aadfb6cbe63731d8dbdbfcad'},\n",
              " {'text': 'Ramesh G, MacLean AG, Philipp MT.',\n",
              "  'text_sha256': '3ee071127474e433055cb1edbf31d67925437bf88501c5a6f63abe4ec67586c7'},\n",
              " {'text': 'Cytokines and chemokines at the crossroads of neuro-inflammation, neurodegeneration, and neuropathic pain.',\n",
              "  'text_sha256': '343a3d6bceec7cb927fb98d64d0f8856a158b7422466f3abdd33bad152fee65a'},\n",
              " {'text': 'Mediators Inflamm.',\n",
              "  'text_sha256': '9332aa23be9bd78affd698ebb872ab6646e97b2fc1c8e9a573e60eeca1e2810a'},\n",
              " {'text': '(2013) 2013:480739. doi: 10.1155/2013/480739 21.',\n",
              "  'text_sha256': '4a2fc1da8d4fc6618ec8b99d4e9eaabc74a634297b254b8ef875c86a12994010'},\n",
              " {'text': 'Goines PE, Ashwood P. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.',\n",
              "  'text_sha256': '010d8306028a7655df764cccb0a25e43948f2e6e2951dcd058be7e7fd8966058'},\n",
              " {'text': 'Neurotoxicol Teratol.',\n",
              "  'text_sha256': '7e661927e0bc575f7059c331786fdac46c05e4068ea6af3fcb231faf4f36f217'},\n",
              " {'text': 'No ascii letters. Please enter your text in English.',\n",
              "  'text_sha256': '55e18657adb0ea0cd6f084024889719072612e5ba463c51df1aea0b14241dd24'},\n",
              " {'text': 'Yang C, Hawkins KE, Dore $, Candelario-Jalil E. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.',\n",
              "  'text_sha256': '4718efa04eef45aaa2830eb773dec67ce0326c26c8257dfeb6dc5349c3419585'},\n",
              " {'text': 'Am J Physiol Cell Physiol.',\n",
              "  'text_sha256': '38bcafc4b731e41bcad3868b4f9faabb035237015fe04fe0ab2740d6eac925ef'},\n",
              " {'text': '(2019) 316:C135.',\n",
              "  'text_sha256': '01fcfaa16367bb7057f6276ecf6f09fd829fe8496253d4ca4d403c9414bcb4af'},\n",
              " {'text': 'doi: 10.1152/ajpcell.00136.2018 23.',\n",
              "  'text_sha256': '3d1f93b7446e4db77a220a20546204f8814e7b86377e2d6951dc3a786397ed1f'},\n",
              " {'text': 'Hauguel-de Mouzon $, Guerre-Millo M. The placenta network and inflammatory signals.',\n",
              "  'text_sha256': 'c9f851f2f269a8244f502247eca85af3f02587b3efd6853bc99a7b76cc1a9a78'},\n",
              " {'text': 'Placenta.',\n",
              "  'text_sha256': '980aee8e2ef5d9a8b6313aee499312c7796a4c92dd00aae5fd174b5c4235c325'},\n",
              " {'text': 'No ascii letters. Please enter your text in English.',\n",
              "  'text_sha256': '55e18657adb0ea0cd6f084024889719072612e5ba463c51df1aea0b14241dd24'},\n",
              " {'text': 'Siwetz M, Blaschitz A, El-Heliebi A, Hiden U, Desoye G, Huppertz B, et al.',\n",
              "  'text_sha256': '39c7f50197ac8826f666490267a7dcbb26729c900e61db5646155e6adafbf233'},\n",
              " {'text': 'TNF-alpha alters the inflammatory secretion profile of human first trimester placenta.',\n",
              "  'text_sha256': '821ea63a08257be0e4c01fa86ea26bd47a76f1d9cdd626dab44c066cd07ec9e6'},\n",
              " {'text': 'Lab Invest.',\n",
              "  'text_sha256': '565b09e37ed1473a758e958ca4f92d14046e7f4688f7977ada5ea53b577b1e63'},\n",
              " {'text': '(2016) 96:428. doi: 10.1038/labinvest.2015.159 25.',\n",
              "  'text_sha256': '213cedc8873f497d53e22ae10cbd377c8670fc572d5f9ab29c6060509f70822e'},\n",
              " {'text': 'Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen R, et al.',\n",
              "  'text_sha256': 'f08a409fae9964a39f7022ef067b2ff6ef0749a643e0b86008e2fb8a07187621'},\n",
              " {'text': 'Increased midgestational IFN-gamma, IL-4 and IL-5 in women bearing a child with autism: a case-control study.',\n",
              "  'text_sha256': '602ffc72bf0cb12a235eace040f88d31b046c104fccc64cfc5e104acb183b776'},\n",
              " {'text': 'Mol Autism.',\n",
              "  'text_sha256': '5489c6c6c68d55589cf591d7cf18f507224dca4795d8af474b08365c804a6d7b'},\n",
              " {'text': 'No ascii letters. Please enter your text in English.',\n",
              "  'text_sha256': '55e18657adb0ea0cd6f084024889719072612e5ba463c51df1aea0b14241dd24'},\n",
              " {'text': \"Carter M, Casey $, O'Keeffe GW, Gibson L, Murray DM.\",\n",
              "  'text_sha256': 'd5f1ba598d9f9bc0b094169320912efd4db1eed28f1bed318d5d97c8063370f2'},\n",
              " {'text': 'Mid- gestation cytokine profiles in of children affected by autism spectrum disorder: a case-control study.',\n",
              "  'text_sha256': '6e3a813ddd1c6b1e6f13603802fe7ea09ff18490ce86fcb33ea3a04405d36ec4'},\n",
              " {'text': 'Sci Rep. (2021) 27.',\n",
              "  'text_sha256': '13c699811c9b7f68d35bb84408f5ffe7b3e31ba693cd58515c6ede5118c0eb75'},\n",
              " {'text': 'Ghassabian A, Albert PS, Hornig M, Yeung E, Cherkerzian $, Goldstein RB, et al.',\n",
              "  'text_sha256': 'caa6e738ffd04c13d4801816e84f7543c837469f831634ff338972c624a263f9'},\n",
              " {'text': 'Gestational cytokine concentrations and neurocognitive development at 7 years.',\n",
              "  'text_sha256': '354eda3805e44e6b948dfb366a7cbf499586dd763ba7ef7e5ad66d6176d29aa2'},\n",
              " {'text': 'Transl Psychiatry.',\n",
              "  'text_sha256': 'd8a45756c3837d10f038dafd04382668e71f9ef1e05b0c1b0f21620f416b517a'},\n",
              " {'text': '(2018) 8:64. doi: 10.1038/s41398-018-0112-z Frontiers in Psychiatry | www.frontiersin.org June 2022 | Volume 13 | Article 834910',\n",
              "  'text_sha256': '5e054f29a7ce7296cafbfd2f8b37c0fa2805e9f7122cdf410dbc9fdaf5ae6b5d'}]"
            ]
          },
          "metadata": {},
          "execution_count": 93
        }
      ]
    }
  ]
}